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Abstract
Synthetic biology is the design and implementation of novel biological devices via the
application of engineering principles to biological systems research. Mathematical
modelling is an invaluable tool in developing our understanding of biological system
dynamics and characterising small parts and circuits for the assembly of higher-level
systems.
In this thesis, mathematical modelling approaches are applied to three bio-
logical circuits of interest. A novel mechanistic model of the DNA recombination
reactions comprising a genetic switch reveals the input criteria and operational spec-
ifications required of a digital data storage module. Specific layering of the compo-
nents comprising recombinase-based genetic switches can provide cellular Boolean
logic operations. A novel mechanistic model of a two-input temporal logic gate is
able to simulate and predict in vivo dynamical responses captured by a large ex-
perimental dataset. Experimental implementation of recombinase-based circuitry is
unpredictable and can lead to lengthy development times, providing clear evidence
of the advantages of utilising mathematical models in synthetic biology.
Antibiotic resistance has become one of the most prominent challenges facing
medicine today, placing immense importance on the characterisation of new natural
products. The first detailed mathematical model of the methylenomycin A produc-
ing gene cluster in the bacterium Streptomyces coelicolor is developed through the
application of model selection to a large set of candidate system architectures.
Mathematical models presented in this thesis can be adapted and expanded
to suit many different experimental conditions and system responses, facilitating the
design of novel synthetic biological circuitry.
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Chapter 1
Introduction
1.1 Main contributions of the thesis
This thesis presents three mathematical modelling investigations relating to biolog-
ical systems that represent potentially fundamental components in the assembly of
novel synthetic circuits. Characterisation of such circuits is often an ad hoc and time
consuming process if performed through experimentation alone. Hence, synthetic
biology approaches are increasingly reliant on predictive mathematical models in
developing understanding of desirable dynamical responses. The modelling investi-
gations presented in this thesis are focused on DNA recombination and the regula-
tion of antibiotic production and are mechanistic in nature; considerable efforts are
made to account for maximal biological detail wherever possible. The content of
the thesis is delivered with the following general structure:
Chapter 2 consists of an introduction to the field of synthetic biology and
the relevant mathematical modelling techniques that facilitate the analysis of the
biological systems investigated in this thesis. The motivation behind the application
of mathematical modelling approaches in synthetic biology is discussed, highlighting
the importance of interdisciplinary communication and collaboration in the devel-
opment of the field.
Chapter 3 consists of the research relating to the characterisation of the
recombinase-based genetic toggle switch which we have come to refer to as a rewritable
recombinase addressable data (RAD) module. Although site-specific recombinases
(SSRs) are attracting increasing attention as reliable DNA manipulation tools, there
is not currently a wealth of mathematical modelling investigations concerning the
operational properties of the associated circuitry. In this chapter, we identify op-
timal switching profiles through the construction and experimental validation of a
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mechanistic model of the RAD module.
Chapter 4 presents an extension of the research presented in Chapter 3
through a mechanistic modelling investigation relating to a recombinase-based two-
input temporal logic gate. Standard logic functions have been identified through
several transcriptional and recombinase-based circuits however, temporal logic gates
are not well documented in the literature. Our mechanistic model is comprised of
multiple integration pathways taken from our validated RAD module model and
provides quantitative simulations of the available experimental data.
Chapter 5 describes the experimentation carried out to develop understand-
ing of DNA recombination and experimental data collection. The objective of these
experiments is to examine the efficiency of the integrase-excisionase-mediated exci-
sion (deletion) of a gene coding for bioluminescence in the bacterium Streptomyces
coelicolor. This work highlights a number of limitations with current experimental
protocols, which are currently still at an early stage of maturity. However, it also
provides some valuable insights into the underlying biology of recombinases, and
suggests ways in which these systems could be further developed in future studies.
Chapter 6 consists of the research relating to the identification of the most
plausible modelling architecture of the regulatory system controlling methyleno-
mycin production in the model organism Streptomyces coelicolor. Although ho-
mologous regulatory systems have been identified in numerous microorganisms, no
attempt has been made to characterise methylenomycin regulation in silico. Our
model architecture is identified through a probabilistic model selection approach
and is optimised against experimental time course data. Model simulations can also
replicate qualitative experimental observations regarding mutant bacterial strains.
Chapter 7 describes the overall conclusions arising from the research con-
ducted in this thesis and discusses the potential of future work in expanding the im-
pact of novel synthetic systems comprising the circuits investigated. We summarise
the results presented in each chapter and discuss some of the broader implications
these have on future research. We discuss the benefits of extending model reduc-
tion efforts in order to facilitate extensive mathematical analysis of our mechanistic
models in the future. A number of opportunities for further research are presented,
such as developing our temporal logic gate model in order to examine the functional
differences between distinct integrases, and the effect that altering the roles of these
integrases has on the output of the logic gate. We also outline plans for further col-
laborative work relating to mechanistic modelling and experimental implementation
of higher-level systems in mammalian cell lines.
Synthetic biology is reliant upon the shared expertise of biologists and engi-
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neers in collaborative research efforts. Effective communication of information and
ideas is fundamental to bridging the gap between these disciplines. To this end,
the introductory material in this thesis is written in a style that is intended to be
accessible to biologists encountering advanced mathematics, and to mathematicians
and engineers encountering advanced cellular biology.
1.2 Publications arising from this research
• J. Bowyer, J. Zhao, S. Rosser, S. Colloms and D. Bates. Development and ex-
perimental validation of a mechanistic model of in vitro DNA recombination.
In Proceedings of the 37th Annual International Conference of the IEEE En-
gineering in Medicine and Biology Society, Milano, Italy, August 2015, pages
945-948, doi: 10.1109/EMBC.2015.7318519. (relating to Chapter 3)
• J. Bowyer, J. Zhao, P. Subsoontorn, W. Wong, S. Rosser and D. Bates. Mech-
anistic modelling of a rewritable recombinase addressable data module. IEEE
Transactions on Biomedical Circuits and Systems, 10(6):1161-1170, December
2016, doi: 10.1109/TBCAS.2016.2526668. (relating to Chapter 3)
• J. Bowyer, V. Hsiao and D. Bates. Development and experimental validation
of a mechanistic model of a recombinase-based temporal logic gate. In Proceed-
ings of the 12th IEEE BioMedical Circuits and Systems Conference, Shanghai,
China, October 2016, pages 464-467, doi: 10.1109/BioCAS.2016.7833832. (re-
lating to Chapter 4)
• J. Bowyer, V. Hsiao, W. Wong and D. Bates. Mechanistic modelling of a
recombinase-based two-input temporal logic gate. IET Engineering Biology,
1(1):40-50, July 2017, doi: 10.1049/enb.2017.0006. (relating to Chapter 4)
• J. Bowyer, E. de los Santos, K. Styles, A. Fullwood, C. Corre and D. Bates.
Modeling the architecture of the regulatory system controlling methyleno-
mycin production in Streptomyces coelicolor. BMC Journal of Biological En-
gineering, July 2017. (relating to Chapter 6)
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Chapter 2
Mathematical Modelling in
Synthetic Biology
2.1 An introduction to synthetic biology
Synthetic biology is a highly interdisciplinary field of research with a primary focus
on the application of engineering principles to biological systems. The characterisa-
tion of small biological parts and circuits is essential in providing the building blocks
with which to assemble novel devices. In this context, biological parts are the genetic
elements that mediate the natural processes of life. Rigorous analysis of natural sys-
tems and mechanisms that have evolutionary prominence will facilitate the design
and construction of biological modules capable of potentially unlimited user-defined
outputs. From an analytical perspective, synthetic biology is fundamentally com-
prised of mathematical biology approaches to examining the dynamical behaviour
of biological systems through a mathematical framework. This premise undergoes
a natural progression towards systems biology research whereby analysis of specific
mechanistic properties is able to reveal performance criteria and other functional
insights. The motivation behind synthetic biology, and the reason why the field ex-
ists in its own right, is the idea that standardised biological parts can be assembled
to form small circuitry and larger-scale modules in a manner analogous to electri-
cal circuits and machinery. Classical engineering principles such as system design
and optimisation contribute significantly to this research effort, however, as the
name implies, synthetic biology is, first and foremost, a biology discipline. Hence,
the natural flow of genetic information exists at the core of engineering biological
systems.
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2.1.1 The central dogma of molecular biology
In order to highlight the relevance of the central dogma of molecular biology within
synthetic biology, it is necessary to review the biology of the cell. There are many
different types of cell, appearing across all domains and kingdoms of organisms, that
consist of many different types of organelle [Nicholl, 2008]. An organelle is a cellular
component that provides a specific function, akin to organs in the human body.
Despite this remarkable variety in their internal composition, all cells are united, at
least initially, by the presence of genetic material (usually DNA) that provides the
information necessary for the cell to function. The broad classification of cells relates
to the internal disposition of the DNA; in eukaryotic cells, most notably animal
and plant cells, DNA is contained within a membrane-bound nucleus whereas, in
prokaryotic cells such as bacteria, the DNA is not membrane-bound (Figure 2.1).
Additional internal structure is provided by other membranes in eukaryotic cells,
 
Eukaryotic cell Prokaryotic cell 
10 – 100µm 1 – 10µm 
Cell membrane 
Mitochondrion 
Ribosome 
Nuclear membrane 
Nucleus 
DNA 
Lysosome 
Cytoplasm 
Cytoplasm 
Ribosome 
DNA 
Cell membrane 
Cell wall 
Figure 2.1: Schematic diagram of a eukaryotic cell and a prokaryotic cell. Cell
membranes, ribosomes and DNA are common to both cells however, these two
cellular compositions are largely distinct in general; some detail is omitted here for
the sake of brevity.
which are also typically larger than prokaryotic cells [Alberts et al., 2002]. There
exist upper and lower limits on the optimal size of cells [Marshall et al., 2012] since
essential gas and nutrient exchange is mediated by diffusion, which is dependent on
the dimensions of the molecules involved in this process. It is an increase in the total
number of cells that permits the increase in the size of multicellular eukaryotes, not
an increase in individual cell size. Mitochondria, ribosomes and lysosomes are the
organelles responsible for cellular respiration, protein synthesis and waste removal
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respectively, making them vital to the maintenance of the cell.
The importance of DNA cannot be underestimated given the intrinsic rela-
tionship it shares with cellular classification and functionality. That is, the func-
tional properties of a cell are defined by its DNA, which provides the instructions
for the synthesis of proteins which, in turn, manage the processes of life. Put simply,
DNA is the blueprint of life and there are three main criteria that allow it to fulfil
such a crucial biological role [Nicholl, 2008]. Firstly, DNA must be able to produce
identical copies of itself through replication in order for genetic material to be passed
on during the growth and development of new cells. Secondly, the stability of the
molecule must be sufficiently high to maintain the regular functionality of genetic
material for many years in living organisms. Thirdly, the effects of evolutionary
pressures must be able to induce small alterations in the genetic code, referred to as
mutations, to allow organisms to survive and adapt to changes in their immediate
environments. These criteria are satisfied largely by the molecular composition of
DNA which reveals the ingenuity of complementary base pairing and, consequently,
the language of genetics.
Deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), as their names
suggest, are nucleic acids. They are comprised of monomeric components known
as nucleotides and chains of these nucleotides, called polynucleotides, give nucleic
acids their overall structure. Three smaller components comprise the nucleotides
themselves: a sugar, a phosphate group and a nitrogenous base. It is the sugar
component that defines the nucleotide, 2′-deoxyribose in DNA and ribose in RNA,
and this also determines the structural characteristics of the polynucleotide along
with the phosphate group. DNA adopts a double stranded, helical structure that
was first proposed by James Watson and Francis Crick in 1953 [Alberts et al., 2002].
The characteristics of the polynucleotide that relate to genetic information dissemi-
nation and storage are provided by the nitrogenous bases which therefore have great
importance in relation to the coding function of nucleic acids. There are four dis-
tinct nitrogenous bases in DNA, namely, adenine (A), guanine (G), cytosine (C)
and thymine (T); the thymine base is replaced by the functionally equivalent uracil
(U) in RNA. These bases form the language of genetics by virtue of a ‘dictionary’ of
combinations that code for specific amino acids. Adenine and guanine are classified
as purines, which have a double-ring chemical structure, whereas cytosine, thymine
and uracil are classified as pyrimidines, which have a single-ring chemical structure.
Base pairing is key to encoding and decoding genetic information and is strictly
conditional on one particular arrangement, that is, A paired with T (or U) and G
paired with C. The only satisfactory arrangement is a purine-pyrimidine base pair
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due to the structural limitations of the nucleic acid and the atomic composition of
the bases themselves. An A-T base pair is secured by two hydrogen bonds whereas
a G-C base pair is secured by three hydrogen bonds. The four letter alphabet of
bases (A, G, C and T) defines a language of three-letter ‘words’ that code for the
requisite molecules that drive gene expression. Genetic information is ultimately
expressed via proteins, a significant subset of which constitute the enzymes that
catalyse metabolic reactions.
All natural proteins are comprised of unique sequences of amino acids called
polypeptides, synthesised from a set of twenty distinct amino acids [Nicholl, 2008].
The genetic sequences that code for individual amino acids, known as codons, are
three bases in length. The reason for this is that if the bases were used singly to
code for individual amino acids, there would only be four possible choices and hence
a maximum of only four amino acids that could be synthesised. There still wouldn’t
be enough permutations to code for twenty amino acids if the bases were coded in
pairs, since only sixteen distinct choices are available (42 = 16 < 20). However,
triplets of bases are able to provide the sufficient permutations (43 = 64 > 20) and
these triplets form the three-letter words that code for each amino acid. Hence,
the minimum coding requirement on a DNA strand for a protein consisting of 100
amino acids would be 300 nucleotides. Utilising codons that are three bases in
length clearly provides more words in the dictionary than are actually necessary;
there are three codons that signal the termination of protein synthesis, referred to as
stop codons, and the remaining codons are accounted for by the fact that groups of
distinct codons are able to code for the same amino acid, referred to as a redundancy
in the code.
The chemical structure of RNA differs from that of DNA in the sense that it
is most commonly a single stranded molecule. There are three main classes of RNA
molecules, the most abundant of which is ribosomal RNA (rRNA), making up ap-
proximately 85% of total cellular RNA. It is the RNA component of ribosomes, which
is essential in translating the information necessary for gene expression. Transfer
RNA (tRNA) provides amino acids with the specificity required for correct inser-
tion into the polypeptide undergoing synthesis and comprises approximately 10%
of total RNA. Genetic information is transported through the nuclear membrane to
the ribosome by messenger RNA (mRNA) which usually comprises less than 5% of
total cellular RNA [Voit, 2013].
Given the immense significance of DNA and genetic dissemination across the
field of biology, the central dogma of molecular biology (Figure 2.2) intuitively con-
stitutes a basic overview of gene expression as follows: gene expression is initiated
7
0 
DNA mRNA Proteins 
transcription translation 
reverse transcription 
DNA replication 
Figure 2.2: Schematic diagram representing the central dogma of molecular biology.
Genetic material is disseminated in a unidirectional manner with the exception of
reverse transcription. Figure adapted from Nicholl [2008].
by transcription, the process in which an enzyme known as RNA polymerase con-
verts DNA into a complementary mRNA strand. The mRNA is then transported
through the nuclear membrane into the cytoplasm in order to carry out the second
stage of gene expression, translation. When the mRNA encounters a ribosome, the
ribosome translates the mRNA to form polypeptides which fold to produce active
proteins capable of performing cellular functions. The passage of genetic informa-
tion is unidirectional with the exception of reverse transcription whereby DNA is
synthesised from RNA, for example, in the event of infection of a host cell by a
retrovirus (RNA-based virus) [Nicholl, 2008].
Engineering biological systems inevitably constitutes a systematic analysis of
the processes outlined in the central dogma. In order to realise specific engineered
biological outputs it is necessary to alter this natural flow of cellular processes which,
in itself, encapsulates much of what might be regarded as the essence of synthetic
biology. A key concept that has been adopted widely across the field is that such
processes can be regarded as input-output systems comprised of a wealth of biolog-
ical machinery and components. It is important, therefore, that synthetic biologists
are able to design novel systems using standardised components (parts) that perform
as expected in the relevant biological contexts. The definition of standardisation in
a biological context is analogous to that in modern engineering and manufactur-
ing, whereby a universally recognised catalogue of components facilitates efficient
module assembly and reliable functionality. There are a number of transcriptional
elements that have already been standardised sufficiently for engineering synthetic
circuitry [Purnick and Weiss, 2009]. These include promoters, sequences that are
bound by RNA polymerase to initiate transcription; repressors, proteins that pre-
vent transcription by binding to promoters instead of RNA polymerase; termina-
tors, sequences that cause transcription to end; and ribosome binding sites (RBSs),
mRNA sequences that recruit ribosomes to initiate translation. Standardisation of
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biological parts is achieved through extensive experimentation and, in turn, well
documented functional profiles that can be disseminated and applied universally.
Standardised parts, known as BioBricks, are essential to the construction of novel
synthetic systems with respect to the compatibility required in the design process
and the ease of their physical assembly in model organisms. In this way, innovative,
user-defined functionality can be realised through circuit design analogous to that
of electronic circuits. The majority of the implementation of synthetic biological
systems is currently performed in the model bacterium Escherichia coli. Over many
years of research, E. coli has been fully characterised, and was one of the first mi-
croorganisms to have its genome sequenced, making it ideally suited to laboratory
procedures and experimentation [Alberts et al., 2002]. That said, a host of other
bacteria, yeasts and mammalian cells are also used to implement novel circuits based
on their metabolic and growth characteristics, among others. With respect to hu-
man benefits such as disease therapeutics, and other biomedical solutions arising
from the application of synthetic biological devices, implementation within eukary-
otic cells will naturally be required in order to realise the potential efficacy of such
systems.
2.1.2 An overview of recent research in synthetic biology
Synthetic biology is a relatively new field of research. The emergence of the funda-
mental concepts that have come to define the subject were first demonstrated at the
turn of the millennium through two innovative synthetic systems, the ‘repressilator’
[Elowitz and Leibler, 2000] and the ‘toggle-switch’ [Gardner et al., 2000]. These two
pioneering circuits provide clear evidence that novel functionality can be achieved
through the assembly of biological parts, capturing the essence of synthetic biology
and delivering the proof of concept that has unlocked the potential of the field.
Furthermore, these systems were both published in conjunction with mathematical
modelling investigations, illustrating the fundamental necessity within synthetic bi-
ology to exploit interdisciplinary research efforts and the predictive capabilities of
mathematical models through computational simulation.
The repressilator is designed to produce regular oscillatory behaviour using
components that are not found in any natural circadian clock, that is, a ‘body clock’
that operates on an oscillatory 24-hour period in tandem with the day-night cycle.
Three repressor proteins, LacI, TetR and CI, comprise a cyclic negative feedback
loop that exhibits temporal oscillations in the concentration of each of these protein
components (Figure 2.3A). LacI inhibits the production of TetR which, in turn,
inhibits the production of CI which then completes the cycle by inhibiting LacI
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Figure 2.3: Schematic diagram representing the first synthetic biological circuitry.
A) The repressilator gives rise to oscillatory behaviour through a mutually inhibitory
arrangement of three repressor proteins. B) The genetic toggle switch gives rise to
bistability through a mutually inhibitory arrangement of two repressible promoters.
Figure adapted from Elowitz and Leibler [2000] and Gardner et al. [2000].
production. The TetR repressor is tagged with green fluorescent protein (GFP),
with the levels of fluorescence being representative of TetR concentration in the
cell, and thus provides observable periodicity as a readout of the system state over
time. The two genetic constructs comprising the repressilator and the reporter are
built into separate plasmids and transformed into E. coli.
A simple mathematical model of transcriptional regulation was used to de-
sign the repressilator. The model consists of six coupled equations representing
the rate of change of the three repressor protein concentrations as well as their
corresponding mRNA concentrations. Model simulations demonstrate that the sys-
tem exhibits temporal oscillations in the concentrations of its three components,
in alignment with the observed experimental dynamics. Model analysis reveals a
unique steady state to which there are two possible solutions, depending on the
reactions rates comprising the model parameter set. Firstly, the solution converges
towards a stable steady state or, secondly, the steady state may become unstable
leading to the desired sustained oscillations. The behaviour of dynamical systems
is greatly influenced by the rates of the associated reactions, in this case transcrip-
tion and translation rates as well as the rate of protein and mRNA degradation.
The model assisted in identifying that oscillations are instigated by reduced tran-
scriptional leakiness and similarity in protein and mRNA degradation rates. As
a result, two alterations were made to increase the chance of the synthetic net-
work functioning in the oscillatory regime. Firstly, hybrid promoters were used to
address transcriptional efficiency and, secondly, a protein destruction marker was
used to establish comparable effective lifetimes of the repressor proteins and mRNA.
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Hence, the repressilator provides a near perfect example of the benefit of modelling
insight on the direction of experimentation and the in vivo implementation of artifi-
cial networks that might otherwise have required far greater time frames to achieve
through experimental trials. That said, the repressilator is also shown to exhibit
noisier and more variable behaviour compared to that of natural circadian clocks
and thus highlights a major challenge in synthetic biology concerning reliable and
robust deployment of novel systems in vivo [Elowitz and Leibler, 2000].
The design of the genetic toggle switch is centred on bistability, whereby
two inducible stable states form the basis of a synthetic gene-regulatory network.
A mutually inhibitory arrangement of repressible promoters gives rise to the bista-
bility that characterises the system, effectively providing an ‘on’ or ‘off’ switch-like
response. Theoretically, this design could facilitate the expression of any gene of
interest. The toggle switch is composed of two constitutive promoters (P1 and P2)
each of which is positioned upstream of two repressors (R1 and R2) (Figure 2.3B).
In the absence of induction, each promoter is able to transcribe the repressor corre-
sponding to the opposite promoter however, transcription of the two repressors will
cause inhibition of the corresponding promoters and nullify the output of the system.
Induction of R1 will cause repression of P1 and will therefore nullify transcription
of R2 which allows P2 to perform unrestricted transcription, thus establishing one
of the two stable gene expression states. The second state is realised in a similar
manner through induction of R2. A reporter gene gfpmut3 is positioned downstream
of P2, tagging this state with GFP in order to clearly monitor the readout of the
system as a function of fluorescence intensity. Induction of R1 therefore results in
the expression of GFP, termed the high state, and induction of R2 which inhibits
GFP expression, i.e. no output, is termed the low state. Transient repressor in-
duction is achieved chemically or thermally, giving the user temporal control of the
output of the toggle switch without the need for continuous induction. As with
the repressilator, the genetic constructs of the toggle switch are plasmid-based and
transformed into E. coli.
The simple mathematical model of the toggle switch consists of two equa-
tions describing the rate of change in concentration of the two repressors and is
parameterised in accordance with their cooperativity and rates of synthesis, two
properties believed to be fundamental to the network. Cooperativity refers to the
effect of ligand binding on the affinity of subsequent ligand binding at other sites on
the same molecule, be it positive or negative. The model reveals the conditions nec-
essary for bistability: balanced promoter strengths give rise to the one unstable and
two stable steady states that provide the two basins of attraction required for the
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desired bistability, whereas unbalanced promoter strengths produce just one stable
steady state. The size of the bistable region is directly proportional to the magni-
tude of the cooperativity of repression. The toggle switch is designed to incorporate
the fewest genes and regulatory elements possible in facilitating robust bistable be-
haviour. That is, the inherent variability of gene expression has a negligible effect
on the two states, thus minimising the chance of random switching events, and the
criteria for bistability comprise a relatively large portion of the parameter space,
not limited to a small subset [Gardner et al., 2000].
To reiterate, as with the repressilator, the approach to engineering a genetic
toggle switch is driven primarily by the manipulation of the network architecture
which represents a substantial deviation from conventional genetic engineering prac-
tices that typically achieve desired outputs via the restructuring of the relevant
regulatory elements themselves. The toggle switch again captures the essence of
synthetic biology by demonstrating qualitative agreement between mathematical
modelling and experimental observations. As an inducible gene regulatory circuit,
the toggle switch forms a cellular memory unit which has an array of potential
applications in biotechnology, biocomputing and gene therapy.
The repressilator and the toggle switch initiated what has become known
as the first wave of synthetic biology [Purnick and Weiss, 2009]. This initial phase
focused primarily on parts characterisation in order to accumulate a wide-ranging
selection of BioBricks with which to engineer such novel systems. As a result, a
number of small circuits were published, some being oscillators [Atkinson et al.,
2003; Goh et al., 2008; Stricker et al., 2008; Swinburne et al., 2008; Tigges et al.,
2009] and switches [Kramer et al., 2004b; Atkinson et al., 2003; Ham et al., 2008]
akin to the aforementioned pioneering studies as well as other innovative designs
including pulse generators [Basu et al., 2005] and logic circuits [Win and Smolke,
2008; Rinaudo et al., 2007]. The first signs of extending research beyond simple gene
regulatory networks are identified even during this early period with the advent of
cell-cell communication circuits [You et al., 2004] and post-translational regulation
[Park et al., 2003]. Difficulties arose regarding ad hoc approaches to circuit as-
sembly and optimisation which resulted in time consuming, laborious iterations of
experimentation to establish desired functionality. Hence, it became apparent that
further progress would be dependent on large-scale standardisation, reiterating the
importance of extensive parts characterisation.
By 2003, the international genetically engineered machine (iGEM) founda-
tion was established [Cameron et al., 2014]. This independent, non-profit organisa-
tion promotes the advancement of synthetic biology and the development of a collab-
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orative, interdisciplinary community. One of the main programs of the foundation
is the annual iGEM competition, the first of which was held at the Massachusetts
Institute of Technology (MIT) in 2004 and hosted five teams from American univer-
sities. Today, approximately 300 teams from more than 30 countries compete. The
competition gives students of multiple disciplines the opportunity to design novel
synthetic circuits using the catalogue of BioBricks currently available. These parts
comprise one of the foundation’s other main programs, the Registry of Standard
Biological Parts (RSBP). The registry currently consists of over 20, 000 compatible
BioBricks that provide an open source of parts during competition and for synthetic
biology research across the community. New synthetic circuitry and BioBricks es-
tablished by iGEM teams and other labs are added to the registry in order to expand
the scope of the registry and field alike. The first international meeting on synthetic
biology (SB1.0) was also held at MIT in 2003. This provided the platform for bi-
ologists, chemists, physicists, engineers, computer scientists and mathematicians to
lay the foundations of a collective vision [Cameron et al., 2014].
As synthetic biology continued to gain momentum, a host of other break-
through systems emerged [Cameron et al., 2014]. Quorum sensing, the popula-
tion density-dependent response of a system, was engineered in E. coli in order
to facilitate multicellular patterning [Basu et al., 2005; You et al., 2004]. Post-
transcriptional and post-translational regulation was developed through RNA-based
circuitry [Isaacs et al., 2003; Bayer and Smolke, 2005]. Specific Boolean logic opera-
tions such as AND gates were realised in vivo via engineering the tRNA required for
translation [Anderson et al., 2006] and also in other studies through orthogonal ribo-
somes [Rackham and Chin, 2005]. The most notable breakthrough of this period is
arguably the synthetic production of precursors to artemisinin, an antimalarial drug
produced naturally by the plant Artemisia annua, in the yeast Saccharomyces cere-
visiae [Martin et al., 2003; Ro et al., 2006]. This progress has significantly improved
our quantitative understanding of biological systems, with respect to the character-
isation and availability of circuits and modules, and has revealed the engineering
principles required of a proficient design strategy.
The current transition into the second wave of synthetic biology promises to
prioritise the development of systems-level circuitry through the assembly of char-
acterised modules [Purnick and Weiss, 2009]. It is here that many of the challenges
and potential pitfalls faced by the community will have the greatest effect. For
example, issues relating to standardisation will continue to resurface as synthetic
biologists look to develop the modularity of devices across a multitude of cellular
and environmental contexts. Intercellular, intracellular and extracellular properties
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all present a daunting task concerning compatibility, particularly as the complex-
ity of synthetic systems increases. Noise is another potentially problematic factor
that directly affects the reliability and predictability of systems. Understanding
noise and developing new methods for overcoming the associated ramifications will
represent major progress towards realising expected system dynamics [Purnick and
Weiss, 2009]. Epigenetics, the change in heritable information that occurs at a tran-
scriptional level in response to environmental factors, without any alteration to the
nucleotide sequence itself, also raises issues when considering how an engineered
module might be suitably reset following an epigenetic event that compromises its
desired functionality [Zheng et al., 2008].
The fundamental distinction between biological and physical systems regard-
ing noise and other internal and external perturbations implies that it is entirely
feasible that the methods required to realise the true potential of synthetic biology
will inevitably be equally distinctive [Church et al., 2014]. Well established engineer-
ing principles have contributed to the status quo, however, their adequacy will no
doubt be severely scrutinised as we confront the most complex and ground-breaking
applications in synthetic biology. As a result, the standardisation and develop-
ment of the methodologies required to engineer next-generation synthetic biological
systems may need to take equal standing with device characterisation and modu-
larity as the top priorities in the field. Indeed, biology may require its own specific
branch of engineering altogether; concerns regarding module compatibility might
only be solved by switching the focus of engineering away from individual circuits
and towards the environments that pose the greatest threat to reliable deployment.
A synthetic cell organelle capable of overseeing highly modular system operations
across all cells and organisms could therefore be a defining goal for the field.
This being said, the number of novel circuits being published continues to
rise in light of concerted efforts to overcome the aforementioned challenges [Cameron
et al., 2014]. Further work on the antimalarial drug artemisinin has lead to in-
creased efficiency of its commercial production through a redeveloped artemisinic
acid biosynthetic pathway [Paddon et al., 2013]. Biofuel production in E. coli has
been made possible by adapting the cell’s natural amino acid biosynthetic pathway
for alcohol synthesis [Atsumi et al., 2008]. An alternative approach to biofuel syn-
thesis employs a dynamic sensor-regulator system (DSRS) to regulate biodiesel ex-
pression via control of a transcription factor, that is, a protein that controls the rate
of transcription of mRNA from DNA by binding to specific DNA sequences [Zhang
et al., 2012]. A host of other engineered microbial devices have also emerged; syn-
thetic quorum sensing circuitry has enabled E. coli to detect tumour microenviron-
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ments and respond by invading cancer cells [Anderson et al., 2006], edge-detection
circuitry can perform computations of light images [Tabor et al., 2009] and bacterio-
phage (bacteria-infecting viruses) have been reprogrammed to target and degrade
bacterial biofilms that are prominent in the development of diseases and exhibit
antimicrobial resistance [Lu and Collins, 2007]. The scope of RNA-based devices
has also expanded, with microbial kill switches that demonstrate improved leakage
minimisation and modularity [Callura et al., 2010], and logic circuits that are capa-
ble of performing multiple Boolean operations governing the computation of gene
expression and, in turn, cell function [Win and Smolke, 2008].
Although the range of new circuitry and their applications is highly diverse,
the majority of existing systems are reliant, at least in part, on the detection and/or
storage of information in eliciting an engineered response [Alon, 2006]. The storage
of information, in particular, is crucial to the maintenance of reliable functionality
and highlights the general importance of cellular memory. If bistability is exhibited
by a transcriptional response, then an ‘on’ or ‘off’ genetic state is produced. The
inheritance of this state, through DNA replication and cell division, provides a
lasting memory of the response [Burrill and Silver, 2010]. The study of natural
biological memory began over 50 years ago when French biologists Franc¸ois Jacob
and Jacques Monod proposed a qualitative description of the link between cellular
memory and transcriptional regulation [Burrill and Silver, 2010]. Their experimental
work on the activation and repression of enzymatic lactose metabolism in E. coli
that became the ‘operon model’ won them the 1965 Nobel Prize in Physiology
or Medicine with their colleague Andre´ Lwoff [Morange, 2010]. This conceptual
breakthrough transformed perceptions regarding how the array of distinct tissues
arising in multicellular organisms express different sets of genes, despite the fact
that all cells contain the same heritable genetic material [Morange, 2013].
The lac operon has since become the foremost example of microbial gene
regulation, by virtue of the research of Jacob, Monod and Lwoff, enabling E. coli to
metabolise lactose in the absence of its primary carbon source, glucose. In response
to the availability of environmental resources, E. coli switches to expression of the lac
operon genes which produces β-galactosidase, an enzyme capable of breaking down
lactose into glucose and galactose [Morange, 2013]. Memory has been identified
in many other natural environments: the bacteriophage λ is known to adopt two
distinct life cycles on infection of a host bacterium, namely, a lysogenic state which
allows the phage to live dormant within the host or a lytic state in which the
host is destroyed and the viral progeny released [Ptashne, 2004]. As an example of
cellular memory, eliciting a lasting response to a transient stimulus, λ is particularly
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efficient: the lysogenic phage can remain dormant indefinitely until induction causes
lytic growth across the entire population [Ptashne, 2006]. The immune and nervous
systems also have the capacity for the retention of large quantities of information in
order to remember, and act upon, new and old unfamiliar antigens or to manage the
trillions of synaptic transmission events that occur in the brain [Burrill and Silver,
2010]. These systems present a clear motivation for engineering synthetic circuits
that possess memory capable of storing information in the form of genetic states
and highly stable maintenance of dynamical responses.
Synthetic transcriptional memory circuits that apply the core principles in-
troduced by the toggle switch have demonstrated novel functionality within bacteria
[Kobayashi et al., 2004] and other cellular contexts such as yeast [Becskei et al., 2001;
Ajo-Franklin et al., 2007] and mammalian cells [Tigges et al., 2009; Kramer et al.,
2003, 2004b]. Engineered E. coli can retain memory of DNA damage, demonstrating
everlasting phenotypic changes [Kobayashi et al., 2004]. A genetic switch has been
constructed in S. cerevisiae, providing an autocatalytic bistable cellular response in
the presence of continuous stimulation [Becskei et al., 2001] and bistability in yeast is
also demonstrated through positive feedback [Ajo-Franklin et al., 2007]. The toggle
switch presented in Chinese hamster ovary (CHO) cells [Tigges et al., 2009] is based
largely on its bacterial counterpart [Kobayashi et al., 2004] and realises the potential
for epigenetic transgene control in mammals. Such genetic switches, capable of pro-
ducing and sustaining two or more distinct genetic states upon transient induction,
demonstrate behaviour analogous to that of transistors in electronic circuitry and
thus have considerable potential in engineering cellular memory.
Transient operation of memory devices is an important criterion since con-
tinuous exposure to the relevant inducer is likely to be undesirable, especially in the
realm of drug-inducible systems. A pioneering synthetic event-counter [Friedland
et al., 2009] demonstrates how E. coli can be programmed to count up to three
induction events through two distinct toggle switch circuit designs. The first de-
sign, termed the riboregulated transcriptional cascade (RTC), utilises a chain of
transcriptional elements to record the expression of specific proteins in response to
pulses of arabinose. The second design, termed the DNA invertase cascade (DIC),
utilises proteins capable of specific binding to DNA recognition sites resulting in the
subsequent rearrangement of intermediate genetic sequences, a process called DNA
recombination, which provide inducible gene expression that is hard-wired into the
cellular DNA. Both approaches are viable for engineering cellular memory [Fried-
land et al., 2009] and thus present synthetic biologists with two effective modules for
incorporating memory into higher-level systems. For example, engineering human
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immune cells could dramatically improve the efficacy of cancer therapies. T cells
are a type of human immune cell or lymphocyte that are responsible for immune
responses to tumour development. However, tumour cells have become increasingly
adept at evading immune responses, and thus adoptive immunotherapy treatments
are in development to amplify the efficacy of T cell responses. Current strategies
involve removing T cells from the blood of a patient then making the appropri-
ate genetic modifications to target the specific tumour microenvironment, before
finally reintroducing the cells into the patient [Kershaw et al., 2013]. However, off-
target effects of the engineered T cells have led to clinical toxicities and while safety
‘kill’ switches can nullify such problems, this also terminates the therapy. Synthetic
memory-based circuitry is capable of introducing sophisticated ‘pause’ switch dy-
namics, facilitating inducible, temporal control of the engineered immune response.
Characterising the cellular profile of populations of cancer cells and engineering an
immune response to such phenomena would inhibit the development of cancerous
tumours and other diseases that proliferate in a similar fashion [Burrill and Silver,
2010].
2.2 An introduction to mathematical modelling
A key tool in synthetic biology is mathematical modelling. By building a mathe-
matical model of a system of interest, it is easier to develop an understanding of the
relevant biology, and it is also relatively quick and simple to examine certain aspects
of the system through model development. The efficacy of mathematical modelling
is, however, directly proportional to the accuracy with which the biological system
in question can be represented mathematically.
In the majority of cases, it is sufficient to model biological systems using
ordinary differential equations (ODEs) since most systems consist of molecular re-
actions to which the law of mass action can be applied. This approach can capture
the dynamics of a system over time with sufficient accuracy, but it does have lim-
itations. Being entirely deterministic, ODEs fail to represent spatial components
and do not account for any degree of stochasticity. When spatio-temporal detail is
required from a model, solutions can be found using partial differential equations
(PDEs). PDEs capture not just dynamic trends but also allow analysis of vari-
ables with respect to changes in their location. However, this added detail requires
significant mathematical investment which may render the analysis unjustifiably
complex. An alternative to PDEs is agent-based modelling (ABM) which is also
capable of accounting for spacial properties by analysing the system components as
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their populations develop and simulating the interactions that arise within a virtual
environment. Accounting for stochasticity can be crucial in gaining an accurate rep-
resentation of a system and may require approaches such as stochastic differential
equations (SDEs) or hybrid systems. Modelling challenges for synthetic biologists
usually involve finding the most accurate mathematical representation of the given
biological system and deciding on a modelling strategy that presents good value for
mathematical investment [Voit, 2013].
The output of a mathematical model is dependent on the associated model
parameters which, in the case of biological systems, often represent the rates of
the associated molecular reactions. Tuning sets of parameter values governing a
mathematical model will vary its outputs in ways that can align simulations to real
world observations [Arpino et al., 2013]. Such observations often take the form of
experimental data and a wide variety of analytical tools are available to ascertain the
strength of the model in replicating a desired output. Model development is therefore
an iterative process that tests adaptations made to a model in light of apparent
discrepancies and continues until a number of conditions, including optimisation
and biological plausibility, are met [Klipp et al., 2005].
2.2.1 Mathematical models in synthetic biology
Although biological experimentation will always provide the keenest insight into
system dynamics, if performed correctly, characterisation of the relevant circuitry
is ideally suited to mathematical modelling approaches. As an additional tool in
the analysis of system dynamics, mathematical models can achieve highly accurate
simulations and predictions of biological systems. The statistician George Box said
that “All models are wrong but some are useful”, a sentiment that has been adopted
widely in academic communities to encapsulate the status quo. At face value, this
may appear to be a pessimistic outlook however it is the subset of useful models
that have the potential to elucidate systems in biology, as well as numerous other
research fields. It must be accepted that all models are wrong simply because the
systems that they are designed to simulate are almost always so complex that it is
impossible to account for all of the associated variables. Attempting to construct an
exact model that simulates a given system perfectly is therefore futile; after all, by
definition, a model is a representation and does not claim to be anything more than
that. That said, significant qualitative, and often quantitative, system dynamics
can be captured by mathematical models of varying complexity, making them very
useful in synthetic biology.
Fundamentally, mathematics offers a highly rigorous framework with which
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to model and analyse natural systems. For centuries mathematics has been viewed
as the language of nature, forming the basis of multiple fundamental principles
across the sciences. Applied mathematics, in particular, facilitated the development
of calculus in response to progressive ideas in physics and has subsequently led
to the establishment of many, if not all, of the mathematical branches comprising
classical engineering disciplines. With regards to biology, mathematical applications
have established numerous subject areas that constitute the field of mathematical
biology in its own right. For example, exponential and logistic growth functions
are intrinsic to the study of standard population dynamics and can simulate the
behaviour of more intricate systems such as the oscillations observed in predator-
prey populations. Analysis of infectious disease epidemics is also fundamentally
based on an array of mathematical modelling approaches which ultimately enables
health authorities to intervene effectively; selection of the most suitable approach
is dependent upon the assumptions made with regard to the specific context of the
problem at hand.
Mathematics is also fundamental to systems biology, facilitating the analy-
sis of dynamical systems relating to gene regulation and many other intercellular
and intracellular processes including cell-cell signalling and chemotaxis. Systems
biology constitutes a large part of synthetic biology since dynamical systems anal-
ysis is entirely relevant and crucial to the research effort, with the added emphasis
on novel circuit design setting synthetic biology apart. Mathematical frameworks
offer an ideal platform for the generation of computer code in an age of ongoing ex-
pansion in computing power. Programming software has become prevalent in both
academia and industry due to its speed and reliability. The language of computing
was borne out of mathematics and subsequently presents the ideal environment for
the deployment and development of numerical tasks. For example, numerical anal-
ysis provides an array of algorithmic methods that facilitate the computer-aided
calculation of model outputs.
One of the main benefits of mathematical modelling in synthetic biology is
the relatively short time frames required to produce simulations and other outputs
of interest. Whilst experimentation provides the most trusted evidence of dynam-
ical behaviour, procedures necessarily require long time frames for completion and
are invariably subject to human error. Even experiments that are performed suc-
cessfully are influenced by inherent noise that can skew results and hence collating
good data is time consuming, especially with the additional requirement that exper-
iments be repeated multiple times to prevent the propagation of anomalous results.
The in silico simulations that models provide can be thought of as computational
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experiments that are performed on the order of seconds. Therefore, practical experi-
mentation can be directed by computational results and thus development times are
greatly reduced through an optimised allocation of resources. Furthermore, certain
aspects of system dynamics are particularly difficult to ascertain due to the limita-
tions of current experimental procedures, but a useful model has the potential to
give insights into any such aspect. This means that not only is the standard practice
of experimental observation and measurement providing the necessary benchmarks
with which to align model performance widely accepted, but also that the contrary is
valid; model simulations and predictions are able to reveal any number of significant
mechanistic properties that might require further experimental verification.
Of course, mathematical models are highly rigorous representations of their
associated natural systems as long as they are derived correctly and are well in-
formed. Model derivation typically utilises the law of mass action, a long standing
method that translates the rate of change of the physical quantity of a particular
entity into a mathematical framework. Models constructed in this way are referred
to as deterministic and are commonplace in the literature [Elowitz and Leibler,
2000; Gardner et al., 2000; Tindall et al., 2012; Bonnet et al., 2012; Hancock et al.,
2015] however, many other derivation techniques are valid in the appropriate con-
text and can provide equally insightful results. The reaction networks that inform
model derivation are formulated based on biological knowledge and hence the qual-
ity of a model is directly proportional to the quality of the information available
in biological literature. A validated mathematical model that exhibits useful, user-
defined outputs can be adapted to emulate any number of experimental conditions
and can be disseminated easily without loss of information. Model validation is
largely dependent on, but not limited to, the analysis of the fitness of simulations
compared to experimental observations. Hence, the collection and dissemination of
well established experimental data is vital in predictive modelling efforts and illus-
trates further the importance of the interdisciplinary nature of the synthetic biology
community.
2.2.2 The trade-off between mechanistic and black box modelling
approaches
Selection of a modelling strategy is dependent upon the nature of the associated
biological system and the desired output, and there exists numerous mathemat-
ical frameworks that facilitate a wide variety of model analysis techniques [Voit,
2013]. Arguably, the more important choice relates to the degree of accuracy re-
quired from the model. The trade-off between simplicity and accuracy is at the core
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off all modelling investigations and useful results are unlikely to be obtained with-
out establishing an effective compromise. Generally, accounting for minimal detail
decreases mathematical investment whereas increased complexity requires greater
investment. The former case is often referred to as black box modelling; black box
models are typically over-simplified in order to provide generic, qualitative outputs
and are so named due to their lack of mechanistic detail which boils down to a
case of input-output with little knowledge or clarity regarding the relevant system
structure. The latter case is often referred to mechanistic modelling; mechanistic
models account for specific biological mechanisms and other structural details with
a view to providing quantitative, physically valid outputs. Note that a spectrum of
mechanistic complexity exists which places black box models at one extreme and
white box models (white box models will be referred to as mechanistic models for
the purposes of this work) at the other extreme with grey box models referring to
any intermediate modelling approach that contains a mixture of elements.
The distinction between black box and mechanistic modelling can be illus-
trated by considering the enzyme-substrate interaction model that forms the basis
of Michaelis-Menten enzyme kinetics:
E + S
k1−−⇀↽−
k−1
C
k2−→ E + P, (2.1)
where E is the enzyme, S is the substrate, C is the enzyme-substrate complex formed
in the reaction and P is the product formed by the reaction; k1 and k−1 represent the
forward and backward reaction rates of the reversible complex formation respectively
and k2 represents the reaction rate of the irreversible product formation. In a
black box modelling approach, we over-simplify these interactions by neglecting the
formation of the enzyme-substrate complex and, instead, consider a single reaction
that results in product formation via enzyme-substrate binding:
E + S
k3−→ P, (2.2)
where k3 represents the reaction rate of the irreversible product formation and en-
capsulates all three reaction rates from (2.1). The interactions denoted by (2.2) and
(2.1) can therefore inform the derivation of black box and mechanistic models of
enzyme kinetics respectively. The black box model exhibits the same dynamics for
both the enzyme and the substrate as their concentrations decrease towards zero over
time; the product is shown to increase in concentration as expected (Figure 2.4A).
In contrast, the mechanistic model includes the added dynamics of the enzyme-
substrate complex and exhibits subtly different outputs overall (Figure 2.4B). The
21
 A B 
Figure 2.4: Comparison of black box and mechanistic enzyme kinetics model out-
puts. A) The black box model accounts for product, P , formation by virtue of
enzyme, E, and substrate, S, binding interactions. B) The mechanistic model ac-
counts for additional detail regarding the formation of the intermediate complex,
C. All parameters and initial concentrations of enzyme and substrate used in sim-
ulations set equal to 1; initial concentrations of complex and product set equal to
0.
enzyme dynamics in particular are significantly different since the black box model
does not account for enzyme dissociation from the complex. Although the substrate
and product dynamics are qualitatively similar for both models, there are clear
distinctions that highlight the consequences of over-simplification.
Comparisons of the black box and mechanistic models demonstrate the un-
derlying system dynamics that can be overlooked through generalisation. This ex-
ample is, however, particularly simplistic even in the case of our mechanistic model
considering the intricacy that can potentially arise in biological systems. The mech-
anistic model consists of one more biological entity and two more reaction rates than
the black box model which presents a negligible increase in mathematical investment.
Numerous mathematical modelling techniques are required to produce the simula-
tions in Figure 2.4, the details of which are given in the following sections. Note that
these simulations require information regarding the parameter values corresponding
to the associated reaction rates as well as the initial concentrations of the associated
biological entities. The parameter values, k1, k−1, k2 and k3 in this example are
all arbitrarily set equal to 1 for comparable simulations. The initial conditions are
selected given the context of the problem; only the enzyme and substrate are present
at time zero and are therefore given arbitrary initial concentrations of 1 whereas the
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complex and product are formed over time and are not present initially, resulting in
initial concentrations of 0.
It is mechanistic modelling approaches that are adopted throughout this the-
sis in order to construct the most structurally detailed biological models possible
that can be validated quantitatively, and thus provide physically valid outputs. The
systems-level understanding and experimental data available to us is particularly
well founded by virtue of multiple collaborative efforts and extensive literature min-
ing. Despite the substantial increase in mathematical investment presented by the
large, complex models that we aim to produce, we are confident that rigorous math-
ematical analysis poses a manageable obstacle, the cost of which is outweighed by
the insight gained from our results.
2.3 Mathematical modelling techniques
2.3.1 Ordinary differential equations and initial value problems
Mathematical models of physical systems require the appropriate mathematical
framework for describing specific processes and interactions. For example, if two
variables, x and y, are directly proportional to each other we write,
y ∝ x. (2.3)
This describes the relationship whereby an increase/decrease in the variable x results
in an increase/decrease in the variable y and vice versa. There is, however, a lack
of information regarding the magnitude of the increase in y for a given increase in
x. We therefore transform (2.3) into the following mathematical equation,
y = kx, (2.4)
where k is a constant, known as the coefficient of proportionality, and hence the
ratio of x and y is equal to this constant value,
k =
y
x
, (2.5)
for all non-zero values of x and y. Figure 2.5 illustrates how the relationship between
x and y is influenced by k. When k = 1, y = x and thus y bisects the positive
quadrant of the axes through the origin. When the value of k is increased i.e. k = 5,
the magnitude of y is increased fivefold for every x value thus producing a steeper
line. When the value of k is decreased i.e. k = 0.2, the magnitude of y is decreased
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 Figure 2.5: Comparisons of varied k values in the linear function y = kx. The
gradient of the line increases for larger values of k and decreases for smaller values
of k.
fivefold for every x value thus producing a line with decreased steepness. This direct
proportionality is exhibited by the relationship between the diameter of a circle and
its circumference, that is,
C = pid, (2.6)
where C and d denote the circumference and diameter of a circle respectively and the
coefficient of proportionality is equal to the irrational constant pi. Proportionality
gives rise to simple linear relationships such as (2.6) however, the same principles
can also be applied to more intricate and complex relationships. Mathematical
models are often formulated in light of information regarding the rate of change in
the relevant variables over time. In order to describe the rate of change over time
mathematically for a given variable y, we take the derivative with respect to time,
t,
dy
dt
, (2.7)
where dy and dt denote the change in y and the change in t respectively. Using this
framework, we are able to construct mathematical models of systems in which the
rate of change in the output variable of interest is proportional to the variable itself.
For example, consider a population growth model whereby the rate of change of the
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population at any given time is directly proportional to that population,
dP
dt
∝ P, (2.8)
where P and t denote population and time respectively. The variable P on the right
hand side is positive, indicating population increase or growth; negative terms are
used to model the behaviour of negative growth or decay in such systems. This
relationship is transformed into a mathematical equation in the same way as (2.3),
that is,
dP
dt
= kP, (2.9)
where the constant k is a newly derived coefficient of proportionality. Both P and
its derivative, or differential, appear in (2.9) and hence we refer to this equation as
an ordinary differential equation (ODE). In order to determine the function that
describes the growth of this population over time, we must solve this ODE and
therefore obtain a function for P only. Solving ODEs can involve many different
calculus-based methods and techniques depending on the nature of the given equa-
tion. This particular case is sufficiently straightforward to employ the method of
separation of variables as follows:
dP
dt
= kP,
=⇒ 1
P
dP = k dt,
=⇒
∫
1
P
dP =
∫
k dt,
=⇒ lnP = kt+ c,
=⇒ P = exp(kt+ c),
=⇒ P = exp(kt) exp(c),
∴ P = A exp(kt),
where c is the constant of integration and A = exp(c) is also constant. Assuming that
we have sufficient knowledge of the system, we can make an appropriate estimate
for the value of the constant parameter k. Taking k = 0.5 we have,
P = A exp(0.5t). (2.10)
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At this stage, (2.10) is a general solution to the ODE by virtue of the fact that,
although we have determined the function that describes the evolution of the popu-
lation over time, the function can exhibit an infinite number of solutions dependent
on the value of the constant A. In order to determine the exact solution to the
ODE, we require additional information regarding the size of the population at a
given time point. This is known as an initial condition since the information is given
for the case when time is zero and consequently, together with the original ODE
(2.9), describes an initial value problem (IVP). In this example, consider the initial
condition that the population is equal to ten when time is zero, P = 10 at t = 0,
then,
10 = A exp(0),
=⇒ A = 10,
∴ P = 10 exp(0.5t). (2.11)
The function (2.11) is the exact solution to the IVP, exhibiting a single trajectory
describing the growth of the population (Figure 2.6). The function can be used
 
Figure 2.6: Exact solution to the IVP described by (2.9) and the initial condition
P = 10 at t = 0 (P (0) = 10). The dashed arrows depict the graphical prediction of
the population size at t = 4.
to predict the size of the population at future time points by simply evaluating the
function at the time point of interest. For example, if we want to know the projected
population at four time points after population growth was initiated, we determine
26
P at t = 4,
P = 10 exp(0.5× 4),
=⇒ P = 10 exp(2),
∴ P = 73.9. (1 d.p.)
Similarly, if we want the time taken for the population to reach a particular size then
we can substitute the desired population size into (2.11) and solve for t instead. Note
that the choice of the constant parameter k in (2.10) was made assuming sufficient
knowledge of the system. However, in practice, it is common that the relevant
model parameters are not well established. This has implications regarding the
interpretation and plausibility of solutions to IVPs that will be covered in further
detail in the remainder of this chapter.
2.3.2 The law of mass action
The application of mass action kinetics to systems of biological reactions is funda-
mental to the construction of deterministic mathematical models. The law states
that the rate of a chemical reaction is directly proportional to the product of the
reactants. This facilitates the derivation of a system of ODEs from the relevant sys-
tem of biochemical equations representing the dynamical interactions of a biological
reaction network. Each ODE in the model describes the dynamical evolution of the
corresponding biological entity with respect to time. For example, consider a basic
biological process in which A reacts with B to form C at a rate k:
A+B
k−→ C, (2.12)
where A, B and C represent three distinct biological entities. Application of the law
of mass action enables us to derive the rate of change in molecular concentration for
each of these entities; molecular concentration being the standard dimensionality in
mathematical modelling efforts. Firstly, the rate of change in concentration of A is
proportional to the product of A and B and is also negative since A is depleted in
the reaction:
d[A]
dt
= −k[A][B], (2.13)
where the reaction rate k equates to the coefficient of proportionality and the square
bracket notation is used to denote concentration. Secondly, B plays an equivalent
role in the reaction to A and therefore we derive an equivalent ODE for the rate of
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change in concentration of B:
d[B]
dt
= −k[A][B]. (2.14)
Thirdly, the rate of change in concentration of C is proportional to the product of
A and B, but is positive since C is accumulated in the reaction:
d[C]
dt
= k[A][B]. (2.15)
Having derived the full mathematical model for this basic biological reaction, we
have identified the reaction rate k as the sole model parameter. The magnitude
of this parameter will determine the dynamical responses of the three dependent
variables (biological entities). Since this model encompasses just one reaction it is
no surprise that the same term appears in each model ODE, albeit with varying
sign. In general, biological networks of interest consist of many different molecular
interactions that translate to ODEs with many different terms, the extent to which
is directly influential in selecting methods of ascertaining the appropriate solutions.
2.3.3 Explicit and numerical solutions to initial value problems
Simulating biological system dynamics in silico involves solving the associated model
ODEs. The previous example model (2.13)-(2.15) is sufficiently simple to solve
explicitly via calculus, subject to the appropriate initial conditions. At the start of
the reaction, the reactants A and B are present whereas C is yet to be produced
and hence we define the following initial conditions, dropping the square bracket
notation for convenience:
at t = 0 : A = A0 > 0, B = B0 > 0, C = C0 = 0, (2.16)
where A0, B0 and C0 are constants representing the initial concentrations of A,
B and C respectively. Subtracting (2.14) from (2.13) enables the derivation of a
conservation relation on A and B (we assume that all matter is conserved within
the system, with the specific quantities described by the initial concentrations):
dA
dt
− dB
dt
= −kAB − (−kAB) = 0,
=⇒
∫
dA
dt
− dB
dt
dt =
∫
0 dt,
=⇒ A−B = c,
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=⇒ c = A0 −B0, (at t = 0)
∴ A−B = A0 −B0, (2.17)
where c is the constant of integration and t is the independent time variable. The
conservation relation (2.17) takes two forms dependent on the nature of the initial
concentrations of the reactants i.e.A = B, (A0 = B0)A = B +A0 −B0. (A0 6= B0) (2.18)
In the case where the two initial concentrations are equal, (2.13) becomes:
dA
dt
= −kA2,
and hence,
1
A2
dA = −k dt,
=⇒
∫
1
A2
dA =
∫
−k dt,
=⇒ − 1
A
= −kt+ c,
=⇒ c = − 1
A0
, (at t = 0)
=⇒ − 1
A
= −kt− 1
A0
,
∴ A = 1
kt+ 1A0
. (2.19)
Substituting (2.19) into (2.15) gives
dC
dt
=
k
(kt+ 1A0 )
2
,
=⇒
∫
dC =
∫
k
(kt+ 1A0 )
2
dt,
=⇒ C = − 1
(kt+ 1A0 )
+ c,
=⇒ c = C0 + 1
(0 + 1A0 )
= A0, (at t = 0)
∴ C = A0 − 1
(kt+ 1A0 )
.
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Solving the system for the case where the two initial concentrations of the reactants
are not equal in a similar manner provides the full explicit solution for C:
C = A0 − 1kt+ 1
A0
, (A0 = B0)
C = exp((B0−A0)kt)−11
A0
exp((B0−A0)kt)− 1B0
. (A0 6= B0)
(2.20)
Generally, mathematical models of large and complex biological systems rarely ex-
hibit explicit solutions since the integration step of the necessary calculations is
often intractable using standard calculus. In these cases, numerical programming
software such as MATLAB is used to compute model outputs. Such software em-
ploys an array of numerical methods in order to obtain accurate approximations to
integrals that give rise to the relevant solution trajectories. An integral is defined
as the area under the curve described by a given function, bounded by an interval
in the domain of the function. A standard approach to approximating integrals is
the trapezium rule which calculates the area of one or more trapeziums of similar
dimensions to the bounded area under the curve. The area of a trapezium is given
by,
A = h
(
a+ b
2
)
(2.21)
where a and b are the lengths of the two parallel sides of the trapezium and h is the
height, the distance between these two sides (Figure 2.7A). Hence, for a function
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Figure 2.7: The trapezium rule. A) Diagram of a standard trapezium and the
necessary labelled dimensions required to calculate its area. B) Graph depicting
the approximation of an integral of the function f(x) using the trapezium rule with
one trapezium (n = 1). C) Graph depicting the approximation of an integral of the
function f(x) using the trapezium rule with three trapeziums (n = 3). Functions
and trapezium edges are plotted using blue and orange lines respectively.
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f(x), the integral of f(x) in an interval of its domain [a, b] can be approximated by
the area of the trapezium described by the length of the interval, b−a, the function
evaluations at the endpoints of this interval, f(a) and f(b), and the line connecting
these two points (Figure 2.7B). The area of this trapezium is therefore given by,
A = (b− a)
(
f(a) + f(b)
2
)
, (2.22)
where the length of the interval [a, b] is (b−a) corresponding to h and, consequently,
(2.22) gives an approximation to the integral of f(x) in this interval,∫ b
a
f(x) dx ≈ (b− a)
(
f(a) + f(b)
2
)
. (2.23)
Note that this approximation arises from the straight line connecting f(a) and f(b)
which causes either an overestimate or underestimate of the area under the curve
depending on the nature of the function in the given interval (Figure 2.7B). The
accuracy of the approximation can be improved by dividing the interval into multiple
trapeziums of equal width and summing the areas of the individuals (Figure 2.7C).
For example, if we divide the interval [a, b] into three equal parts by introducing
intermediate points u and v we can describe the area of three trapeziums using the
function evaluations at these points (f(a), f(u), f(v) and f(b)) and the distances
between them, such that,∫ b
a
f(x) dx ≈ (u− a)
(
f(a) + f(u)
2
)
+ (v − u)
(
f(u) + f(v)
2
)
+ . . .
(b− v)
(
f(v) + f(b)
2
)
,
where the heights of the trapeziums are equal, each being one third of the length of
the whole interval, and hence,∫ b
a
f(x) dx ≈ (b− a)
3
((
f(a) + f(u)
2
)
+
(
f(u) + f(v)
2
)
+
(
f(v) + f(b)
2
))
,
≈ (b− a)
3
(
f(a)
2
+
f(u)
2
+
f(u)
2
+
f(v)
2
+
f(v)
2
+
f(b)
2
)
,
≈ (b− a)
3
(
f(a)
2
+ f(u) + f(v) +
f(b)
2
)
,
≈ (b− a)
6
(f(a) + 2f(u) + 2f(v) + f(b)) .
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The improvement in accuracy of the approximation gained by increasing the number
of trapeziums from one to three can be seen by comparing the area between the
orange and blue lines in Figure 2.7B and Figure 2.7C. Approximating the integral
by a number of trapeziums n gives the general formula for the trapezium rule,∫ b
a
f(x) dx ≈ h
2n
(f(a1) + 2f(a2) + 2f(a3) + · · ·+ 2f(an) + f(an+1)) , (2.24)
in the interval [a, b] divided into n equal parts such that a = a1 < a2 < a3 < · · · <
an+1 = b. The most accurate approximations are achieved for large n values and
hence, although this results in a large number of calculations that would quickly be-
come unmanageable by hand, this method is ideally suited to computational analysis
whereby vast numbers of calculations can be performed in very short time frames.
In practice, numerical integration methods employed computationally are performed
iteratively, in the form of algorithms, since this provides a large number of simple
calculations each of which is dependent on the prior solution. The trapezium rule
forms the basis of an equivalent iterative method known as the second order Runge-
Kutta method (RK2). Runge-Kutta methods are a family of iterative numerical
integration techniques whose accuracy improves with increased order of the rele-
vant equations. The most commonly used method in computational mathematical
programming is the fourth order Runge-Kutta method (RK4). Consider an IVP:
dy
dt
= f(t, y), f(t0) = y0, (2.25)
defined for a function, y(t), where t is the independent time variable, as is the
standard for modelling biological systems. In order to recover the function y from
the derivative in (2.25) we can integrate both sides:∫
dy
dt
dt =
∫
f(t, y) dt,
=⇒ y =
∫
f(t, y) dt .
We therefore require the integral of the function f(t, y) and hence the solution to
(2.25) can be approximated numerically via the RK4 equations:
y?n+1 = y
?
n +
h
6
(k1 + 2k2 + 2k3 + k4),
tn+1 = tn + h,
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where y?n is the approximate solution for y at time tn for n = 0, 1, 2, . . . ; h is the
step size and we have:
k1 = f(tn, y
?
n),
k2 = f(tn +
h
2
, y?n +
h
2
k1),
k3 = f(tn +
h
2
, y?n +
h
2
k2),
k4 = f(tn + h, y
?
n + hk3),
where k1 gives the derivative of the function at the start point of the interval h (tn),
k2 gives the derivative of the function at the midpoint of the interval h (tn+
h
2 ) using
k1, k3 gives a second calculation of the derivative of the function at the midpoint
using k2 and k4 gives the derivative of the function at the endpoint of the interval h
(tn+h). This method allows the approximate solution at the next time point, y
?
n+1,
to be calculated using the known information regarding the approximate solution at
the previous time point, y?n. The four increments, k1,2,3,4 are four separate attempts
to predict the next y? value, each based on a different principle. The first increment,
k1, predicts the next approximate solution by virtue of the gradient at the start
point; an assertion that in isolation forms the basis of the first order Runge-Kutta
method (RK1), also known as the Euler method. The second increment, k2, predicts
the next approximate solution by virtue of the midpoint of the interval described
by the step size h which, when utilised only with k1, forms the basis of RK2. The
third increment, k3, predicts the next approximate solution by virtue of a secondary
consideration of the gradient at the midpoint, using k2. The fourth increment, k4,
predicts the next approximate solution by virtue of the gradient at the endpoint,
using k3. Finally, the overall calculation of y
? is determined based on a weighted
average of all four increments, with the greater weight given to the increments at the
midpoint; resulting from the derivation of the RK4 equations in a similar manner
to that in the derivation of the trapezium rule (2.24).
The increased accuracy that RK4 provides by comparison to lower order
methods arises from the increased number of increments subject to weighted av-
eraging. The standard ODE solver in MATLAB is ode45 which employs a slight
adaptation on RK4 known as the Dormand-Prince method (RKDP). This method
has the advantage over standard RK4 due to the six increments that are used to
calculate each approximate solution, as well as a more precise weighted average of
these increments. RKDP is an adaptive Runge-Kutta method, capable of selecting
adapted step sizes based on the error calculated at each step as the algorithm con-
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verges. Standard ODE solvers such as ode45 provide sufficient accuracy for solutions
to systems of one or more ODEs where the relevant parameter space is relatively
small. In some cases, however, it is necessary that model parameters vary by sev-
eral orders of magnitude, causing the rate of change of certain variables to evolve
very quickly or slowly compared to others. These scenarios are referred to as stiff
equations or models and standard numerical methods are unable to provide suf-
ficient accuracy. MATLAB provides ODE solvers designed specifically for solving
stiff systems, such as ode15s. In contrast to the numerical integration methods em-
ployed by non-stiff ODE solvers, the method employed by ode15s is the numerical
differentiation formulas (NDFs). NDFs are a modification of backward differenti-
ation formulas (BDFs). The backward difference calculations employed by NDFs
facilitate the analysis of adaptive step-size problems and provide increased stability
compared to standard BDFs, making them ideally suited to solving stiff equations.
Note that non-stiff solvers such as ode45 are capable of solving stiff equations, but
they take considerably longer due to the vast number of iterative steps required to
establish a reasonable solution.
To illustrate the accuracy of numerical methods for solving systems of ODEs
in silico, we compare both explicit and numerical solution trajectories for the exam-
ple model (2.13)-(2.15) (Figure 2.8). No distinction can be made when comparing
the explicit solutions for C (2.20) to the corresponding numerical solutions, for both
sets of initial conditions. The effect of varying the value of the model parameter is
also demonstrated; when k is given a relatively large value of 5 the solution reaches
steady-state faster than when k is given a smaller value. Hence, the concentration of
C is shown to increase faster for greater reaction rates and thus presents an expected
result for this basic example. The numerical solutions in Figure 2.8 were computed
in MATLAB using ode45 since the model is relatively small in size and contains just
one parameter taking nominal values that does not present any stiffness.
2.3.4 Model reduction
Conservation relations such as (2.17) provide simple linear relationships between
model variables that, in addition to facilitating the calculation of explicit solutions,
can enable model reduction. That is, the total number of model ODEs and parame-
ters can be reduced which, in turn, simplifies the subsequent mathematical analysis
of the model. For example, we can determine the linear relationship between the
example model variables A and B by making A the subject of (2.17):
A = B +A0 −B0. (2.26)
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Figure 2.8: Comparison of explicit and numerical solutions to the example model.
The explicit solution A) and the numerical solution B) are plotted for the initial
condition A0 = B0 = 1. The explicit solution C) and the numerical solution D) are
plotted for the initial condition A0 = 2, B0 = 1. Five distinct trajectories are plotted
in each case for five values of the model parameter k such that k = {0.2, 0.5, 1, 2, 5}.
We are now able to eliminate the ODE associated with A and substitute (2.26) into
the remaining model ODEs to yield the following reduced model:
dB
dt
= −k(B +A0 −B0)B, (2.27)
dC
dt
= k(B +A0 −B0)B. (2.28)
We can also sum (2.27) and (2.28) to determine a second conservation relation on
B and C:
B = B0 − C, (2.29)
which allows us to eliminate the ODE associated with B and therefore yield the
following fully reduced model:
dC
dt
= k((B0 − C) +A0 −B0)(B0 − C), (2.30)
= k(A0 − C)(B0 − C), (2.31)
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where the only dependent variable remaining in the system is C since A0 and B0
are constants. The numerical solution to (2.31) is identical to that of C in the full
example model (Figure 2.9) and hence we have demonstrated that model reduction
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Figure 2.9: Numerical solutions of the example model. A) The solution trajectory
for C arising from the numerical solution of the full example model consisting of
three ODEs. B) The numerical solution of the reduced example model consisting of
the single ODE governing the dynamical response of C.
retains mechanistic output. Model reduction can also be achieved through alterna-
tive methods such as the equilibrium and quasi-steasy-state assumptions that assist
in the reduction of the Michaelis-Menten enzyme kinetic model [Murray, 2002].
We have reduced the example model from three ODEs to just one, which is
particularly beneficial since there is only one ODE to analyse and therefore the re-
quired mathematical investment has been minimised. Model analysis often involves
the calculation of explicit solutions however, in the case of the example model, it is
not apparent whether solving (2.31) explicitly via calculus would yield our known
solution (2.20) with significantly less mathematical investment than the method
outlined in section 2.3.3. The benefits of model reduction are more substantial for
larger, mechanistic models consisting of many ODEs since, not only are the original
mechanistic properties of the model preserved, but the reduction in dimensionality
can alleviate the complexity of subsequent model analysis [Hancock et al., 2015].
The mechanistic models presented in this thesis are constructed for the pur-
pose of simulation and prediction, with a focus on their ability to replicate experi-
mental data and observations in silico. We are interested in verifying whether the
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networks and system architectures, developed through literature mining and exper-
imental collaboration, are suitable for deriving mathematical models that can pro-
vide quantitative predictions of the relevant system dynamics in order to facilitate
novel circuit design. Hence, we do not attempt to reduce our mechanistic models
and, instead, analyse the quality of model outputs as opposed to the underlying
mathematical structure.
2.3.5 Non-dimensionalisation
Deriving and simulating mathematical models using the methods outlined in this
section provide significant insights into the dynamical nature of the associated bi-
ological systems. The accuracy of model outputs is improved greatly by a strong
knowledge of the relevant reaction rate constants since well established parameter
values come associated with a specific dimensionality that is highly influential within
the context of the model. However, it is usually the case that knowledge of a full
parameter set for a given model is lacking due to difficulties recording the required
measurements experimentally. In order to overcome such uncertainties, it is often
beneficial to remove all dimensionality from a model so that direct mathematical
comparisons can be made. This non-dimensionalisation is performed by writing each
dependent and independent variable in terms of model parameters shown to possess
the required dimensionality.
Considering the basic example model, we confirm the dimensionality of the
dependent and independent variables:
[A] = [B] = [C] =
mol
L
= M, [t] = T, (2.32)
where we briefly reintroduce the square bracket notation to indicate that we are
considering dimensionality; M is the molar concentration given by the ratio of the
amount of substance in moles, mol, and the liquid volume of the substance in litres,
L, and T is time dimensionality. Therefore, considering (2.13)
dA
dt
= −kAB,
we require that each term in the equation, including the differential, must be di-
mensionally consistent such that[
dA
dt
]
≡ [kAB],
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=⇒ [dA]
[dt]
= [k][A][B],
=⇒ M
T
= [k]M2,
∴ [k] = 1
MT
. (2.33)
Examination of the remaining model ODEs (2.14) and (2.15) provides identical
derivation of the dimensionality of the parameter k. Since the dimensionality of k
does not match that of the dependent and independent variables, we require one
or more additional model terms in order to construct parameters with the correct
dimensional properties. Consider the dimensionality of A0,
[A0] = M. (2.34)
Hence A0 has the appropriate dimensionality to non-dimensionalise the dependent
variables and, when used in conjunction with k, provides a constant term with the
appropriate dimensionality to non-dimensionalise the independent time variable:[
1
A0k
]
=
1
[A0][k]
=
1
M
MT
=
MT
M
= T. (2.35)
Therefore, we can introduce the following non-dimensional variables,
A = A0Aˆ, B = A0Bˆ, C = A0Cˆ, t =
τ
A0k
, (2.36)
where the hat notation represents non-dimensional dependent variables and τ rep-
resents non-dimensional time. Substituting (2.36) into (2.13) we have,
d(A0Aˆ)
d( τA0k )
= −k(A0Aˆ)(A0Bˆ),
=⇒ kA20
dAˆ
dτ
= −kA20AˆBˆ,
∴ dAˆ
dτ
= −AˆBˆ,
and by imposing the same substitutions on (2.14) and (2.15) we derive the full
non-dimensional basic example model,
dAˆ
dτ
= −AˆBˆ, (2.37)
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dBˆ
dτ
= −AˆBˆ, (2.38)
dCˆ
dτ
= AˆBˆ. (2.39)
We must also derive the corresponding non-dimensionalised initial conditions (Aˆ0,
Bˆ0 and Cˆ0), noting that, from (2.36), t = 0 =⇒ τ = 0:
A = A0Aˆ, B = A0Bˆ, C = A0Cˆ,
=⇒ A0 = A0Aˆ0, =⇒ B0 = A0Bˆ0, =⇒ C0 = A0Cˆ0, (at τ = 0)
=⇒ Aˆ0 = 1. =⇒ Bˆ0 = B0
A0
. =⇒ Cˆ0 = 0. (2.40)
The non-dimensionalisation process decreases the number of model parameters by
one. The parameter k derived for the original dimensional model is therefore lost
and the solution trajectories are now solely dependent on the ratio of the initial
concentrations of the dependent variables, Bˆ0. When the initial concentrations of
the reactants (A0 and B0) are equal, Bˆ0 = Aˆ0 = 1 and hence Aˆ and Bˆ exhibit the
same dynamical response; depleting to zero as the production of Cˆ increases to one
at steady-state (Figure 2.10A). In contrast, when Bˆ0 =
1
2 i.e. there is double the
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Figure 2.10: Comparison of numerical solutions to the non-dimensional example
model. Solution trajectories are plotted for all three non-dimensional dependent
variables (Aˆ, Bˆ and Cˆ). A) Numerical solutions for the initial condition Bˆ0 = 1
(A0 = B0 = 1). B) Numerical solutions for the initial condition Bˆ0 =
1
2 (A0 = 2,
B0 = 1).
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initial concentration of A as B, we see distinct dynamical responses for Aˆ and Bˆ
(Figure 2.10B). All of Bˆ is depleted in the reaction whereas half of Aˆ is depleted
since there is half as much of Bˆ to interact with. The production of Cˆ is therefore
restricted and reaches the same steady-state value as the remaining concentration
of free Aˆ.
2.4 Parameter inference
Information regarding model parameter values is very important regardless of whether
or not the model is dimensional, since non-dimensional model parameters are in-
variably comprised of ratios of the original dimensional parameters. Hence, a sound
knowledge of the model parameter values or even a general notion of their rela-
tive magnitudes can be very valuable in computing reliable model simulations and
predictions.
It is, however, highly likely that the relevant reaction rates, translating to
model parameters, are shrouded with uncertainty. This is mainly due to the diffi-
culties that arise in recording the appropriate measurements experimentally. Even
if one particular reaction is found to be straightforward to characterise, the dimen-
sionality and complexity of mathematical models often generates tens or hundreds
of parameter values and so the task of acquiring numerical experimental data for
an entire parameter set quickly becomes intractable. There are several approaches
to overcoming this obstacle that often involve selecting ‘candidate’ parameter sets,
usually at random, and comparing the output generated to a desired response. If
a candidate parameter set is able to accurately replicate the desired response then
it can be deduced that those particular parameter values are optimal. Parameter
inference is the name given to problems of this nature and the techniques designed
to solve them can be very useful in analysing model performance.
2.4.1 Global optimisation
Establishing reliable parameter sets for making accurate model simulations is diffi-
cult without significant investment of resources towards the design and performance
of biological experimentation. A number of computational methods exist that look
to overcome this limitation, the most reliable of which are global optimisation tech-
niques. Optimisation of a mathematical model involves searching a predefined pa-
rameter space for the solution that provides the best fit to experimental observations
or an ideal output [Hendrix and Gazdag-Toth, 2010]. That is, the optimal parameter
set is located that minimises the error between model outputs and the associated
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experimental data. Global optimisation techniques are designed to locate optimal
parameter sets globally within often very large parameter spaces, avoiding local
minima. One such method, the genetic algorithm (GA), is a particularly powerful
global optimisation tool and is exploited regularly in biological model parameter
inference [Chen and Chen, 2010; Fernandez et al., 2011]. The GA converges to the
global minimum within the allocated parameter space by evolving an initial pop-
ulation of randomly generated solutions over a large number of generations. This
process is based on natural selection, giving the best solutions in the population the
best chance of creating the next generation of solutions.
Identifying optimal solutions is dependent upon the user-defined fitness func-
tion. Fitness functions typically calculate the error between model outputs and ex-
perimental data and can be as simple or as intricate as is necessary for obtaining the
global optimal solution. The GA function in MATLAB has a wide array of options
that can assist the accuracy and speed of a given optimisation run, however many
of the default settings are sufficient for the majority of inference problems. As an
example, consider our basic model (2.13)-(2.15). The first step is to identify the
number of model parameters that will be subject to inference, which in this case
is one since our model has only one parameter, k. Next we select the appropriate
population size and number of generations; the MATLAB defaults of 50 and 100 re-
spectively will be sufficient for one model parameter. We then define the size of the
parameter space by selecting lower and upper bounds to impose on the parameters;
the randomly generated initial population and all subsequent evolved populations
examined by the GA can only take values between these bounds. Here we select a
lower bound of 0 and an upper bound of 1, noting that we require k > 0 for biolog-
ical plausibility. We also require data for the model to replicate; for the purposes
of this example we will use the synthetic dataset, Concentration 1, in Table 2.1.
The synthetic data describes the accumulation of C at eleven time points and hence
Time 0 5 10 15 20 25 30 35 40 45 50
Concentration 1 0.00 0.41 0.58 0.65 0.72 0.75 0.79 0.83 0.84 0.85 0.84
Concentration 2 1.00 0.79 0.71 0.75 0.81 0.85 0.88 0.96 0.93 0.98 0.99
Table 2.1: Synthetic data used to demonstrate parameter inference and model se-
lection. Times and concentrations are given in arbitrary units to provide illustrative
observations.
the model output for C will be matched to this data. Finally, we define the fitness
function that will establish the strength of each individual solution. In this case we
take the error to be the mean absolute value of the difference between our model
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outputs and the synthetic data at the eleven corresponding time points,
E =
1
11
11∑
i=1
|xi − di|, (2.41)
where E is the mean error calculated by the fitness function and xi and di are the
model outputs and data values at each of the relevant time points, ti, respectively.
The global minimum mean error computed when the GA terminated was
E = 0.0095, achieved by the corresponding optimal parameter value k = 0.1285.
This considerably low fitness score reveals that our basic model is very capable of
replicating the synthetic dataset (Figure 2.11A). The GA converged to this optimal
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Figure 2.11: Optimal solution and convergence plot for GA global optimisation of
the basic model. A) The optimal parameter obtained by the GA, k = 0.1285, used
to simulate the model output for C against the synthetic dataset. B) The GA
converged to the best score (global minimum mean error), E = 0.0095, after 66
generations.
solution after 66 generations, indicating that the relative tolerance of the fitness
function was met (Figure 2.11B). That is, if the average relative change in the best
fitness function value over a predefined number of generations is less than or equal to
a predefined tolerance then the algorithm will decide that the global minimum has
been located and terminates. In this case the predefined values for the generations
and tolerance were the MATLAB defaults 50 and 10−6 respectively. Note that
the GA will terminate based on a number of factors, however, the most common
causes are the number of total generations or the relative tolerance, whichever is
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reached first. Running the identical optimisation for a second time demonstrates the
random nature of the GA. Although a secondary identical GA run obtains almost
exactly the same result as before (k = 0.1286), the convergence of the algorithm is
significantly different (Figure 2.12A). The best score at the first generation is lower
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Figure 2.12: Convergence plots for two identical GA optimisation runs. A) A second
identical optimisation of the basic model converges to an almost identical optimal
solution, but in 62 generations, demonstrating that inherent randomness causes all
GA runs to be distinct. B) A third identical optimisation of the basic model, with
the exception of parameter normalisation, increases the efficiency of the GA run,
converging to an identical optimal solution in 51 generations.
than that of the first run since the initial population is generated randomly and is
therefore unlikely to produce the same best scoring solution initially. The process of
breeding the solutions to create new generations is also subject to randomness as the
population evolves and hence we also see a difference in the number of generations
required for the GA to terminate, 62 generations compared to the previous 66. Aside
from the optional inputs that can be altered to improve GA performance, we can also
normalise the parameter space to enable a more methodical search. Normalising the
parameter space between −1 and 1 is an effective way of forcing the GA to search
for optimal values in the same way for all individual parameters inferred. Imposing
all lower bounds of −1 and all upper bounds of 1 will force the GA to search [−1, 1]
for all potential solutions. The following calculations of the midpoint, m, and the
mean, µ, of the actual parameter set must be made to prevent the GA using the
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incorrect normalised values to simulate model outputs:
m =
(u− l)
2
,
µ =
(l + u)
2
,
where l and u are the lower and upper bounds imposed on the actual parameter set
respectively. The GA can then retrieve the actual values to be used in simulating
the model via the following calculation:
pA = mpN + µ,
where pA and pN are the actual and normalised parameter sets respectively. Run-
ning a third identical GA optimisation of the basic model using this normalisation
technique yields a more efficient result than both of the previous runs (Figure 2.12B).
The third run obtains the same best score as the second run (k = 0.1286) which indi-
cates that the optimal parameter was located in all three runs. This third run does,
however, yield a more efficient convergence, requiring only 51 generations to locate
the same optimal parameter and global minimum error with respect to the synthetic
dataset. Note that normalisation of the parameter space is not greatly advantageous
in relatively simple cases such as our basic model as the increased efficiency amounts
to relatively small time savings. However, this procedure becomes particularly ben-
eficial when optimising large models with multiple parameters, especially when the
bounds imposed on each parameter are varied significantly for reasons regarding the
context of the problem. Despite identifying the same optimal solution in each of
our three trials, this is not guaranteed in general; multiple ‘optimal’ parameter sets
may exist, capable of matching experimental data to a similar degree, depending
on the constraints imposed upon the parameter space. Distinct optimal parameter
sets can often be indicative of the inference algorithm identifying local minima, in
which case several factors may require further consideration such as the sensitivity
of the system to changes in parameter values, the size of the parameter space and
the quality of the data.
To reiterate, the best optimisation results are achieved for relatively large
population sizes and generations compared to the number of parameters subject to
inference. However, this also significantly increases the computational workload and
hence a reasonable compromise is required for viable development times. Such com-
promises can still present a very time consuming task and hence GA optimisation
is often implemented through parallelisation. Parallel computing allows computa-
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tional tasks to be distributed across multiple processors, allowing the workload to
be run as several simultaneous jobs. We employ a parallelised MATLAB coding of
the GA on a high-performance computing cluster to implement global optimisation
of mathematical models in the shortest possible time frames.
2.4.2 Approximate Bayesian computation
The analysis of data recorded through biological experimentation naturally com-
prises the application of statistical methods. Statistics are able to reveal underlying
trends and relationships associated with datasets and variables that may not be
immediately apparent. Simple statistical measures such as the mean, mode, me-
dian, standard deviation and interquartile range (IQR) give a good indication of the
spread of data and can also illustrate the extent of any correlations or skewness.
Statistical data analysis in biology (biostatistics) can be performed using a host of
more advanced methods depending on the information required. Commonly ap-
plied methods include the χ2 (chi-squared) test which calculates the deviation of a
dataset from the expected values of the null hypothesis, that is, assuming that there
is no effect of a given factor on the dataset, how much deviation from ‘no effect’
is actually caused by that factor, and the Spearman’s rank correlation coefficient
which generates a number between 1 and −1 that represents the strength of the
relationship between two variables when described by a monotonic function. That
said, these methods can only be applied directly to data and do not offer any means
of measuring correlations that might exist between experimental observations and
model outputs. We are, however, able to exploit the statistical certainty of the re-
lationship between experiment and computation via parameter inference techniques
based on probability. Such methods are also capable of model selection, the proba-
bilistic discrimination of two or more models of the same system, which can identify
the model most likely to have produced the associated experimental data.
Probability theory is fundamental to statistical analysis in providing rigorous
means of determining the likelihood of certain events occurring. The probabilistic
relationship between two events can be depicted in the form of a Venn diagram
(Figure 2.13); the probability of event A, P (A), is depicted by the left hand circle, the
probability of event B, P (B), is depicted by the right hand circle and the probability
of both events occurring, P (A ∩ B), is depicted by the central area of intersection
between the two circles. Two events that are mutually exclusive, such as a coin toss,
cannot both occur and hence there is no intersection in these cases; P (A ∩B) = 0.
The area of the outer rectangle containing the intersecting circles represents the
entire probability and is therefore equal to 1. For mutually non-exclusive events
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Figure 2.13: Venn diagram depicting the probability of two events, A and B, by
virtue of the areas of the intersecting circles. The areas of the two circles are equal
purely for illustrative purposes. P (A) and P (B) denote the probabilities of event
A and B occurring respectively; P (A ∩ B) denotes the probability of both events
occurring and corresponds the area of intersection between the two circles.
which have, or are at least assumed to have, some shared dependency, we can
calculate the probability of one event occurring given the prior occurrence of another
event by virtue of conditional probability theory:
P (A|B) = P (A ∩B)
P (B)
, (2.42)
where P (B) > 0 and P (A|B) denotes the conditional probability of event A given
event B, which is equal to the ratio of the probability of the intersection between the
two events and the probability of event A. That is, if P (A ∩ B) is relatively large,
there will intuitively be a high probability of A occurring in the event that B has
occurred however, if P (A ∩ B) is small then it becomes more unlikely that A will
occur given B has occurred. Conditional probability is axiomatic in the application
of probability theory since it provides a platform for accounting for any preconceived
relationships or dependency that might exist between events of interest. Consider
the probability of B given A:
P (B|A) = P (B ∩A)
P (A)
. (2.43)
The intersection of A and B, P (A∩B), and the intersection of B and A, P (B ∩A),
are the same (Figure 2.13) and hence,
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P (B|A) = P (A ∩B)
P (A)
, (2.44)
which we can rearrange to determine the intersection of A and B in terms of condi-
tional probability:
P (A ∩B) = P (B|A)P (A). (2.45)
Substituting (2.45) into (2.42) gives the full conditional probabilistic relationship
between two mutually non-exclusive events known as Bayes’ theorem:
P (A|B) = P (B|A)P (A)
P (B)
, (2.46)
where P (B) > 0. This theorem forms the basis of Bayesian inference, a potent class
of statistical inference techniques that facilitates the parameterisation of mathemat-
ical models through the imposition of prior knowledge on the problem, usually in
the form of experimental data, and is therefore well suited to mathematical mod-
elling investigations in biological systems research. Bayesian inference enables us
to calculate the probability that a particular parameter set, θ, gives rise to a given
experimental dataset, D, by virtue of Bayes’ theorem:
P (θ|D) = P (D|θ)P (θ)
P (D)
, (2.47)
where P (θ|D) and P (θ) are referred to as the posterior distribution and prior dis-
tribution respectively. Probability distributions such as the posterior and prior in
Bayes’ theorem are functions that describe the probability that the subject variable
will take a possible value. This applies to random variables and the appropriate
probability distributions take on different forms depending on whether the variable
is discretely random or continuously random [Ross, 2010]. In this case, we are only
interested in varying θ with respect to our observed data, D, which is fixed. Hence,
P (D) is constant and has no meaningful influence on the overall inference of the
posterior distribution, resulting in the following proportionality:
P (θ|D) ∝ L(θ|D)P (θ), (2.48)
where L(θ|D) is referred to as the likelihood function. The elucidation of the poste-
rior distribution is dependent on the likelihood function and the prior distribution
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and forms a general result of probability theory:
posterior distribution ∝ likelihood function× prior distribution. (2.49)
The likelihood is a function of the model parameters that determines the probabil-
ity that a particular parameter set is responsible for producing the observed data,
whereas the prior distribution explicitly prescribes the biological knowledge regard-
ing the model parameters before the relevant experiments were carried out [Liepe
et al., 2014]. Evaluation of the posterior distribution is typically performed through
approximate Bayesian computation (ABC). The likelihood function is comparable
to the fitness functions used in parameter optimisation strategies such as the GA
however, it can only be expressed explicitly for appropriately simple models and
hence ABC expands the scope of model analysis by bypassing the need to evaluate
such functions. Instead, bespoke computational tools such as ABC-SysBio can be
employed to obtain the desired result. ABC-SysBio is a Python software package
that is designed specifically for parameter inference and model selection in biolog-
ical systems research [Liepe et al., 2014]. The program enables ABC inference of
mathematical models via sequential Monte Carlo (SMC) approaches [Liepe et al.,
2014; Stumpf, 2014; Smith and Grohn, 2015]. Monte Carlo approaches to compu-
tational simulations involve generating random candidate solutions, testing their
fitness against a desired output and repeating until a viable solution can be identi-
fied. In this way, vast numbers of randomly selected parameter sets can be examined
in building an accurate approximation to the posterior distribution. The methods
were developed by Stanislaw Ulam and John von Neumann in conjunction with top
secret work relating to the development of nuclear weapons. As such, a code name
was required and the term Monte Carlo was adopted after the famous Monte Carlo
casino in Monaco, due to the connection between randomness and games of chance
[Harrison, 2010].
The ABC-SMC approach proceeds in the following manner: the first ‘popu-
lation’ of accepted solutions or ‘particles’ is generated randomly based on the prior
distributions imposed on the model parameters. Each particle gives rise to a sim-
ulated dataset, D?, which is compared to the fixed experimental dataset, D, by
an appropriate distance function and its fitness is scored accordingly. Acceptance
of a particle is dependent on a decreasing sequence of error thresholds, , set to
correspond with each population. That is,
d(D?, D) < i, (2.50)
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where 1 > 2 >. . .> n and d is the distance function. Each subsequent popula-
tion is obtained by perturbing particles from the previous population in accordance
with a predetermined perturbation kernel, proceeding until the model is unable to
produce particles of sufficient fitness to satisfy the immediate threshold.
An array of model-specific criteria are required to allow the ABC-SysBio
package to run efficiently: the sequence of decreasing error thresholds, , must be
provided whereby only the particles capable of providing error less than that of the
threshold will be accepted by the algorithm. Each  must be satisfied in succession
until the particles are unable to satisfy the next threshold. Satisfaction of an in-
dividual threshold is dependent on the number of particles accepted; the number
of acceptable particles required before passage to the next threshold must also be
predetermined. The larger the number of particles, the higher probability of signifi-
cant inference and the longer the duration of algorithm to reach convergence. Each
individual parameter subject to inference requires a prior probability distribution in
order to establish the parameter space within which to locate acceptable particles.
Sequences of numerical values representing the relevant experimental data and the
corresponding time points must also be provided; the number of data points and
time points must be equal. Time course data is currently the only supported data
format. One or more distinct datasets can be supplied and can be fitted to any in-
dividual model variable or combination of variables. Convergence of the algorithm
is dependent on all of the aforementioned factors and hence it may require several
trials to establish the appropriate performance criteria. It is advised that strong
results are repeated multiple times due to the random nature of the Monte Carlo
simulations that drive the algorithm. Note that all models submitted to the ABC-
SysBio package must be written in Systems Biology Markup Language (SBML),
a systems biology programming language based on Extensible Markup Language
(XML).
Implementing ABC-SysBio for one model only initiates parameter inference,
whereas submitting more than one model will initiate model selection. Note that
implementing model selection in ABC-SysBio also conducts parameter inference on
each model subject to selection. At each satisfied error threshold, the algorithm
produces a host of output results including line graph simulations of ten example
particles from the accepted population of particles, histograms of the posterior dis-
tributions relating to each model parameter and, in the case of model selection,
histograms detailing model probabilities and the corresponding population number,
error threshold and acceptance rate. In order to demonstrate parameter inference
in ABC-SysBio we run the algorithm for the same basic model (2.13)-(2.15) that we
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optimised using the GA. The  thresholds were selected knowing that the optimal
GA solution was found to provide a minimal error of 0.0095, that is, the final 
was selected as 0.007 however, this information would not typically be available and
hence an informed estimate of  thresholds is required. The number of accepted
particles required to satisfy each threshold was selected as 1000 to achieve conver-
gence within a viable time frame. The prior distribution imposed on the model
parameter k was selected as a uniform distribution on the interval [0, 1]. The fi-
nal population of 1000 accepted particles satisfied  = 0.01 however, the following
threshold,  = 0.009, was not satisfied which indicates that ABC-SysBio aligns with
the minimum error achieved by the GA. The subset of ten particles plotted at the
last satisfied threshold all show a close match to the synthetic data (Figure 2.14A);
the threshold was satisfied after sampling 5354 particles, giving an acceptance rate
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Figure 2.14: ABC-SysBio parameter inference results. A) A subset of ten solutions
from the final population of accepted solutions all provide a close match to our
synthetic data. B) The inferred probability distribution for the model parameter, k,
reveals a high probability that the optimal value is located in the interval [0.12, 0.13].
of approximately 0.19 i.e. less than 20% of sampled particles were accepted. The
inferred probability distribution on the model parameter k indicates that the proba-
bility is entirely distributed across the interval [0.12, 0.13], aligning with the optimal
value of 0.1285 achieved by the GA (Figure 2.14B). The distance function deployed
to determine particle fitness is customisable and was selected here to be the mean
absolute error to emulate the GA fitness function (2.41).
In order to demonstrate model selection in ABC-SysBio, we require two or
more distinct models of the same biological system [Liepe et al., 2014]. We there-
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fore submit the aforementioned mechanistic and black box models of enzyme kinetics
which will also assist in establishing further evidence of the advantages and disadvan-
tages associated with each modelling strategy. The criteria selected for the previous
demonstration of parameter inference, as well as the mean absolute error distance
function, are retained for this model selection with the following exceptions: the
synthetic dataset is retained since the time course evolution of product is expected
to be similar to that of the basic model however, we also introduce a second dataset
to fit the time course evolution of enzyme (Table 2.1, Concentration 2). Enzyme
concentration is depleted through complex formation with the substrate, but will
replenish as the substrate is converted to product and hence the data values are cho-
sen to reflect this. Since we are inferring against the fit to two distinct datasets, we
also adapt the  sequence to account for greater potential error. The model prob-
abilities are plotted as histograms for each satisfied error threshold, in this case,
producing twelve subplots (Figure 2.15A). Both models have approximately equal
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Figure 2.15: ABC-SysBio model selection results. A) The mechanistic model
achieves a probabilistic certainty of producing our two synthetic datasets with a
minimum error of 0.3. B) The inferred probability distributions for the three mech-
anistic model parameters reveal that parameters 1 and 3 take optimal values in the
interval [0, 0.5] and parameter 2 is optimal in the interval [0.5, 1].
probability of producing the data after the first threshold,  = 2.0, however, by the
tenth threshold,  = 0.5, the mechanistic model (model 1) has achieved a proba-
bilistic certainty of producing the data and an eventual minimum error of  = 0.3.
This is unsurprising when considering that the black box model overlooks the inter-
mediate formation of the enzyme-substrate complex and, in turn, the dissociation
of enzyme that enables its concentration to replenish as the system reaches steady
state. The inference of the three mechanistic model parameters is not as clear as
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the basic model example given the increased difficulty of the twofold data fitting
task (Figure 2.15B). The probabilities are distributed across the entire interval pre-
scribed as the prior distributions however, general trends can still be identified such
as greater probabilities that the optimal values are located in the interval [0, 0.5] for
parameters 1 and 3 (k1 and k2) and in the interval [0.5, 1] for parameter 2 (k−1).
These values suggest that the system requires lower magnitude (slower) reaction
rates in order to mimic the synthetic data on the given timescale. Overall, this
demonstration has revealed that the mechanistic model not only achieves a greater
probability of capturing the desired dynamics, but that it is a statistical certainty
and illustrates the importance of accounting for the maximum amount of biological
detail possible in formulating mathematical models.
Bayesian inference provides an effective model validation method whilst elim-
inating problems regarding over-fitting and uncertainty that have the potential to
compromise optimisation strategies [Liepe et al., 2014]. Although the optimal pa-
rameter set is generally considered to be the most desirable outcome of a given
inference problem, optimisation techniques with this sole focus are susceptible to
placing too much trust in the available data. That is, if the experimental data used
to optimise a model of a biological system contains any element of noise, which is
invariably true, then a good optimisation algorithm will work efficiently to fit the
model to that data, as required, and inadvertently locate noisy parameter sets. Op-
timisation is also prone to locating local minima, creating uncertainty as to whether
the identified solution is truly optimal. Furthermore, even trusted optimal solutions
could potentially be one of many such solutions that provide equally minimal error
and hence a great deal of consideration is required with respect to the robustness
and biological plausibility of solutions, as is the case for interpreting any inference
result. ABC methods avoid these issues by virtue of their probabilistic nature; the
approximate posterior distributions on the inferred parameters are measures of cer-
tainty in themselves and offer a probable subset of the parameter space, rather than
a definitive output to be accepted or rejected. That said, both the definition of the
relevant parameter space and the subsequent exploration of it remains the nucleus of
inference strategies and is arguably confronted with greater sophistication through
optimisation, in comparison with ABC-SMC approaches. As a global optimisation
strategy, the GA is designed specifically to avoid convergence towards local min-
ima, with issues of uncertainty and robustness combated by implementing multiple
runs under identical performance criteria; another general feature of all parameter
inference methods. Both inference strategies outlined in this section possess sev-
eral potential pitfalls which in many cases are only effectively overcome through
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astute implementation and interpretation. Overall, we have established a reliable,
two-pronged tool kit with which to parameterise mathematical models and, in turn,
elucidate biological systems.
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Chapter 3
Mechanistic Modelling of a
Rewritable Recombinase
Addressable Data Module
3.1 Scientific background
3.1.1 DNA recombination
Genetic switches form the basis of engineering cellular memory [Bonnet et al., 2012].
Transcriptional memory devices have demonstrated effective performance across
multiple cellular environments [Gardner et al., 2000; Kramer et al., 2004b] and are
highly orthogonal with regards to assembling multiplexed systems [Stanton et al.,
2014], however regulating gene expression in this manner also has limitations. These
systems are volatile, having to continuously consume resources, in this case for the
production and degradation of repressor, to maintain states [Ajo-Franklin et al.,
2007]. Difficulties also arise when integrating devices into a variety of organisms
given that gene regulation networks vary greatly between distinct cellular environ-
ments. Furthermore, the highly inducible and stable switching that these devices
demand can be compromised by spontaneous switching events caused by the inher-
ent stochasticity of gene regulation [Bonnet et al., 2012]. As a result, research into
cellular memory has become increasingly focused towards site-specific recombinases
(SSRs), capable of precise DNA manipulation both in vitro and in vivo [Grindley
et al., 2006]. This process is known as DNA recombination and facilitates inducible
gene expression that is programmed into the cellular DNA.
DNA-based systems are favourable due to the fact that they exploit a natural
data storage material and have the added advantage of eliminating cell specificity
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requirements. SSRs are classified as belonging to two groups, the tyrosine recombi-
nases and the serine recombinases. The former have been shown to provide effective
genetic switch mechanisms [Buchholz et al., 1996; Kilby et al., 1993; Rossant and
Nagy, 1995] however, their functionality is often dependent upon cell-specific cofac-
tors as in the case of λ integrase [Landy, 2015]. This is problematic in a similar vein
to that of transcriptional systems with regards to the deployment of modules across
multiple organisms. Tyrosine recombinase systems that are not dependent on host
cofactors are bidirectional and are therefore incapable of highly efficient switching
since there can be no guarantee that an induced transition to a desired DNA state
would be effectively maintained without unwanted transitioning back to the original
state [van Duyne, 2001]. In contrast, the serine recombinases do not require such
cofactors and have been used effectively to perform highly efficient unidirectional
gene assembly and modification [Colloms et al., 2014]. This has led to the construc-
tion of a rewritable RAD module exhibiting passive information storage within a
chromosome [Bonnet et al., 2012]. Switching the RAD module ‘on’ requires only
the presence of integrase whereas the ‘off’ switch requires integrase in conjunction
with a recombination directionality factor (RDF), also referred to as excisionase.
The integration and excision events can take on several guises depending on the ini-
tial composition of the genetic sequence and the relevant attachment sites. Specific
recombination arrangements are directly influential upon the operational character-
istics of a genetic toggle switch, such as the RAD module, and higher-order circuitry
that utilises multiplexed switches.
Three distinct DNA recombination mechanisms are known to mediate three
distinct recombination events, referred to as inversion, insertion and deletion. The
first mechanism exploits the inversion event (Figure 3.1A). In this case, antiparallel
attB and attP sites located on the same DNA sequence are subject to binding by
dimeric integrase which causes double stranded breaks in each. That is, integrase
alone is sufficient to mediate a primary inversion event. Exposed ends in the genetic
sequence then bind the opposite ends of the intermediate fragment, resulting in an
inverted section of DNA flanked by newly formed composite attachment sites termed
attL and attR. The binding of RDF molecules to the attL and attR DNA:integrase
synaptic complexes facilitates a successive inversion event. The attL and attR sites
are dismantled, allowing for the exposed ends of the intermediate fragment to adopt
their original orientation and hence re-establish the attB and attP sites.
The second mechanism exploits the deletion and insertion events between
attachment sites on the same DNA sequence (Figure 3.1B). In this case, the attach-
ment sites are identical to that of Figure 3.1A with the exception that the orientation
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Figure 3.1: Schematic diagram of DNA recombination mechanisms. A) Genetic
material flanked by attB and attP is inverted through integration to form attL
and attR. Excision restores attB and attP via a secondary inversion event. B) An
alternative orientation of attB and attP results in deletion of the intermediate genetic
sequence which is inserted in the presence of RDF (excisionase). C) The phage
genome attachment site, attP, is integrated into the host chromosome attachment
site, attB. Excision restores attB and attP, removing the integrated phage genome
from the host chromosome. In all cases, integration gives rise to attL and attR, each
formed of half of attB and attP.
of attB and attP is subtly different i.e. they are parallel as opposed to antiparallel,
akin to attL and attR in Figure 3.1C. Binding of dimeric integrase to attachment
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sites adopting this alternative orientation causes the same double stranded breaks
however, the exposed ends of the intermediate nucleotide sequence are bound to-
gether to form a small loop of DNA that is deleted from the original sequence. The
exposed ends of the original sequence are also bound together to form a single attR
site. RDF binding re-inserts the deleted loop of DNA and reforms attB and attP.
Hence, this alternative orientation of attachment sites does not facilitate the same
inversion of the intermediate genetic fragment depicted in Figure 3.1A, but instead
deletes the fragment entirely with the potential of insertion via an appropriate RDF.
The third mechanism also exploits insertion and deletion. In this case, re-
combination occurs between DNA attachment sites on a bacterial host chromosome
and a bacteriophage (Figure 3.1C). Dimeric integrase bound to a host chromosome
attB site and a bacteriophage attP site causes a double stranded break in each. The
exposed ends of the phage DNA fragment bind to those of the host, thus insert-
ing the fragment into the host chromosome which is flanked by the newly formed
composite attL and attR sites. Following insertion, binding of RDF molecules to
the attL and attR DNA:integrase synaptic complexes facilitates the deletion event.
Here the attL and attR sites are dismantled, thus deleting the genetic insert and
allowing the reformation of the attB and attP sites.
Inversion events giving rise to attL, attR sites and attB, attP sites are gener-
ally referred to as integration and excision respectively since, in the main, integrase
alone mediates the former and a combination of integrase and RDF is necessary to
mediate the latter. In contrast, insertion and deletion events can both potentially
be mediated by integrase alone or integrase and RDF, and are therefore associated
specifically with their aforementioned DNA recombination outcomes. We investi-
gate inversion- and deletion-based DNA recombination systems since the action of
these mechanisms is localised to a single DNA strand which offers greater simplic-
ity compared to the manipulation across disparate genetic sources associated with
insertion. We refer to recombination events as integration and excision according to
the attachment sites and SSRs involved and to the presence of attB, attP sites and
attL, attR sites in the system as the BP and LR states respectively. The concen-
trations of integrase and RDF in the system dictate the efficiency of the switching
between these distinct DNA states. The characterisation of this switching efficiency
is crucial to the deployment of the genetic switch as a component of higher-level sys-
tems. By analysing the criteria required to mediate both highly efficient integration
and excision in silico, optimal system inputs can be identified.
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3.1.2 Existing recombinase-based systems
Many of the earliest publications regarding both tyrosine and serine integrases were
focused on elucidating their structural and functional properties through compre-
hensive experimentation [Thorpe and Smith, 1998; Thorpe et al., 2000; Smith and
Thorpe, 2002; Ghosh et al., 2003; Groth and Calos, 2004]. In light of these obser-
vations and the continued publication of increasingly detailed studies regarding the
nuances underlying DNA recombination, such as the function of the synaptic com-
plex [Rowley and Smith, 2008; McEwan et al., 2009, 2011; Bai et al., 2011; Olorunniji
et al., 2012], a slew of useful applications were identified that prompted the design
and implementation of many novel systems. Serine integrases have become highly
prevalent as integration vectors, emerging as the preferred method of transferring
DNA into other organisms such as streptomycetes [Zhang et al., 2013]. These SSRs
are capable of mediating integration of entire antibiotic biosynthetic clusters into
target genomes [Baltz, 2011, 2012] and are also highly compatible when intercon-
nected within the same organism [Gregory et al., 2003].
Other applications of the serine integrases are focused on therapeutics such
as engineered bacteria that are programmed to invade cancer cells [Anderson et al.,
2006] and the production of two essential human blood-clotting proteins known as
factor XII and factor IX in mice to treat haemophilia A and B respectively [Chavez
et al., 2010; Olivares et al., 2001]. Additional biomedical applications include trans-
genic cattle capable of expressing milk containing the human β-defensin-3 antimi-
crobial peptide which naturally protects the surfaces of human organs and blood
vessels from bacterial colonisation [Yu et al., 2013], inducible production of pluripo-
tent stem cells from human amniotic cells and embryonic cells in mice [Ye et al.,
2010] and engineering specific skin cells and partially specialised stem cells for gene
therapy of skin disorders [Ortiz-Urda et al., 2003, 2002].
Sophisticated methods concerning the assembly and optimisation of complex
large-scale synthetic systems are ideally suited to site-specific DNA recombination
[Xu et al., 2013]. DNA assembly via serine integrases enables the construction
of highly modular pathways that can be adapted without the need for repeated
cloning [Zhang et al., 2008, 2011] and can also facilitate rapid metabolic pathway
assembly [Colloms et al., 2014]. Genome engineering is also benefiting from the
application of serine integrases; φC31 has been utilised for the specific modification
of genomes in mice [Tasic et al., 2011], silkworm embryos [Yonemura et al., 2013,
2012] and zebrafish [Hu et al., 2011; Lister, 2010], thus elucidating gene function
in model organisms, and also for the deletion of genetic markers in plants such as
Arabidopsis (rockcress), wheat and barley [Thomson et al., 2010; Kempe et al., 2010;
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Kapusi et al., 2012], thus generating stable progeny void of undesired DNA.
The potential of recombinase-based circuitry to provide transistor-like be-
haviour in synthetic biological systems has naturally opened up numerous applica-
tions relating to genetic data storage and biocomputing [Baumgardner et al., 2009;
Ham et al., 2008]. Digital data storage in particular has attracted much attention, re-
sulting in several validated memory devices such as the aforementioned event counter
that utilises tyrosine integrase-based recombination to count and record sequential
pulses of inducer; the purely transcriptional circuit tested in parallel was only able to
count induction events [Friedland et al., 2009]. Of course, transcriptional elements
are necessary for realising desired outputs however, these results indicate that their
control must be mediated via DNA recombination in order to achieve memory of
external stimuli. Memory modules can support efficient inducible DNA inversion
in alignment with mathematical modelling simulations [Bonnet et al., 2012], store
over 1 B of digital information via layered arrangements of attachment sites specific
to multiple recombinases [Yang et al., 2014] and represent integral components in
the construction of a biological microprocessor [Moe-Behrens, 2013]. Consequently,
the level of input-output complexity that can be realised is theoretically unbounded
due to the scaling up of systems through numerous pairs of attachment sites corre-
sponding to distinct integrases, therefore providing the platform for engineering the
full range of Boolean logic operations in response to induction of independent serine
integrases [Bonnet et al., 2013; Siuti et al., 2013]. At the current rate of expansion,
it is thought that worldwide data will require in the region of 4×1010 (forty-trillion)
GB of digital storage by 2020 and, although cloud computing is hoped to address
this demand, approximately 90 grams of DNA would be sufficient to store such an
amount [O’Driscoll and Sleator, 2013].
Of the diverse range of recombinase-based systems, only a small fraction have
been published in conjunction with mathematical modelling investigations that re-
veal, for example, specific reaction rates that are currently intractable experimen-
tally, or expected dynamical behaviour via qualitative or even quantitative in silico
simulations as a reference point for in vivo circuit assembly [Ringrose et al., 1998;
Bonnet et al., 2012; Friedland et al., 2009]. Of these extant models, even fewer are
related specifically to serine integrase recombination interactions which may be sur-
prising considering the relative wealth of publications detailing the structural and
functional properties of recombinases that could inform mechanistic model construc-
tion. It is worth reiterating that the repressilator and toggle switch were both de-
signed and characterised in alignment with albeit simple mathematical models. The
deployment of synthetic biological devices is unlikely to ever be entirely predictable
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purely by virtue of experimental observations and thus there exists a definite need
for extensive modelling approaches to serine integrase reactions in order to deliver
and enhance the aforementioned applications.
3.1.3 Existing recombinase-based models
As cellular memory emerges as a defining element of higher-level synthetic biological
systems, the characterisation of the requisite parts will command significant atten-
tion. Hence, predictive analysis of recombinase-based genetic switches is necessary
to provide engineers with reliable operational profiles. Achieving this goal is pos-
sible through the inevitable progression in the efficacy of experimental procedures
due to technological advancements. However, mathematical modelling approaches
have the potential to provide insights that may never be physically possible in the
laboratory. Wider acceptance of the merits of mathematical models in biology and
increased efforts to expand collaborative experimental and computational research
is therefore central to synthetic biological circuit design.
The earliest proposed model of DNA recombination in the literature pro-
vides kinetic analysis of two distinct recombinases known as FLP (flippase) and Cre
[Ringrose et al., 1998]. The model captures a simplistic overview of DNA deletion
via a series of reversible reactions corresponding to monomeric recombinase binding
to DNA attachment sites, synaptic complex formation, recombination and dissocia-
tion. The universal reversibility of the reactions modelled aligns with FLP and Cre
being tyrosine recombinases that exhibit bidirectional recombination and hence the
model also captures the insertion of the circular DNA product back into the genetic
sequence. Two pairs of reactions corresponding to two distinct aspects of synapse
formation were unable to be determined experimentally, resulting in four unknown
model parameters; the remaining four model parameters were established via ex-
perimentation. The model was optimised to infer the four unknown parameters
through fitness function minimisation. As a result, a number of dynamical proper-
ties were validated including that Cre has a higher binding affinity than FLP and
thus the synaptic complex is more stable for Cre which was thought to explain the
100% deletion efficiency of FLP compared to the maximum 75% excision efficiency
of Cre. Furthermore, insertion was shown to be inefficient given the bidirectionality
of tyrosine-mediated recombination that results in unwanted ‘re-deletion’ and, al-
though it may seem intuitive that insertion efficiency would benefit from increased
DNA binding affinity and rate of synapsis, such conditions are in fact detrimental
to insertion efficiency since they favour re-deletion [Ringrose et al., 1998]. There-
fore, this modelling investigation succeeded in highlighting both the optimal model
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parameter set and the operational faults that render the mechanism unsuitable for
use as a cellular memory unit.
A validated model of serine DNA recombination did not arrive until fourteen
years later [Bonnet et al., 2012]. This serine model adopts a simplistic, black box
approach akin to that of [Ringrose et al., 1998] however, in this case, the specific
focus is DNA inversion as opposed to deletion and insertion. The model captures
in vivo DNA recombination reactions relating to the serine integrase gp35 and the
RDF gp47 from the bacteriophage Bxb1 and is referred to as a rewritable RAD
module. In contrast to their tyrosine cousins, serine recombinases mediate unidirec-
tional recombination which makes them conducive to inducible regulation of gene
expression [Bonnet et al., 2013].
The model accounts for the dynamical behaviour summarised in Fig. 3.2:
integrase and RDF are both expressed in monomeric form in solution, but integrase
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Figure 3.2: The RAD module DNA recombination reaction network taken from
Bonnet et al. [2012].
alone undergoes dimerisation in solution. That is, pairs of integrase monomers
bind together in solution to form dimeric complexes. Integrase dimers are then
able to bind specifically to attB and attP sites on the free DNA substrate. One
integrase dimer bound to each attachment site is necessary and sufficient to mediate
the primary inversion event, referred to as integration since it involves integrase
only. This causes the double stranded break in the DNA and the subsequent re-
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ligation of opposing ends of the intermediate genetic fragment that gives rise to the
composite attL and attR sites. RDF monomers only bind to integrase dimers already
bound to DNA, forming a synaptic tetramer. The binding of two RDF monomers
to each integrase:DNA synaptic complex is necessary and sufficient to mediate the
secondary inversion event, referred to as excision since both integrase and RDF are
involved. RDF is also able to bind integrase:DNA complexes in the BP state, thus
inhibiting integration; there is no RDF binding to integrase in solution [Bonnet et al.,
2012]. The BP and LR DNA states are tagged with GFP and RFP respectively to
provide clear readout of the recombination efficiency of the system. The model
describes in vivo DNA recombination and, as such, the expression and degradation
of recombinase proteins represent a key dynamical element; in vitro studies such as
[Ringrose et al., 1998] are void of environmental pressures and hence concentrations
of recombinases are synthesised experimentally. In all, the model is comprised of
nine distinct variables and eight parameters representing the integration-excision
DNA inversion mechanism.
The model was used to identify the operational properties of the RAD module
required for delivering digital information storage. The key feature of the system
is the efficiency of switching between DNA states. This is ascertained by estab-
lishing the concentration every molecular entity in the DNA state of interest and
computing the evolution of the summed total over time. The sum of the relevant
concentrations is referred to as the total register of the system and is calculated in
silico by summing each ODE corresponding to molecular entities in the same DNA
state. Experimentally, the total register of the system is measured directly as the
intensity of GFP or RFP output, with increased fluorescence signifying increased
recombination efficiency. Presuming that the module initially adopts the BP state,
the ‘set’ operation constitutes an efficient ‘on’ switch transitioning the system to the
LR state via induced integrase and an absence of excisionase; the ‘reset’ operation
therefore constitutes an efficient ‘off’ switch that reproduces the initial BP state via
induced integrase and RDF.
The ability of the system to demonstrate robust ‘hold’ states, whereby the
most recent set or reset operation is maintained in the absence of inducer, is an-
other important criterion with regards to temporal control of the module. Switching
efficiency is dependent on the concentrations of integrase and RDF in the system
however, these quantities are difficult to determine numerically. As a result, the
relative ratios of recombinase expression and degradation rates were examined with
respect to the percentage switching efficiency they produced. A vast array of ratios
were tested to provide expected dynamical responses with which to direct exper-
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imentation. That is, no experimental data was used to inform the selection of
individual parameter values or to provide specific outputs for model validation pur-
poses, and thus the model was suitably non-dimensionalised to offer operational
conditions to be emulated experimentally. All model parameters corresponding to
protein:DNA interactions were set equal to 1 with the basal and induced ratios of
recombinase expression and degradation rates set at 0.1 and 10 respectively. RAD
module operations were initially investigated in separation; set operations were iso-
lated with approximately 95% switching efficiency and a robust hold state in the
absence of RDF, which is intuitive given that the set function encompasses the in-
tegration reaction that is solely mediated by integrase. Isolated investigation of
the reset operation revealed reversibility in vivo despite experimental evidence of
approximately 100% switching efficiency regarding Bxb1 integrase and excisionase
in vitro [Ghosh et al., 2006]. This highlights the influence of noisy cellular condi-
tions on recombinase expression and degradation capable of causing re-integration
of the reset inverted genetic sequence that would be observed as reversibility and,
ultimately, system failure.
A full set-reset cycle was also attempted however, it was observed that the
majority of set and reset functions that exhibited high efficiency in isolation were
unable to give rise to sufficiently robust full cycles required of a digital storage
module. For example, the high concentrations of RDF required for efficient reset
operations is sufficient to corrupt efficient set operations since the presence of RDF
is inhibitory in the integration reaction. It was concluded that the model is capable
of identifying the appropriate ranges of recombinase expression and degradation
rates required of a reliable set-hold-reset-hold operative cycle [Bonnet et al., 2012].
That said, assembling the appropriate genetic constructs to realise this predicted
functionality proved to be particularly challenging due to difficulties associated with
inducing the expression of recombinase proteins and the timing of such induction
events within E. coli. Establishing a functional RAD module was eventually achieved
through an ad hoc approach involving ∼400 trials, reiterating the aforementioned
experimental limitations as well as the ramifications of noise and stochastic biological
processes. Given the uncertainty surrounding particular aspects of the system, such
as reversibility of the excision reaction and the search for the conditions necessary
for optimal RAD module operation, it is clear that modelling DNA recombination
warrants further consideration.
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3.2 Formulating a mechanistic model of in vitro RAD
module dynamics
An extensive review of the experimental literature was carried out in order to syn-
thesise the current state of knowledge regarding the mechanistic basis of DNA re-
combination. The literature review identified several mechanistic properties of the
system that are well established; the application of mass action kinetics to each
of the associated biochemical equations allows us to derive the system of ODEs
comprising our mechanistic model, as described below.
Monomeric integrase is known to form dimers reversibly in solution [Bonnet
et al., 2012; Brown et al., 2011; Fogg et al., 2014; Ghosh et al., 2005, 2008; Groth
and Calos, 2004; Gupta et al., 2007; Keenholtz et al., 2011; Khaleel et al., 2011; Liu
et al., 2010; Lucet et al., 2005; Mandali et al., 2013; McEwan et al., 2009, 2011; Miura
et al., 2011; Olorunniji and Stark, 2010; Olorunniji et al., 2012; Rowley and Smith,
2008; Singh et al., 2013; Smith et al., 2004, 2010; Stark et al., 2011; Thorpe et al.,
2000; Yuan et al., 2008; Zhang et al., 2010], and thus we can write the biochemical
equation:
I + I
k1−−−⇀↽ −
k−1
I2 (3.1)
where I and I2 denote monomeric and dimeric integrase respectively and ki are
the relevant reaction rate constants. Reversible reactions are denoted using right
and left arrows with the corresponding forward and backward reaction rates written
above and below respectively.
One integrase dimer bound to attB and attP is necessary to mediate the
integration reaction [Bonnet et al., 2012; Bai et al., 2011; Bibb et al., 2005; Breuner
et al., 1999, 2001; Brown et al., 2011; Cho et al., 2002; Combes et al., 2002; Fogg
et al., 2014; Ghosh et al., 2005, 2008; Groth and Calos, 2004; Gupta et al., 2007;
Keenholtz et al., 2011; Keravala et al., 2006; Khaleel et al., 2011; Kim et al., 2003;
Lewis and Hatfull, 2000; Liu et al., 2010; Mandali et al., 2013; Matsuura et al.,
1996; McEwan et al., 2009, 2011; Miura et al., 2011; Nkrumah et al., 2006; Olivares
et al., 2001; Olorunniji et al., 2012; Pena et al., 1999; Rowley and Smith, 2008;
Rutherford et al., 2013; Singh et al., 2013; Smith et al., 2004, 2010; Stark et al.,
2011; Thomson and Ow, 2006; Thorpe et al., 2000; Thyagarajan et al., 2001; van
Duyne and Rutherford, 2013; Yuan et al., 2008; Zhang et al., 2008, 2010], which is
unidirectional (irreversible) [Bonnet et al., 2012; Bai et al., 2011; Bibb and Hatfull,
2002; Bibb et al., 2005; Brown et al., 2011; Combes et al., 2002; Fogg et al., 2014;
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Groth and Calos, 2004; Gupta et al., 2007; Keravala et al., 2006; Khaleel et al.,
2011; Lewis and Hatfull, 2000; McEwan et al., 2009; Miura et al., 2011; Olivares
et al., 2001; Olorunniji et al., 2012; Rashel et al., 2008; Rowley and Smith, 2008;
Rutherford et al., 2013; Singh et al., 2013; Smith et al., 2010; Swalla et al., 2003;
Thomson and Ow, 2006; Thyagarajan et al., 2001; van Duyne and Rutherford, 2013;
Yuan et al., 2008; Zhang et al., 2008]. This gives the following additional dynamics:
DBP + I2
k4−−−⇀↽ −
k−4
DBP I2, (3.2)
DBP I2 + I2
k5−−−⇀↽ −
k−5
DBP I4, (3.3)
DBP I4
kR−−−→ DLRI4, (3.4)
DBP I2R+ I2
k8−−−⇀↽ −
k−8
DBP I4R, (3.5)
where DBP denotes free DNA in the BP state; DBP I2/DBP I4 denote DNA:protein
complexes with one/two integrase dimers bound in the BP state respectively; DLRI4
denotes the DNA:protein complex with two integrase dimers bound in the LR state;
R denotes monomeric RDF (gp3) and DBP I2R/DBP I4R denote DNA:protein com-
plexes with one/two integrase dimers and one gp3 monomer bound respectively in
the BP state. Reversible reactions are denoted by double arrows with the corre-
sponding reaction rate constants written above and below. Irreversible reactions
are denoted by a single right arrow with the corresponding reaction rate constant
written above. We include (3.5) here to acknowledge that dimeric integrase is able
to bind to any unoccupied attachment site, however, these particular complexes are
not directly involved in the integration reaction. The same dimeric integrase binding
occurs in the LR state and hence gives rise to the following equivalent biochemical
equations:
DLR + I2
k4−−−⇀↽ −
k−4
DLRI2, (3.6)
DLRI2 + I2
k5−−−⇀↽ −
k−5
DLRI4, (3.7)
DLRI2R+ I2
k8−−−⇀↽ −
k−8
DLRI4R, (3.8)
Gp3 binds to dimeric integrase already bound to DNA attachment sites and
it does not bind directly to DNA attachment sites [Bonnet et al., 2012; Ghosh et al.,
2006, 2008; Keenholtz et al., 2011; Khaleel et al., 2011; Singh et al., 2013; Yuan
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et al., 2008]. This gives:
DBP I2 +R
k10−−−⇀↽ −
k−10
DBP I2R, (3.9)
DBP I4 +R
k11−−−⇀↽ −
k−11
DBP I4R, (3.10)
DBP I4R+R
k12−−−⇀↽ −
k−12
DBP I4R2, (3.11)
DLRI2 +R
k10−−−⇀↽ −
k−10
DLRI2R, (3.12)
DLRI4 +R
k11−−−⇀↽ −
k−11
DLRI4R, (3.13)
DLRI4R+R
k12−−−⇀↽ −
k−12
DLRI4R2, (3.14)
where DLRI2/DLRI4 denote DNA:protein complexes with one/two integrase dimers
bound in the LR state; DLRI2R/DLRI4R denote DNA:protein complexes with
one/two integrase dimers and one gp3 monomer bound in the LR state; DBP I4R2/
DLRI4R2 denote DNA:protein complexes with two integrase dimers and two gp3
monomers bound in the BP/LR state.
Binding of gp3 to dimeric integrase already bound to both attL and attR is
necessary to mediate excision, restoring attB and attP [Bonnet et al., 2012; Breuner
et al., 2001; Brown et al., 2011; Combes et al., 2002; Groth and Calos, 2004; Khaleel
et al., 2011; Kim et al., 2003; Lewis and Hatfull, 2000; Liu et al., 2010; Lucet et al.,
2005; Mandali et al., 2013; McEwan et al., 2011; Miura et al., 2011; Nkrumah et al.,
2006; Olorunniji et al., 2012; Pena et al., 1999; Singh et al., 2013; Zhang et al., 2008,
2010]:
DLRI4R2
kR−−−−→ DBP I4R2. (3.15)
In contrast to the strong experimental evidence for each of the aforemen-
tioned mechanisms, we were unable to find a consensus in the literature regarding
three further significant biological details, namely:
1. The directionality of the excision reaction.
2. Gp3 dimerisation and subsequent tetramerisation in solution.
3. Monomeric integrase binding to DNA substrates.
These properties all represent potentially valid mechanisms within a model of DNA
recombination, each resulting in a mathematical model with distinct features. In the
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case of excision reaction directionality, bidirectional excision results in the following
biochemical equation:
DLRI4R2
kR−−−⇀↽ −
k−R
DBP I4R2. (3.16)
Implementing gp3 dimerisation and subsequent tetramerisation requires a
significantly greater number of additional biochemical equations, since this gives
rise to monomeric gp3 forming dimeric gp3, with these dimers binding to dimeric
integrase to form a tetramer in solution, and this tetramer being able to bind directly
to DNA attachment sites. The resultant biochemical equations are as follows:
R+R
k2−−−⇀↽ −
k−2
R2, (3.17)
I2 +R2
k3−−−⇀↽ −
k−3
I2R2, (3.18)
DBP + I2R2
k6−−−⇀↽ −
k−6
DBP I2R2, (3.19)
DBP I2R2 + I2R2
k7−−−⇀↽ −
k−7
DBP I4R4, (3.20)
DLR + I2R2
k6−−−⇀↽ −
k−6
DLRI2R2, (3.21)
DLRI2R2 + I2R2
k7−−−⇀↽ −
k−7
DLRI4R4, (3.22)
where R2 denotes dimeric gp3; I2R2 denotes the integrase:gp3 tetramer; DBP I2R2/
DLRI2R2 and DBP I4R4/DLRI4R4 denote the DNA:protein complexes with one/two
integrase:gp3 tetramers bound in the BP/LR state. We also investigated the per-
formance of a model accounting for gp3 dimerisation only, with no subsequent
tetramerisation in solution.
Monomeric integrase binding to DNA substrates contributes a further twelve
biochemical equations due to the fact that twelve intermediate complexes arise from
monomeric integrase binding compared to simplistic pairwise, dimeric binding:
DBP + I
k13−−−⇀↽ −
k−13
DBP I, (3.23)
DBP I + I
k14−−−⇀↽ −
k−14
DBP I2, (3.24)
DBP I2 + I
k15−−−⇀↽ −
k−15
DBP I3, (3.25)
DBP I3 + I
k16−−−⇀↽ −
k−16
DBP I4, (3.26)
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DBP I2R+ I
k17−−−⇀↽ −
k−17
DBP I3R, (3.27)
DBP I3R+ I
k18−−−⇀↽ −
k−18
DBP I4R, (3.28)
DLR + I
k13−−−⇀↽ −
k−13
DLRI, (3.29)
DLRI + I
k14−−−⇀↽ −
k−14
DLRI2, (3.30)
DLRI2 + I
k15−−−⇀↽ −
k−15
DLRI3, (3.31)
DLRI3 + I
k16−−−⇀↽ −
k−16
DLRI4, (3.32)
DLRI2R+ I
k17−−−⇀↽ −
k−17
DLRI3R, (3.33)
DLRI3R+ I
k18−−−⇀↽ −
k−18
DLRI4R. (3.34)
We also investigated a variety of other models accounting for combinations
of the aforementioned mechanisms as well as alternative gp3 binding mechanisms.
Initial testing of all potential models revealed a consistently higher recombination
efficiency than that observed in our experimental data. Given that in vitro integrase
dimerisation can potentially result in the formation of dysfunctional dimers that are
unable to bind effectively to DNA attachment sites, we incorporated a mechanism
whereby dysfunctional integrase dimers, I2X , form irreversibly in addition to the
reversible formation of functional dimeric integrase:
I + I
kintX−−−−→ I2X , (3.35)
where kintX denotes the rate of dysfunctional integrase dimerisation. As expected,
this mechanism reduced the concentration of functional dimeric integrase, I2, and
hence overall recombination efficiency, since integrase is involved in the mediation
of both recombination reactions.
We tested different models capturing alternative mechanisms implementing
each of the above features against our experimental data (see following section).
The model structure which showed the capability to best match the data is de-
picted in Figure 3.3. Our optimal reaction network consists of a unidirectional
excision reaction and monomeric integrase binding, and includes the formation of
dysfunctional integrase dimers and 2:1 integrase:RDF stoichiometry of the synaptic
complexes. When versions of the model incorporating gp3 dimerisation and sub-
sequent tetramerisation in solution were optimised against the experimental data,
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Figure 3.3: The DNA recombination reaction network used to derive both our in
vitro and in vivo mechanistic models. Molecular entities, reactions and reaction rate
constants common to both models are depicted in black; those depicted in green
describe the in vitro network and those depicted in orange describe the in vivo
network. Blue asterisks highlight DNA:protein complexes that are present in the
model of Bonnet et al. [2012], with the exception of the number of RDF monomers
required to mediate excision. The networks are based on the mechanisms that
have been verified in the current experimental literature along with others validated
computationally. We model the dynamics of φC31 integrase and its RDF, gp3.
Reactions and their rate constants are depicted by arrows and their corresponding
numbered k. The rate of recombination is denoted by kR. Figure adapted from
Bowyer et al. [2015].
the minimum error observed between the data and model outputs was larger than
that observed for models that do not account for the same mechanisms. We there-
fore omitted these mechanisms from the model. The application of mass action
kinetics to the biochemical equations identified through literature mining derives
the following system of 22 model ODEs:
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d[I]
dt
=2k−1[I2]− 2k1[I]2 − 2kintX[I]2+
k−13[DBP I]− k13[DBP ][I] + k−13[DLRI]− k13[DLR][I]+
k−14[DBP I2]− k14[DBP I][I] + k−14[DLRI2]− k14[DLRI][I]+
k−15[DBP I3]− k15[DBP I2][I] + k−15[DLRI3]− k15[DLRI2][I]+
k−16[DBP I4]− k16[DBP I3][I] + k−16[DLRI4]− k16[DLRI3][I]+
k−17[DBP I3R]− k17[DBP I2R][I] + k−17[DLRI3R]− k17[DLRI2R][I]+
k−18[DBP I4R]− k18[DBP I3R][I] + k−18[DLRI4R]− k18[DLRI3R][I], (3.36)
d[I2]
dt
=k1[I]
2 − k−1[I2]+
k−4[DBP I2]− k4[DBP ][I2] + k−4[DLRI2]− k4[DLR][I2]+
k−5[DBP I4]− k5[DBP I2][I2] + k−5[DLRI4]− k5[DLRI2][I2]+
k−8[DBP I4R]− k8[DBP I2R][I2] + k−8[DLRI4R]− k8[DLRI2R][I2], (3.37)
d[R]
dt
=k−10[DBP I2R]− k10[DBP I2][R] + k−10[DLRI2R]− k10[DLRI2][R]+
k−11[DBP I4R]− k11[DBP I4][R] + k−11[DLRI4R]− k11[DLRI4][R]+
k−12[DBP I4R2]− k12[DBP I4R][R] + k−12[DLRI4R2]− k12[DLRI4R][R], (3.38)
d[DBP ]
dt
=k−4[DBP I2]− k4[DBP ][I2] + k−13[DBP I]− k13[DBP ][I], (3.39)
d[DBP I2]
dt
=k4[DBP ][I2]− k−4[DBP I2] + k−5[DBP I4]− k5[DBP I2][I2]+
k−10[DBP I2R]− k10[DBP I2][R] + k14[DBP I][I]− k−14[DBP I2]+
k−15[DBP I3]− k15[DBP I2][I], (3.40)
d[DBP I4]
dt
=k5[DBP I2][I2]− k−5[DBP I4] + k−11[DBP I4R]− k11[DBP I4][R]+
k16[DBP I3][I]− k−16[DBP I4]− kR[DBP I4], (3.41)
d[DBP I2R]
dt
=k−8[DBP I4R]− k8[DBP I2R][I2] + k10[DBP I2][R]− k−10[DBP I2R]+
k−17[DBP I3R]− k17[DBP I2R][I], (3.42)
d[DBP I4R]
dt
=k8[DBP I2R][I2]− k−8[DBP I4R] + k11[DBP I4][R]− k−11[DBP I4R]+
k−12[DBP I4R2]− k12[DBP I4R][R] + k18[DBP I3R][I]− k−18[DBP I4R], (3.43)
d[DBP I4R2]
dt
=k12[DBP I4R][R]− k−12[DBP I4R2] + kR[DLRI4R2], (3.44)
d[DLR]
dt
=k−4[DLRI2]− k4[DLR][I2] + k−13[DLRI]− k13[DLR][I], (3.45)
d[DLRI2]
dt
=k4[DLR][I2]− k−4[DLRI2] + k−5[DLRI4]− k5[DLRI2][I2]+
k−10[DLRI2R]− k10[DLRI2][R] + k14[DLRI][I]− k−14[DLRI2]+
k−15[DLRI3]− k15[DLRI2][I], (3.46)
d[DLRI4]
dt
=k5[DLRI2][I2]− k−5[DLRI4] + k−11[DLRI4R]− k11[DLRI4][R]+
k16[DLRI3][I]− k−16[DLRI4] + kR[DBP I4], (3.47)
d[DLRI2R]
dt
=k−8[DLRI4R]− k8[DLRI2R][I2] + k10[DLRI2][R]− k−10[DLRI2R]+
k−17[DLRI3R]− k17[DLRI2R][I], (3.48)
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d[DLRI4R]
dt
=k8[DLRI2R][I2]− k−8[DLRI4R] + k11[DLRI4][R]− k−11[DLRI4R]+
k−12[DLRI4R2]− k12[DLRI4R][R] + k18[DLRI3R][I]− k−18[DLRI4R], (3.49)
d[DLRI4R2]
dt
=k12[DLRI4R][R]− k−12[DLRI4R2]− kR[DLRI4R2], (3.50)
d[I2X ]
dt
=kintX[I]
2, (3.51)
d[DBP I]
dt
=k13[DBP ][I]− k−13[DBP I]− k14[DBP I][I] + k−14[DBP I2], (3.52)
d[DBP I3]
dt
=k15[DBP I2][I]− k−15[DBP I3]− k16[DBP I3][I] + k−16[DBP I4], (3.53)
d[DBP I3R]
dt
=k17[DBP I2R][I]− k−17[DBP I3R]− k18[DBP I3R][I] + k−18[DBP I4R], (3.54)
d[DLRI]
dt
=k13[DLR][I]− k−13[DLRI]− k14[DLRI][I] + k−14[DLRI2], (3.55)
d[DLRI3]
dt
=k15[DLRI2][I]− k−15[DLRI3]− k16[DLRI3][I] + k−16[DLRI4], (3.56)
d[DLRI3R]
dt
=k17[DLRI2R][I]− k−17[DLRI3R]− k18[DLRI3R][I] + k−18[DLRI4R], (3.57)
where the square bracket notation denotes concentration and the reaction rate con-
stants form the 28 corresponding model parameters, denoted by each numbred k.
The efficiency of the RAD module to switch from one DNA state to the other is
taken to be the concentration of free DNA and DNA complexes in the final state
as a percentage of the concentration of free DNA in the initial state. That is, we
analyse the total register of the system in the DNA state of interest. This simply in-
volves summing the ODEs corresponding to all DNA-based molecular entities of the
same DNA state. Summing each set of nine ODEs corresponding to each DNA state
((3.39)-(3.44) and (3.52)-(3.54) for the BP state; (3.45)-(3.50) and (3.55)-(3.57) for
the LR state) gives two ODEs describing the dynamics of the total register of the
system in BP state, DBPtot, and LR state, DLRtot:
dDBPtot
dt
= −kRDBP I4 + kRDLRI4R2, (3.58)
dDLRtot
dt
= kRDBP I4 − kRDLRI4R2. (3.59)
Our computational model simulations are the numerical solutions to (3.58) and
(3.59) and are converted to a percentage of the initial concentration of DNA to
demonstrate switching efficiency. The total DNA register is calculated in this fashion
for all versions of the recombination network tested. In each case, the full system
of ODEs is solved numerically in order to determine the total register, that is, no
attempt is made to reduce the complexity and dimensionality of our mechanistic
models.
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3.3 Model validation via global optimisation
We compared our model to the existing model of in vivo DNA recombination pro-
posed in Bonnet et al. [2012] for its ability to match and predict a new set of in vitro
data on dynamic and steady-state recombination efficiency in the presence of differ-
ent concentrations of integrase and gp3. The model in Bonnet et al. [2012] is derived
from a simple reaction network comprised of nine molecular entities and is void of
considerable mechanistic detail such as monomeric integrase binding, the intermedi-
ate complexes arising from individual dimeric integrase and monomeric gp3 binding,
and a 2:1 integrase:gp3 complex stoichiometry. To ensure the validity of the model
comparisons, we adapted the model of Bonnet et al. [2012] to the in vitro context
and also imposed the same dysfunctional integrase dimerisation mechanism from our
optimal model (Figure 3.4). Optimal model performance was evaluated by using the
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DNA with AttL and AttR 
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Figure 3.4: The DNA recombination reaction network adapted from Bonnet et al.
[2012]. The exclusion of SSR expression and degradation coupled with the inclu-
sion of dysfunctional integrase dimerisation accounts for our in vitro experimental
conditions.
GA to minimise an error function defined to capture the difference between model
outputs and our experimental data on in vitro steady-state recombination efficiency
for both integration and excision reactions.
Six distinct initial concentrations (0, 50, 100, 200, 400 and 800 nM) of in-
tegrase and gp3 give the 36 pairs of initial concentrations used experimentally to
record the steady-state recombination efficiency of the system. This was performed
72
for both the integration and excision reactions, giving an experimental dataset of
72 values. The efficiencies are given as a percentage of the initial concentration of
free DNA which was set at 10 nM. Time course data was also available whereby the
recombination efficiency of both reactions was recorded at 10 time points (0, 1, 2,
4, 8, 16, 32, 64, 128 and 180 minutes) for two distinct pairs of initial concentrations
of integrase and gp3 (800 nM integrase, 0 nM gp3 and 400 nM integrase, 0 nM
gp3). Our model is well suited to simulating this type of data since the dimensional
outputs of the system (nanomolar concentrations) align with our mass action math-
ematical derivation, and we are able to simulate both the steady-state endpoint and
full dynamical time course response of the total register over the same duration that
the data were recorded (3 hours). Since our dataset was relatively large, we supplied
our GA error function with a subset of the data, with the remaining data used to
evaluate the predictive capabilities of our models. The subset used in data fitting
was chosen to capture the full spectrum of recombination efficiencies, and all models
were optimised against the same subset of experimental data and within the same
parameter space.
The model of Bonnet et al. [2012] is unable to accurately match the subset
of steady-state data (Figure 3.5A). In the case of the integration (BP-LR) reaction,
simulations appear to be accurate for the relatively low concentration of integrase
(50 nM) however, as the concentration of integrase increases, accurate fits can only
be found for 800 nM integrase, 0 nM gp3. In fact, the simple model is only capa-
ble of simulating negligible recombination efficiencies for non-zero concentrations of
gp3, regarding the integration reaction. This may appear to be an intuitive result
given that integrase alone mediates integration, however, our data clearly indicates
that the system can achieve high integration efficiencies in the presence of both
SSRs. Similarly for the excision (LR-BP) reaction, simulations appear to be accu-
rate for 50 nM integrase, but are unable to match the majority of data as integrase
concentration increases. In fact, the model is only capable of simulating negligible
recombination efficiencies for 0 nM gp3 and uniform efficiencies for all non-zero gp3
concentrations, regarding the excision reaction. The former observation is intuitive,
since gp3 is required in combination with integrase to mediate excision, but we have
no logical reason to justify the latter. With regards to prediction, we observe the
same trends for both reactions meaning that the model of Bonnet et al. [2012] is
void of the predictive qualities required of a useful design tool.
In contrast, our mechanistic model clearly provides a strong fit to the subset
of steady-state data used in the GA global optimisation (Figure 3.5B). In the case
of both reactions, we observe accurate replication of the majority of data values.
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B 
Figure 3.5: A) Data fitting/prediction results for the model of Bonnet et al. [2012].
B) Data fitting/prediction results for our mechanistic model. In both A and B the
top row of bar graphs represents the integration reaction and the bottom row of bar
graphs represents the excision reaction. The wider bars represent model simulations
and the thinner bars represent data. Figure adapted from Bowyer et al. [2015].
The model also predicts the remaining data values effectively, presenting a clear
validation of the mechanistic structure we have developed and the potential power
of our model as a design tool. Similar trends are observed when we compare time
course integration simulations (Figure 3.6). For 800 nM integrase, 0 nM gp3 the
model of Bonnet et al. [2012] replicates the overall efficiency, but does not perform
to the same extent for 400 nM integrase, 0 nM gp3. In both cases, the model
exhibits a step-like response which does not match the gradual response recorded
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Figure 3.6: Data fitting results for the model of Bonnet et al. [2012] and our mech-
anistic model against time course data. Model simulations are plotted against two
integration reaction time course data sets; A) and C) initiated with 800 nM inte-
grase; B) and D) initiated with 400 nM integrase. Figure adapted from Bowyer
et al. [2015].
experimentally. Again, our mechanistic model shows much improved performance,
capturing the final efficiencies as well as the appropriate dynamical response in both
cases.
We employed the GA function in MATLAB in order to optimise our models
against the experimental data. For each model the reaction rate constants ki were
chosen as optimisation variables. The GA mimics natural selection; converging to
the global minimum within the allocated parameter space by evolving an initial
population of randomly generated solutions over a large number of generations.
The probability of obtaining the global optimum solution is maximised by selecting
the largest population size and number of generations possible. However, increasing
the computational workload in this manner also greatly increases the time frame
required for the algorithm to converge. Establishing an effective compromise is key
for successful deployment. After a number of trials, the following parameter values
for the GA were chosen:
• Population: 100
• Generations: 1000
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• Bounds imposed on parameter values: [0.001, 1000]
A population size of 100 was selected for the vast majority of optimisations how-
ever, in cases where the number of model parameters was significantly increased, we
increased this figure to ensure that the population:parameters ratio was never less
than 3:1. We selected a particularly large parameter space due to our focus on estab-
lishing optimal model performance in light of the lack of documentation regarding
reaction rates. The GA runs the given model under the same conditions used ex-
perimentally, with the resulting in silico recombination efficiencies subtracted from
the in vitro data values to give a matrix of error values. We then take the absolute
value of each matrix entry and then calculate the total sum to give an overall error,
E, specifically:
E =
4∑
j=1
3∑
i=1
|pij |+
4∑
j=1
3∑
i=1
|qij |, pij ∈ P, qij ∈ Q (3.60)
where P = SBP −DBP and Q = SLR −DLR i.e. P and Q are the 3 × 4 matrices
calculated by subtracting the matrices of data values (DBP , DLR) from the matrices
of model simulations (SBP , SLR) for the BP and LR reactions respectively. The
matrices are comprised of 12 elements since our data subset contains twelve values
for each reaction, and hence the model performs 12 corresponding simulations. The
end result is a set of model parameters that gave rise to the minimum overall error
(Table 3.1).
Repeated optimisation using identical GA options revealed similar optimal
parameter sets, indicating that optimal solutions are limited to this small subset of
the parameter space. On inspection, the variation in the orders of magnitude across
the optimal parameter sets identified for both the simple and mechanistic models
is small, and hence it is likely that these optimal parameter values are biologically
plausible. That said, there is no guarantee that the rates of the reactions comprising
biological systems are always relatively similar in magnitude and therefore experi-
mental measurement will always provide the clearest indication of parameter space
constraints and notions of parameter plausibility.
Although the simplified model presented in Bonnet et al. [2012] is unable
to provide the quantitative simulations we require, such models can be beneficial
in other respects. Simplification reduces the dimensionality and non-linearity of a
model, which ultimately reduces the complexity of any subsequent mathematical
analysis. Overall, decisions regarding the extent of model refinement should align
with specific research objectives. Here, we prioritise the construction of models that
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A
Optimal parameters: simple model
Reaction Value (nM−1s−1) Reaction Value (s−1)
ki 0.009 k−i 0.616
kdi 2.587 k−di 4.140
kdix 0.198 k−dix 0.193
kintX 0.334 kc 0.261
B
Optimal parameters: mechanistic model
Reaction Value (nM−1s−1) Reaction Value (s−1)
k1 163.949 k−1 352.237
k4 509.124 k−4 953.116
k5 210.936 k−5 397.805
k8 274.334 k−8 777.991
k10 54.654 k−10 530.778
k11 0.251 k−11 321.409
k12 0.757 k−12 716.045
k13 109.882 k−13 157.660
k14 1.501 k−14 201.079
k15 0.470 k−15 354.830
k16 477.208 k−16 985.078
k17 137.581 k−17 560.996
k18 223.514 k−18 466.036
kintX 533.668 kR 303.965
Table 3.1: A) Optimal parameter values for the simple in vitro model adapted from
Bonnet et al. [2012], used to generate Figure 3.5A. B) Optimal parameter values
for our mechanistic in vitro model, used to generate Figure 3.5B. These optimal
parameter sets are dimensional with reaction rates in the first and second columns
taking the units nM−1s−1 and s−1 respectively from standard mass action kinetics.
provide the most accurate quantitative outputs possible, and hence maximal mecha-
nistic detail is retained at the expense of mathematical analysis. Future studies will
readdress this balance in order to determine whether the fundamental mathematical
properties of the system can be verified experimentally.
The improvement in performance provided by our mechanistic model, com-
pared to the simpler model, is not parameter-dependent. Increased mechanistic
detail does lead to an increased number of model parameters in this case, however
simply increasing the number of parameters does not ensure greater accuracy. This is
clear given that a number of mechanisms that were explored through model develop-
ment resulted in an increase in the minimal error determined via global optimisation,
despite the fact that their inclusion also increased the number of parameters (see
section 3.2). Model selection methods, such as the ABC-SMC inference employed by
ABC-SysBio, are effective in establishing the relative quality of different candidate
models regardless of whether each candidate has the same number of parameters.
Hence, the application of model selection to a set of candidates that each account
for one mechanistic property of interest presents a more systematic approach to the
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global optimisation trials we performed in this Chapter. It remains to verify that
both methods achieve the same result.
3.3.1 Experimental methods
Experimental data was generated by our experimental collaborators at the Univer-
sity of Glasgow according to the following protocol:
Proteins (φC31 integrase and gp3) were purified as described in Smith et al.
[2004]; Olorunniji et al. [2012]; Khaleel et al. [2011]. Integrase and gp3 were diluted
in integrase dilution buffer [25 mM Tris·HCl (pH 7.5), 1 mM DTT, 1 M NaCl,
and 50% (vol/vol) glycerol] and kept at −20 ◦C. Substrate plasmids containing
inverted repeat recombination sites (pZJ56off with attB and attP; pZJ56on with
attR and attL) used for in vitro assay were prepared from E. coli DH5, using a
plasmid miniprep kit (Qiagen). DNA concentrations were determined by measuring
the absorbance at 260 nm.
In a typical reaction, premixed integrase and gp3 with ten times their final
concentrations were added to a solution of substrate plasmid (∼10 nM) in a reaction
buffer [50 mM Tris·HCl (pH 7.5), 0.1 mM EDTA, 5 mM spermidine, and 0.1 mg/ml
BSA]. Reactions were carried out at 30 ◦C, terminated at various time points, by
heating the samples to 80 ◦C for 10 minutes. Samples were digested with restriction
enzymes, then, treated with 5 µl of loading buffer [25 mM Tris·HCl (pH 8.2), 20%
(wt/vol) Ficoll, 0.5% sodium dodecyl sulphate, 5 mg/ml protease K, 0.25 mg/ml
bromophenol blue] at 37 ◦C for 30 minutes prior to loading onto 1.2% (wt/vol)
agarose gels. Gels were stained with ethidium bromide, destained in electropora-
tion buffer, and photographed using Bio-Rad UV Transilluminator. Recombinant
and non-recombinant DNA bands were quantified using the volume analysis tool of
Quantity One software.
3.4 Non-dimensional simulations of in vivo RAD mod-
ule dynamics
Having validated our mechanistic model against in vitro data, we sought to analyse
model performance within an in vivo context. All available experimental data sug-
gests that the DNA:protein binding interactions of the in vitro system are retained
in vivo, with the introduction of protein expression and degradation representing
the key adaptations. Thus, the mechanisms removed from the model of Bonnet
et al. [2012] in order to analyse in vitro dynamics were restored and we adapted our
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own mechanistic model accordingly (Figure 3.3).
Increased expression and degradation rates of the SSRs are induced to realise
desired RAD module operations and hence we also account for basal expression and
degradation rates occurring in the absence of induction. SSR induction is performed
experimentally through chemical stimuli. The formation of dysfunctional dimeric
integrase is removed from both models as we have no reason to justify its existence
in this context. This reduces the number of ODEs in our mechanistic model to
twenty-one since I2X is no longer present:
d[I]
dt
=ai − yi[I] + 2k−1[I2]− 2k1[I]2+
k−13[DBP I]− k13[DBP ][I] + k−13[DLRI]− k13[DLR][I]+
k−14[DBP I2]− k14[DBP I][I] + k−14[DLRI2]− k14[DLRI][I]+
k−15[DBP I3]− k15[DBP I2][I] + k−15[DLRI3]− k15[DLRI2][I]+
k−16[DBP I4]− k16[DBP I3][I] + k−16[DLRI4]− k16[DLRI3][I]+
k−17[DBP I3R]− k17[DBP I2R][I] + k−17[DLRI3R]− k17[DLRI2R][I]+
k−18[DBP I4R]− k18[DBP I3R][I] + k−18[DLRI4R]− k18[DLRI3R][I], (3.61)
d[I2]
dt
=k1[I]
2 − k−1[I2]− yi[I2]+
k−4[DBP I2]− k4[DBP ][I2] + k−4[DLRI2]− k4[DLR][I2]+
k−5[DBP I4]− k5[DBP I2][I2] + k−5[DLRI4]− k5[DLRI2][I2]+
k−8[DBP I4R]− k8[DBP I2R][I2] + k−8[DLRI4R]− k8[DLRI2R][I2], (3.62)
d[R]
dt
=ax − yx[R] + k−10[DBP I2R]− k10[DBP I2][R] + k−10[DLRI2R]− k10[DLRI2][R]+
k−11[DBP I4R]− k11[DBP I4][R] + k−11[DLRI4R]− k11[DLRI4][R]+
k−12[DBP I4R2]− k12[DBP I4R][R] + k−12[DLRI4R2]− k12[DLRI4R][R], (3.63)
d[DBP ]
dt
=k−4[DBP I2]− k4[DBP ][I2] + k−13[DBP I]− k13[DBP ][I], (3.64)
d[DBP I2]
dt
=k4[DBP ][I2]− k−4[DBP I2] + k−5[DBP I4]− k5[DBP I2][I2]+
k−10[DBP I2R]− k10[DBP I2][R] + k14[DBP I][I]− k−14[DBP I2]+
k−15[DBP I3]− k15[DBP I2][I], (3.65)
d[DBP I4]
dt
=k5[DBP I2][I2]− k−5[DBP I4] + k−11[DBP I4R]− k11[DBP I4][R]+
k16[DBP I3][I]− k−16[DBP I4]− kR[DBP I4], (3.66)
d[DBP I2R]
dt
=k−8[DBP I4R]− k8[DBP I2R][I2] + k10[DBP I2][R]− k−10[DBP I2R]+
k−17[DBP I3R]− k17[DBP I2R][I], (3.67)
d[DBP I4R]
dt
=k8[DBP I2R][I2]− k−8[DBP I4R] + k11[DBP I4][R]− k−11[DBP I4R]+
k−12[DBP I4R2]− k12[DBP I4R][R] + k18[DBP I3R][I]− k−18[DBP I4R], (3.68)
d[DBP I4R2]
dt
=k12[DBP I4R][R]− k−12[DBP I4R2] + kR[DLRI4R2], (3.69)
d[DLR]
dt
=k−4[DLRI2]− k4[DLR][I2] + k−13[DLRI]− k13[DLR][I], (3.70)
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d[DLRI2]
dt
=k4[DLR][I2]− k−4[DLRI2] + k−5[DLRI4]− k5[DLRI2][I2]+
k−10[DLRI2R]− k10[DLRI2][R] + k14[DLRI][I]− k−14[DLRI2]+
k−15[DLRI3]− k15[DLRI2][I], (3.71)
d[DLRI4]
dt
=k5[DLRI2][I2]− k−5[DLRI4] + k−11[DLRI4R]− k11[DLRI4][R]+
k16[DLRI3][I]− k−16[DLRI4] + kR[DBP I4], (3.72)
d[DLRI2R]
dt
=k−8[DLRI4R]− k8[DLRI2R][I2] + k10[DLRI2][R]− k−10[DLRI2R]+
k−17[DLRI3R]− k17[DLRI2R][I], (3.73)
d[DLRI4R]
dt
=k8[DLRI2R][I2]− k−8[DLRI4R] + k11[DLRI4][R]− k−11[DLRI4R]+
k−12[DLRI4R2]− k12[DLRI4R][R] + k18[DLRI3R][I]− k−18[DLRI4R], (3.74)
d[DLRI4R2]
dt
=k12[DLRI4R][R]− k−12[DLRI4R2]− kR[DLRI4R2], (3.75)
d[DBP I]
dt
=k13[DBP ][I]− k−13[DBP I]− k14[DBP I][I] + k−14[DBP I2], (3.76)
d[DBP I3]
dt
=k15[DBP I2][I]− k−15[DBP I3]− k16[DBP I3][I] + k−16[DBP I4], (3.77)
d[DBP I3R]
dt
=k17[DBP I2R][I]− k−17[DBP I3R]− k18[DBP I3R][I] + k−18[DBP I4R], (3.78)
d[DLRI]
dt
=k13[DLR][I]− k−13[DLRI]− k14[DLRI][I] + k−14[DLRI2], (3.79)
d[DLRI3]
dt
=k15[DLRI2][I]− k−15[DLRI3]− k16[DLRI3][I] + k−16[DLRI4], (3.80)
d[DLRI3R]
dt
=k17[DLRI2R][I]− k−17[DLRI3R]− k18[DLRI3R][I] + k−18[DLRI4R], (3.81)
where ai and yi denote the expression and degradation rates of integrase respectively
and ax and yx denote the expression and degradation rates of RDF respectively. All
in vivo modelling utilises the model of Bonnet et al. [2012] and our mechanistic
model developed previously in their non-dimensional forms, in order to permit valid
numerical simulations and direct mathematical comparisons [Bonnet et al., 2012;
Wu et al., 2013]. Analysis of the dimensionality of the terms in our mechanistic
model reveals that our model parameters have one of three dimensions:
[ai] = [ax] =
M
T
, (3.82)
[yi] = [yx] = [k−n] = [kR] =
1
T
, (3.83)
[kn] =
1
MT
, (3.84)
for n ∈ {1, 4, 5, 8, 10, 11, 12, 13, 14, 15, 16, 17, 18}. Hence, we have,[
k−1
k1
]
=
[k−1]
[k1]
=
1
T
1
MT
=
1
T
.
MT
1
= M, (3.85)
80
which identifies the ratio k−1k1 as having the appropriate dimensionality for rescaling
concentration. With this, and taking the reciprocal of kR with the appropriate
dimensionality to rescale time (T ), we can introduce the following non-dimensional
variables:
X =
k−1
k1
Xˆ ∀X ∈ (3.61)− (3.81), (3.86)
t =
1
kR
τ, (3.87)
where X represents all dependent variables in our model (equations (3.61)-(3.81)),
Xˆ represents the corresponding non-dimensional variable and τ represents non-
dimensional time. Substituting (3.86) and (3.87) into (3.61)-(3.81) yields our full
non-dimensional model:
dIˆ
dτ
=a¯i − y¯iIˆ + 2k¯−1Iˆ2 − 2k¯−1Iˆ2+
k¯−13 ˆDBP I − k¯13 ˆDBP Iˆ + k¯−13 ˆDLRI − k¯13 ˆDLRIˆ+
k¯−14 ˆDBP I2 − k¯14 ˆDBP IIˆ + k¯−14 ˆDLRI2 − k¯14 ˆDLRIIˆ+
k¯−15 ˆDBP I3 − k¯15 ˆDBP I2Iˆ + k¯−15 ˆDLRI3 − k¯15 ˆDLRI2Iˆ+
k¯−16 ˆDBP I4 − k¯16 ˆDBP I3Iˆ + k¯−16 ˆDLRI4 − k¯16 ˆDLRI3Iˆ+
k¯−17 ˆDBP I3R− k¯17 ˆDBP I2RIˆ + k¯−17 ˆDLRI3R− k¯17 ˆDLRI2RIˆ+
k¯−18 ˆDBP I4R− k¯18 ˆDBP I3RIˆ + k¯−18 ˆDLRI4R− k¯18 ˆDLRI3RIˆ, (3.88)
dIˆ2
dτ
=k¯−1Iˆ2 − k¯−1Iˆ2 − y¯iIˆ2+
k¯−4 ˆDBP I2 − k¯4 ˆDBP Iˆ2 + k¯−4 ˆDLRI2 − k¯4 ˆDLRIˆ2+
k¯−5 ˆDBP I4 − k¯5 ˆDBP I2Iˆ2 + k¯−5 ˆDLRI4 − k¯5 ˆDLRI2Iˆ2+
k¯−8 ˆDBP I4R− k¯8 ˆDBP I2RIˆ2 + k¯−8 ˆDLRI4R− k¯8 ˆDLRI2RIˆ2, (3.89)
dRˆ
dτ
=a¯x − y¯xRˆ+ k¯−10 ˆDBP I2R− k¯10 ˆDBP I2Rˆ+ k¯−10 ˆDLRI2R− k¯10 ˆDLRI2Rˆ+
k¯−11 ˆDBP I4R− k¯11 ˆDBP I4Rˆ+ k¯−11 ˆDLRI4R− k¯11 ˆDLRI4Rˆ+
k¯−12 ˆDBP I4R2 − k¯12 ˆDBP I4RRˆ+ k¯−12 ˆDLRI4R2 − k¯12 ˆDLRI4RRˆ, (3.90)
d ˆDBP
dτ
=k¯−4 ˆDBP I2 − k¯4 ˆDBP Iˆ2 + k¯−13 ˆDBP I − k¯13 ˆDBP Iˆ, (3.91)
d ˆDBP I2
dτ
=k¯4 ˆDBP Iˆ2 − k¯−4 ˆDBP I2 + k¯−5 ˆDBP I4 − k¯5 ˆDBP I2Iˆ2+
k¯−10 ˆDBP I2R− k¯10 ˆDBP I2Rˆ+ k¯14 ˆDBP IIˆ − k¯−14 ˆDBP I2+
k¯−15 ˆDBP I3 − k¯15 ˆDBP I2Iˆ, (3.92)
d ˆDBP I4
dτ
=k¯5 ˆDBP I2Iˆ2 − k¯−5 ˆDBP I4 + k¯−11 ˆDBP I4R− k¯11 ˆDBP I4Rˆ+
k¯16 ˆDBP I3Iˆ − k¯−16 ˆDBP I4 − ˆDBP I4, (3.93)
d ˆDBP I2R
dτ
=k¯−8 ˆDBP I4R− k¯8 ˆDBP I2RIˆ2 + k¯10 ˆDBP I2Rˆ− k¯−10 ˆDBP I2R+
k¯−17 ˆDBP I3R− k¯17 ˆDBP I2RIˆ, (3.94)
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d ˆDBP I4R
dτ
=k¯8 ˆDBP I2RIˆ2 − k¯−8 ˆDBP I4R+ k¯11 ˆDBP I4Rˆ− k¯−11 ˆDBP I4R+
k¯−12 ˆDBP I4R2 − k¯12 ˆDBP I4RRˆ+ k¯18 ˆDBP I3RIˆ − k¯−18 ˆDBP I4R, (3.95)
d ˆDBP I4R2
dτ
=k¯12 ˆDBP I4RRˆ− k¯−12 ˆDBP I4R2 + ˆDLRI4R2, (3.96)
d ˆDLR
dτ
=k¯−4 ˆDLRI2 − k¯4 ˆDLRIˆ2 + k¯−13 ˆDLRI − k¯13 ˆDLRIˆ, (3.97)
d ˆDLRI2
dτ
=k¯4 ˆDLRIˆ2 − k¯−4 ˆDLRI2 + k¯−5 ˆDLRI4 − k¯5 ˆDLRI2Iˆ2+
k¯−10 ˆDLRI2R− k¯10 ˆDLRI2Rˆ+ k¯14 ˆDLRIIˆ − k¯−14 ˆDLRI2+
k¯−15 ˆDLRI3 − k¯15 ˆDLRI2Iˆ, (3.98)
d ˆDLRI4
dτ
=k¯5 ˆDLRI2Iˆ2 − k¯−5 ˆDLRI4 + k¯−11 ˆDLRI4R− k¯11 ˆDLRI4Rˆ+
k¯16 ˆDLRI3Iˆ − k¯−16 ˆDLRI4 + ˆDBP I4, (3.99)
d ˆDLRI2R
dτ
=k¯−8 ˆDLRI4R− k¯8 ˆDLRI2RIˆ2 + k¯10 ˆDLRI2Rˆ− k¯−10 ˆDLRI2R+
k¯−17 ˆDLRI3R− k¯17 ˆDLRI2RIˆ, (3.100)
d ˆDLRI4R
dτ
=k¯8 ˆDLRI2RIˆ2 − k¯−8 ˆDLRI4R+ k¯11 ˆDLRI4Rˆ− k¯−11 ˆDLRI4R+
k¯−12 ˆDLRI4R2 − k¯12 ˆDLRI4RRˆ+ k¯18 ˆDLRI3RIˆ − k¯−18 ˆDLRI4R, (3.101)
d ˆDLRI4R2
dτ
=k¯12 ˆDLRI4RRˆ− k¯−12 ˆDLRI4R2 − ˆDLRI4R2, (3.102)
d ˆDBP I
dτ
=k¯13 ˆDBP Iˆ − k¯−13 ˆDBP I − k¯14 ˆDBP IIˆ + k¯−14 ˆDBP I2, (3.103)
d ˆDBP I3
dτ
=k¯15 ˆDBP I2Iˆ − k¯−15 ˆDBP I3 − k¯16 ˆDBP I3Iˆ + k¯−16 ˆDBP I4, (3.104)
d ˆDBP I3R
dτ
=k¯17 ˆDBP I2RIˆ − k¯−17 ˆDBP I3R− k¯18 ˆDBP I3RIˆ + k¯−18 ˆDBP I4R, (3.105)
d ˆDLRI
dτ
=k¯13 ˆDLRIˆ − k¯−13 ˆDLRI − k¯14 ˆDLRIIˆ + k¯−14 ˆDLRI2, (3.106)
d ˆDLRI3
dτ
=k¯15 ˆDLRI2Iˆ − k¯−15 ˆDLRI3 − k¯16 ˆDLRI3Iˆ + k¯−16 ˆDLRI4, (3.107)
d ˆDLRI3R
dτ
=k¯17 ˆDLRI2RIˆ − k¯−17 ˆDLRI3R− k¯18 ˆDLRI3RIˆ + k¯−18 ˆDLRI4R, (3.108)
where the parameter k1 has been factored out of the system, thus reducing the total
number of parameters by one, and we denote non-dimensional parameters using the
same corresponding numerical subscripts as the dimensional model with the addition
of the bar notation. The square bracket notation is no longer appropriate since we
have removed dimensionality from the model.
The main focus of our in vivo investigation is the excision reaction, since
the integration reaction is straightforward to elucidate; over-expression of integrase
is guaranteed to induce highly efficient integration for relatively low gp3 expression
since integration is mediated by integrase only. However, the excision reaction is nu-
anced by its mediation by both SSRs and directly influences the functionality of the
RAD module as a result. A brute-force approach of over-expressing integrase and
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gp3 simultaneously to achieve highly efficient excision is an intuitive notion before
considering that desirable RAD module functionality will often require hold states.
That is, once excision has been induced through simultaneous over-expression, it
is likely that spontaneous re-integration will occur due to high residual integrase
concentration and gp3 dissociation. Therefore it is not conceptually obvious how
to induce highly efficient excision and then hold that state equally efficiently in the
absence of induction. Figure 3.7 depicts the in vivo RAD module dynamics for 2.5
repeated OFF-HOLD-ON-HOLD operative cycles for both the simple model and
our mechanistic model. We define RAD module operations as follows: ON is an
 
Figure 3.7: RAD module in vivo switching efficiencies for the model of [Bonnet
et al., 2012] and our mechanistic model. Both models simulate 2.5 repeated OFF-
HOLD-ON-HOLD operative cycles. All non-dimensional parameter values for both
models are set equal to 1 to simulate these plots with the exception of ai and ax.
For the ON operation ai = 10, ax = 0.1; the OFF operation ai = ax = 10; the
HOLD operation ai = ax = 0.1.
integration reaction induced through increased integrase levels only, OFF is an ex-
cision reaction induced through simultaneously increased integrase and gp3 levels
and HOLD is the restoration of basal SSR levels following either ON or OFF opera-
tions. Both models exhibit consistent switching efficiencies across each of their own
repeated cycles which demonstrates that the module can maintain performance over
many identical induction events. That is, the process of inducing desired SSR expres-
sion/degradation should permit efficient module operations whenever required, and
regardless of switching the module ON or OFF. Both models hold state efficiently
following an integration reaction since basal SSR levels are restored in the absence of
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induction and hence there is insufficient gp3 to mediate natural re-excision. There
is, however, a notable distinction between the performance of the models in the
efficiency of the HOLD state following the induction of an excision reaction. We
observe natural re-integration efficiencies of ∼47% for the model of Bonnet et al.
[2012] against ∼23% for our mechanistic model. This suggests that the efficiency of
RAD module HOLD states following excision is, in fact, greater than expected from
the model of Bonnet et al. [2012]. To determine the reasons for this, we analyse the
mechanistic distinctions between the two models. Compared to the simple model,
our mechanistic model accounts for the following additional mechanisms:
1. Monomeric integrase binding to free DNA substrates.
2. Formation of synaptic complexes with 2:1 stoichiometry.
3. Formation of intermediate DNA:protein complexes.
Figure 3.8 shows the effect of these biological distinctions on HOLD state efficiency
following excision. We apply each distinction to the model of Bonnet et al. [2012]
 
Figure 3.8: RAD module in vivo HOLD state efficiencies for the model of Bonnet
et al. [2012] and our mechanistic model. The dashed line plots demonstrate the
improvements on HOLD state efficiency made by each distinction between the two
models. Intermediate complexes and monomeric integrase binding are abbreviated
to IC and MIB respectively. In each case an OFF-HOLD operative cycle is simulated,
that is, ai = ax = 10 followed by ai = ax = 0.1. All remaining non-dimensional
parameters are set equal to 1.
cumulatively to observe their influence on HOLD state efficiency. The addition of in-
termediate complexes is shown to reduce natural re-integration efficiency by ∼11%
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and thus improves HOLD state efficiency. The addition of monomeric integrase
binding is shown to further reduce natural re-integration efficiency by ∼12%. We
therefore deduce that the 2:1 integrase:gp3 stoichiometry accounts for the remain-
ing ∼1% that separates the re-integration efficiencies of the two models. With a
contribution of ∼1%, the stoichiometry of synaptic complexes follows the previously
observed trend of having minimal effect on RAD module dynamics. In contrast,
monomeric integrase binding and intermediate DNA:protein complexes provide the
vast majority of improvement in HOLD state efficiency for our mechanistic model, in
almost equal measure. We note here that the formation of intermediate DNA:protein
complexes is, in part, due to the monomeric integrase binding, however, these com-
plexes also arise from our pairwise dimeric integrase binding and monomeric gp3
binding. The disadvantage of minimal intermediate complexes and protein binding
pathways is clear with regard to the model of Bonnet et al. [2012]. Following an effi-
cient OFF operation, the concentration of SSRs is restored to a basal level. At this
point, there is insufficient protein to hold the system in the DBP I4R4 complex and
the first interaction that can possibly occur is the dissociation of gp3. This dissoci-
ation immediately produces the DBP I4 complex which is then able to re-integrate.
By contrast, the transition from the DBP I4R2 complex to the DBP I4 complex is
not as straightforward in our mechanistic model. In the absence of induction, gp3
dissociation produces the intermediate DBP I4R complex which itself can potentially
give rise to three other complexes, only one of which, DBP I4, would then be able to
re-integrate.
We ideally require the RAD module to function at 100% efficiency for all
three operations. Our results indicate that the efficiency of a HOLD following an
OFF switch is proportional to the maintenance of the DBP I4R2 complex. This
could be problematic when executing a regime whereby increased SSR expression is
both induced and ceased in a simultaneous manner. Alternatively, we examine an
approach whereby the induction of integrase and gp3 ceases at separate time points.
Ceasing induction of gp3 prior to that of integrase is illogical given that gp3 is re-
quired to maintain the DBP I4R2 complex and prolonged induction of integrase will
only facilitate greater re-integration efficiency. Therefore we investigate the effect of
ceasing integrase induction prior to that of gp3 on HOLD state efficiency. Figure 3.9
depicts this effect in the form of a plot of natural re-integration efficiency against in-
creasing time intervals, δt, between ceasing integrase induction and gp3 induction.
The performance of both the model of Bonnet et al. [2012] and our mechanistic
model is plotted, with each y-intercept representing the ∼47% and ∼23% natural
re-integration efficiencies for simultaneous cessation (δt = 0), respectively. Regard-
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 Figure 3.9: RAD module in vivo natural re-integration efficiencies for the model of
Bonnet et al. [2012] and our mechanistic model. Natural re-integration efficiency
is plotted against the time interval between integrase cessation and gp3 cessation,
δt. In each case an OFF-HOLD operative cycle is simulated, that is, ai = ax = 10
followed by ai = ax = 0.1. All remaining non-dimensional parameters are set equal
to 1.
ing the model of Bonnet et al. [2012], as δt increases we observe a minimal reduction
in natural re-integration efficiency. This suggests that, although delaying the cessa-
tion of gp3 provides a small improvement, any gp3 dissociation that occurs during
prolonged induction still provokes an almost immediate re-integration given the in-
herent transitioning to the DBP I4 complex. However, in the case of our mechanistic
model we observe a significant reduction in natural re-integration efficiency as δt
increases. The dissociation of gp3 gives rise to the intermediate DBP I4R complex
and, with prolonged gp3 induction, the system is therefore weighted in favour of the
transition to the DBP I2R and DBP I3R complexes as well as the reformation of the
DBP I4R2 complex.
We note that regimes incorporating induction cessation intervals eliminate
the HOLD state from the RAD module operative cycle. This may not be desirable
for applications regarding biological data storage that are dependent on lasting re-
sponses to transient stimuli. However, this may assist in the development of other
potential RAD module applications that are not as reliant on HOLD states, such
as medical treatments for diseases related to the inheritance of cellular states. We
have established that prolonged gp3 induction is capable of reducing re-integration
efficiency and thus improving functionality, given that we have considered natural
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re-integration to be synonymous with spontaneous switching and ultimately dys-
functionality of the module. However, if we neglect dependency on HOLD states,
then harnessing natural re-integration can provide very simple and highly efficient
RAD module functionality. Figure 3.10 depicts the dynamical response of the RAD
module for 2.5 repeated OFF-ON operative cycles. Here the ON, OFF operations
 
Figure 3.10: RAD module in vivo switching efficiencies for our mechanistic model.
We simulate an OFF-ON-OFF-ON-OFF operative cycle. For the ON operation
ax = 0.1 and for the OFF operation ax = 10. Throughout the operative cycle,
ai = 10. All remaining non-dimensional parameter values are set equal to 1.
are defined as the cessation of gp3 induction and the induction of gp3 respectively;
integrase induction remains constant throughout. Since both operations are me-
diated, either solely or in part, by integrase, the state of the system is dependent
only on gp3 concentration. That is, when there is no induction of gp3 the constant
induction of integrase causes a fully efficient ON switch which will remain until gp3
induction causes a fully efficient OFF switch. Induction of gp3 must last for the
duration of the desired OFF switch, at which point cessation of gp3 induction is
sufficient to cause another fully efficient ON switch through natural re-integration.
3.5 Conclusions
We have described the development of a detailed mechanistic model of a rewritable
recombinase addressable data module, based on a wide-ranging synthesis of available
experimental data on the biomolecular interactions underlying DNA recombination.
We demonstrated the capability of this model to match and predict in vitro experi-
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mental data on recombination efficiencies across a range of different concentrations
of integrase and gp3, thus validating its efficacy as a design tool for building future
synthetic circuitry. Investigation of in vivo recombination dynamics revealed the
importance of fully accounting for all mechanistic details in models of DNA recom-
bination, in order to accurately predict the effect of different switching strategies on
RAD module performance.
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Chapter 4
Mechanistic Modelling of a
Recombinase-Based Two-Input
Temporal Logic Gate
4.1 Scientific background
4.1.1 Boolean algebra and logic gates
Binary systems are the language of almost all modern computers and other digital
devices [Gillies, 2010]. The origin of such systems can be traced back to ancient
Greek philosophers who devised a structured logic paradigm known as propositional
logic whereby propositions are classified as TRUE or FALSE. That is, the state
of a given proposition is represented in a discrete, binary manner; there are only
two possible states that can be achieved. Propositions based on functions of other
propositions are constructed via three basic logical connectives, AND, OR and NOT.
For example, consider the following statement: “I will play football this evening
if I finish work on time and there are enough other players to play the match”.
Here the proposition of playing football is dependent on the two other propositions
regarding finishing work on time and having a sufficient number of players in total.
The connective ‘and’ in the statement translates to the logic AND connective by
specifying that the outcome of the statement will occur only if both conditional
propositions are TRUE. All other combinations of the proposition states will result
in the statement being FALSE and hence all possible outcomes can be represented
in a table of potential inputs and outputs commonly known as a truth table which,
in this case, is representative of the typical AND function (Table 4.1).
In the nineteenth century, the mathematician George Boole formulated a
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Finish on time Enough players Play football
FALSE FALSE FALSE
TRUE FALSE FALSE
FALSE TRUE FALSE
TRUE TRUE TRUE
Table 4.1: Truth table of propositional logic. This proposition is a function of two
other propositions which must both be TRUE in order for the overall outcome to
be TRUE, thus representing a typical AND logic function.
mathematical framework for the composition and manipulation of logic functions
and operations that became known as Boolean algebra. Under this construct, the
TRUE and FALSE states are substituted with the numerical values 1 and 0 respec-
tively, thus permitting the application of standard algebraic manipulations from
mathematics. The AND and OR binary operators translate to multiplication and
addition of Boolean variables respectively and follow the same general associative,
commutative and distributive rules of standard algebra. Note that, although the
AND function demonstrates intuitive multiplicative results for the Boolean 1 and 0
states, Boolean arithmetic is not generally analogous to standard arithmetic high-
lighted clearly by the OR function which implies that 1 + 1 = 1. This is a funda-
mental property of Boolean logic, since no state other than 1 or 0 can be achieved,
and therefore should not be viewed as regular numerical addition. For two inputs
A and B, the Boolean AND, OR and NOT functions all provide a distinct output
O represented by their corresponding truth table (Table 4.2). There exists a total
AND OR NOT
A B O A B O A O
0 0 0 0 0 0 0 1
1 0 0 1 0 1 1 0
0 1 0 0 1 1
1 1 1 1 1 1
Table 4.2: Truth tables for the AND, OR and NOT logic functions. The AND func-
tion provides output only when both inputs are present; the OR function provides
output whenever at least one input is present; the NOT function provides an output
that is the opposite of the given input.
of sixteen Boolean logic functions with each producing distinct functional outputs
dependent upon the nature of two specific inputs; logic functions are not limited
to two inputs with the number of inputs, n, giving rise to 2n outputs. A physical
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device that implements Boolean logic functions is referred to as a Boolean logic gate
and each of these sixteen distinct gates has a corresponding schematic representa-
tion when depicted in electronic circuit designs. Any calculation can be performed
through intricate patterns of logic gates and, as a consequence, they form the basis
of modern digital computation [Gillies, 2010].
The genetic switches mediated by SSRs are the precursors to synthetic bi-
ological logic gates. Both tyrosine and serine recombination mechanisms are capa-
ble of eliciting Boolean logic gate functionality within biological cells [Branda and
Dymecki, 2004; DuPage et al., 2009; Friedland et al., 2009; Bonnet et al., 2013].
Tyrosine recombinase-based systems are either dependent on host cofactors or are
reversible which poses problems with modularity and performance efficiency that
have not been identified with serine recombinases. The standard serine recombi-
nase genetic switch is switched on via the induction of integrase which mediates
integration and generates a new DNA state. The original state is recovered via the
induction of excisionase. By considering integrase as the system input, the standard
switch is initially set in its primary state, state 1, in the absence of integrase and
then generates the new state, state 2, upon induction (Figure 4.1A). This provides
inducible control over two distinct genetic outputs which is particularly valuable in
regulating gene expression. There is, however, a maximum of two outputs that can
be controlled in this manner given that the system has one integrase input specific
to the relevant attachment sites on the DNA strand. As demonstrated, logic gate
functions are dependent on two distinct inputs that are either ‘on’ (1) or ‘off’ (0) and
therefore biological logic gates require at least two integrase inputs (Figure 4.1B).
This requires two pairs of specific attachment sites corresponding to two distinct
integrases; multiple identical pairs of attachment sites will be bound by the same
integrase and would present the same standard switch mediated by a single integrase
input. This also means that combining logic gates to create more sophisticated cir-
cuitry can only be achieved using orthogonal gates that employ distinct recombinase
inputs [Fernandez-Rodriguez et al., 2015], and hence the functional specifications of
characterised recombinases will be crucial in the circuit design process. A recent
study has demonstrated that recombinase-based switches that can store 1 b of infor-
mation, such as the RAD module, are able to provide over 1 B of memory capacity
when layered in the appropriate manner. This is made possible by the extensive
characterisation of distinct integrases that do not exhibit the crosstalk that may po-
tentially cause the gate to fail, and are therefore completely viable for use as system
inputs [Yang et al., 2014].
The precise arrangement and orientation of distinct attachment sites is vital
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Figure 4.1: Schematic diagrams of one-input and two-input serine integrase-
mediated synthetic circuitry. A) the recombinase-based one-input toggle switch. B)
the recombinase-based two-input logic gate. C) the recombinase-based two-input
temporal logic gate. Blue and orange triangles depict attachment sites correspond-
ing to integrase A and integrase B respectively; grey lines depict DNA strands;
arrows depict serine-integrase-mediated integration events.
to realising the desired logic output. By positioning the attachment site pairs se-
quentially along the DNA strand in an antiparallel manner, the initial sequence of
nucleotide bases will encode state 1 in the same way as a standard switch. How-
ever, more distinct DNA states can be obtained via induction of each integrase
input, integrase A and integrase B. Integrase A will mediate the inversion of the
genetic sequence between its corresponding attB and attP sites and produce the
encoded state 2; integrase B will mediate the equivalent reaction to produce state
3. Simultaneous induction of integrase A and integrase B results in the inversion of
both corresponding genetic sequences which encodes the final output, state 4. The
same four distinct DNA states are achieved if the timing of the induction events
is staggered, rather than simultaneous, since state 1 and state 2 both reach state
4 in the presence of the appropriate integrase. This dynamical behaviour defines
a truth table for the standard two-input biological logic gate (Table 4.3A). State
transitioning is a unidirectional process unless excisionase-mediated reset functions
are incorporated, however this will invariably compromise the dynamical behaviour
of the logic gate or toggle switch in question [Bonnet et al., 2012; Bowyer et al.,
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A B
A B O A B O
0 0 State 1 0 0 State 1
1 0 State 2 1 0 State 2
0 1 State 3 0 1 State 3
1 1 State 4 1? 1 State 4
1 1? State 5
Table 4.3: Truth tables for the standard and temporal biological logic gates. A) The
standard logic gate provides the typical four outputs as DNA states that could be
engineered to deliver any logic function. B) The temporal logic gate also provides
four distinct outputs since at least two of the states are identical; stars denote which
of the two integrase inputs is induced first.
2016].
The most interesting distinction to be made between the biological logic gate
and the idealised Boolean logic gate that it seeks to emulate is that the biological
logic gate is able to encode up to four distinct states as opposed to a maximum of
two states. That is, although the integrase inputs driving the biological gate occupy
binary states, the outputs are four distinct genetic sequences each of which could
potentially code for a different molecular product if engineered in the appropriate
manner. Indeed, designing genetic sequences and attachment site pairs that produce
desired gene expression only when the configuration reaches that of state 4 would
encompass the AND gate function (i.e. state 1 = 0, state 2 = 0, state 3 = 0, state
4 = 1). This might be particularly useful in cases where extra stringency on the
control of gene expression is required. On the other hand, restricting the scope of
biological output to one of two binary states may be viewed as prosaic in light of
the potential variety of operations.
The biological logic gate has the capacity for even further functional ad-
vantages when considering the temporal induction of integrase inputs [Hsiao et al.,
2016]. As previously described, sequential positioning of two distinct attachment
site pairs will provide a maximum of four outputs due to staggered induction events
giving rise to the same end state, but alternative initial arrangements are capable
of providing additional information. For example, overlapping attachment sites has
the ability to define integration pathways culminating in two distinct end states,
given the appropriate initial orientation of the attachment sites (Figure 4.1C). Such
circuit designs exploit the DNA inversion event by placing attachment sites in the
intermediate genetic sequence between two corresponding attachment sites thus re-
sulting in an inverted genetic sequence giving rise to a new DNA state as well as an
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inverted attachment site whose role in any subsequent integration events is altered
and may potentially partake in either inversion or deletion.
Positioning the attachment site pairs in an overlapping arrangement on the
DNA strand with one antiparallel pair (corresponding to integrase A) and one par-
allel pair (corresponding to integrase B) presents a similar state 1 to that of the
standard logic gate design. However, in this case integrase A will mediate the in-
version of the genetic sequence between its corresponding attB and attP sites and
produce the encoded state 2 comprised of both pairs of attachment sites in an an-
tiparallel arrangement. Integrase B will, instead, mediate the deletion of the genetic
sequence between its corresponding attachment sites to produce state 3, comprised
of two disparate attachment sites. Induction of integrase B following integrase A
will then transition state 2 to state 4 via a secondary inversion event due to the
new antiparallel orientation of the corresponding attachment sites. Integrase A is
unable to perform integration following induction of integrase B since there is no
longer an appropriate pair of attachment sites to target and thus state 5 is identical
to state 3. Hence, we have a temporal logic gate capable of delivering five outputs
in response to two inputs (Table 4.3B) however, this functionality is restricted to at
least two of the five outputs being identical which, biologically, presents the poten-
tial for inducible control over four molecular products, as is the case for the standard
logic gate. Thus, although the number of distinct outputs has not improved, the
temporal logic gate is able to infer both the order of induction events and the time
between each event since staggered induction does not produce identical end states
(Figure 4.2). A temporal logic gate therefore has unique functional properties that
make it highly suitable for synthetic biosensor applications.
An important factor to consider with respect to temporal logic gates is the
time interval between induction events since simultaneous induction of input inte-
grases will likely result in a split end state whereby both state 4 and state 5 are
accessed. Ideally, the appropriate induction will facilitate maximal transitioning
to the desired DNA state however, the conditions required to achieve this are not
obvious. Mathematical models can examine large arrays of performance criteria in
order to determine optimal inputs and provide operational profiles that can inform
the selection of the most suitable circuit designs based on the desired outputs.
4.1.2 Existing logic gate systems
Most approaches to engineering cellular logic employ two-input circuit designs in
which the orientation and arrangement of specific attachment sites, analogous to
gate-gate layering in conventional electronics, is used to mediate all conceivable
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Figure 4.2: Schematic diagrams summarising biological logic outputs. A) the stan-
dard logic gate transitions through four distinct states with the end state accessed
regardless of the timing of integrase inputs. B) the temporal logic gate transitions
through five states with certain states only accessible via specific induction time
schedules.
logic functions [Tamsir et al., 2011; Moon et al., 2012]. Transcriptional systems have
facilitated the construction of numerous logic functions including NOTIF, NOT-IF-
IF, NAND, OR, NOR and INVERTER gates by virtue of synthetic transcription
factors in mammalian cells [Kramer et al., 2004a]. A similar approach based on
chimeric transcription factors can enable simple transcriptional AND gating [Shis
et al., 2014]. Mammalian logic circuits can also exploit protein splicing mediated
by self-splicing protein domains known as inteins to build AND gates [Lohmueller
et al., 2012] and has been extended to realise a 3-input AND gate [Lienert et al.,
2014]. Other transcriptional AND gates are achieved through the combinatorial
presence of both a T7 polymerase and a suppressor tRNA, supD [Anderson et al.,
2006] as well as through promoter inputs controlling hrpR and hrpS in conjunction
with an hrpL promoter output [Wang et al., 2014]. The first example of a genetic 2-4
decoder expressing fluorescent protein promoter outputs has also been demonstrated
in eukaryotic cells [Guinn and Bleris, 2014]. Several alternative mechanisms for
implementing biological logic have been devised that are mediated by ribosomes
[Rackham and Chin, 2005], RNA [Win and Smolke, 2008; Benenson et al., 2004],
RNAi [Rinaudo et al., 2007; Xie et al., 2010, 2011] and deoxyribozymes [Stojanovic
and Stefanovic, 2003].
Scaling up the complexity of electronic circuitry involves layered combina-
tions of logic gates which can be replicated biologically to create advanced circuitry
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capable of adding and subtracting digital information. This has been demonstrated
through a combination of transcriptional and translational control whereby two N-
IMPLY gates were layered to create an XOR circuit which was then developed into
a half-adder circuit by virtue of an additional AND gate [Auslnder and Fusseneg-
ger, 2013]. Transcriptional AND gates implementing two promoter inputs can be
layered, with promoter outputs providing inputs to downstream gates, to achieve all
logic functions. Combinations of AND gates permitted the implementation of 3- and
4-input AND gates with the 4-input AND representing the largest synthetic gene
circuit constructed at the time, in terms of the number of regulatory proteins used
[Moon et al., 2012]. The advent of greater system complexity requires greater con-
sideration of parts modularity. One potential solution could be wiring logic circuits
across cellular populations using quorum sensing circuitry to overcome such issues
by installing different system components in different cells, rather than complete
assembly within individual cells, and employing cell-cell communication strategies
to realise overall logic functions [Tabor et al., 2009; Regot et al., 2011; Tamsir et al.,
2011].
Many of the aforementioned transcriptional logic circuits are transient in
their responses and are generally unable to provide lasting outputs in the absence
of induction. However, integration of memory and logic has been demonstrated
through a ‘push-on push-off’ switch that connects a bistable memory module with
a transcriptional NOR gate module. The circuit is able to alternate between green
and red fluorescent protein outputs in response to sequential induction via pulses
of ultraviolet light and can hold the current state for the duration of the interval
between pulses. That said, just three consecutive switching events were achieved
experimentally and it was observed that efficiency decreased with each event [Lou
et al., 2010]. As a result, DNA-based systems may be preferable for robust biological
computation coupled with cellular memory as demonstrated by DNA recombination
circuits such as the RAD module [Bonnet et al., 2012].
Although it remains to verify that SSRs can operate with the same reliabil-
ity as bistable transcriptional circuits, given the practical difficulties associated with
efficient integrase-excisionse-mediated reset functions [Bonnet et al., 2012; Bowyer
et al., 2016], the overwhelming advantage of exploiting the stability of DNA suggests
that SSRs have the edge when it comes to engineering biological logic gates [Fried-
land et al., 2009; Purcell and Lu, 2014]. The unidirectional recombinases Bxb1
and φC31 mediate control over promoters, terminators and other transcriptional
gene regulatory elements to perform all sixteen two-input logic gate functions. For
example, an AND gate can be constructed by placing one inverted promoter and
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one terminator in tandem upstream of an output gene, each flanked by distinct
attachment site pairs corresponding to Bxb1 and φC31. Expression of the SSR
corresponding to the sites flanking the inverted promoter will cause inversion and
hence establish regular promoter orientation however, the action of the promoter
will be blocked by the terminator. Expression of the SSR corresponding to the sites
flanking the terminator will also cause inversion and hence the terminator will no
longer block the upstream promoter however, the promoter will remain inverted
and the gene of interest is not expressed. When both Bxb1 and φC31 are expressed
simultaneously, both the inverted promoter and the terminator will undergo inver-
sion resulting in unrestricted transcription of the gene of interest by the upstream
promoter and hence the target gene will only be transcribed in the presence of both
inputs.
Two inverted promoters placed in tandem and controlled in the same fashion
will produce an OR gate function and thus all logic gates can be formed by virtue
of a specific initial arrangement of attachment sites and transcriptional elements.
Since the inversion events rewrite the genetic sequence, the state of the system is
stored stably within the DNA and permits sequential memory logic that will give, in
the case of the AND gate, the desired output if the two inputs were ever expressed as
opposed to the equivalent memory-less circuits which provides the desired output if
the two inputs are expressed at a given time [Siuti et al., 2013]. A similar approach
is capable of achieving the same variety of logic gate functions through inversion of
terminators only. By positioning a promoter upstream of two terminators, flanked
by distinct attachment site pairs, and a target gene, the gene will be expressed only
when both SSRs have been induced and cause inversion of their respective terminator
hence capturing the same AND gate dynamics described previously [Bonnet et al.,
2013].
These recombinase-based systems are able to match the reliability of bistable
transcriptional systems since the inversion events that drive the logic gates are me-
diated solely by the selected integrases. Integrase alone is sufficient to mediate
integration reactions and hence integrase-mediated inversions, insertions and dele-
tions are dependent purely on the concentration of integrase which, assuming the
appropriate induction is delivered, can give rise to maximal efficiency and, in turn,
reliability. Therefore, reliability issues arise with greater significance when attempt-
ing to incorporate excisionase-mediated reset functions [Bonnet et al., 2012; Bowyer
et al., 2016]. Reset functions are useful however, as they, theoretically, allow the sys-
tem to re-establish previously accessed states and thus offer a chain of states that can
be transitioned through in any consecutive order as opposed to sequential memory
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logic gates that transition in a forward, unidirectional manner. Until the dynamical
nuances of integrase-excisionse multiplexed systems are characterised, circuit de-
signs are likely to benefit from sole focus towards integrase-mediated recombination
and the exclusion of any excisionase-mediate reset functionality.
4.1.3 Existing logic gate models
Temporal logic gates generate as many distinct outputs as standard logic gates, but
are also capable of inferring additional information due to the significance of the
timing of input induction events. Both the temporal order of induction events and
the length of time allowed between them can influence the output of the system. The
first experimentally validated temporal logic gate is capable of recording analogue
signal timing and the duration of sequential induction events with respect to a
bacterial cell population [Hsiao et al., 2016].
The temporal logic gate demonstrates ‘A then B’ logic in E. coli through a
system of two orthogonal integrases (integrases A, TP901-1, and B, Bxb1). Being
a temporal logic gate, the system is capable of accessing five genetic states (Figure
4.2B) however, the circuit design comprises just two states of interest in order to
elicit reliable timing and recording of induction events. The initial state is com-
prised of one inverted terminator and one inverted promoter flanked by the attB
and attP sites corresponding to integrases A and B which overlap one another and
are themselves flanked by the genes coding the mKate-2 RFP and superfolder-GFP
proteins, neither of which are expressed due to the inverted terminator blocking
transcription of RFP via the inverted promoter. The antiparallel orientation of the
integrase A attachment sites is selected in order to permit inversion whereas the
parallel orientation of the integrase B attachment sites is selected in order to permit
deletion. Therefore, induction of integrase B deletes both the inverted promoter
and the integrase A attP site from the DNA strand, leaving the inverted terminator
behind in a new genetic state, Sb (state 3), which again results in no fluorescent
protein expression. Subsequent integrase A induction elicits no further response
since integrase A has only the remaining attB site on the DNA strand to target.
However, initial induction of integrase A mediates inversion of the genetic sequence
between the corresponding attachment sites containing the inverted terminator and
the integrase B attB site. As a result, the terminator is unable to block transcription
via the inverted promoter and RFP is expressed, Sa (state 2). Subsequent integrase
B induction is then able to mediate a secondary inversion event, since the associated
attB site was inverted along with the terminator via integrase A, which results in
inversion of the terminator-promoter pair and triggers expression of GFP, Sab (state
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4). Table 4.4 gives the truth table for this particular temporal logic gate. Switching
A B O
0 0 State 1: 0
1 0 State 2: RFP
0 1 State 3: 0
1? 1 State 4: GFP
1 1? State 5: 0
Table 4.4: Truth table for the synthetic temporal logic gate reported in [Hsiao et al.,
2015]. The output of the logic gate is dependent on the order of induction events and
the time delay between events, with the star notation denoting the input induced
first.
between four distinct states is achievable via standard logic gates however, such
gates produce the same state with simultaneous input induction and regardless of
delays between induction events. That is, the benefits of this particular temporal
system allow the user to infer which induction event has occurred first, since ‘A then
B’ operations give GFP output as opposed to no output for ‘B then A’ operations,
and also the time delay between induction events, since the ratio of RFP to GFP
output will vary for varying time delays. A simple stochastic model of this circuit
was created to help develop better intuition for overall circuit behaviour, but this
model does not account for any specific molecular interactions between the integrases
and the DNA, instead representing integrase activity as probabilities based on con-
centration [Hsiao et al., 2016]. This model was shown to be effective for predicting
overall final population fractions as well as the forward experimental design of the
system. However, the inherent limitations of the model design mean that the circuit
cannot be simulated on a molecular scale, and timescales with regards to specific
molecular interactions cannot be incorporated. In taking a more mechanistic mod-
elling approach, we model the two-integrase temporal logic gate circuit developed
in Hsiao et al. [2016] by integrating multiple DNA recombination interactions from
our validated mechanistic model of the RAD module [Bowyer et al., 2015, 2016].
We demonstrate that the mechanistic model successfully captures key dynamical
features of circuit time course trajectories derived from in vivo experimental data,
thus improving our capability to perform model-aided integrase circuit design.
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4.2 Formulating an in vivo reaction network of a recombinase-
based temporal logic gate
The model of [Hsiao et al., 2016] describes the transitioning of the temporal logic
gate from the original DNA state (S0) to each of the three end states (Sa, Sb and
Sab) via three corresponding rate constants describing inversion mediated by TP901-
1 (integrase A), and both deletion and inversion mediated by Bxb1 (integrase B). We
replace these all-encompassing parameters with a mechanistic integration reaction
structure, in which inversion and deletion events are initiated by the binding of one
integrase dimer at each of the associated attachment sites (four integrase monomers
in total) and are strictly unidirectional [Groth and Calos, 2004; Olorunniji et al.,
2012] (Fig. 4.3). We account for dimerisation of both monomeric SSRs, allowing
 
 
 
 
 
 
  Deletion Inversion 
Linear DNA state via 
integrase B excision, state 3 
(Sbl) 
Secondary integrated DNA 
state via integrase A and 
integrase B, state 4 (Sab) 
State 2 
Output: 
RFP 
 
State 4 
Output: 
GFP 
 
State 1 
Output: 
None 
 
Integrase monomer 
Integrase dimer 
Integrase dimer 
(dysfunctional) 
 
Original DNA state, state 1 
(S0) 
Empty set, representing 
protein expression and 
degradation 
Primary integrated DNA 
state via integrase A, state 2 
(Sa) 
Intermediate DNA:protein 
complexes in state 2 
Intermediate DNA:protein 
complexes in state 3 
Intermediate DNA:protein 
complexes in state 1 State 3 
Output: 
None 
 
γbas,ind δ 
δ δ 
γbas,ind δ 
δ δ 
Integrase A Integrase B 
Circular DNA state via 
integrase B excision (Sbc) 
kRA kRB 
kintX kintX k1 
k-1 
k1 
k-1 
Inversion kRB 
Intermediate DNA:protein 
complexes in state 4 
Figure 4.3: Schematic diagram of the mechanistic two-input logic gate reaction net-
work. The sequence of DNA:protein interactions facilitating inversion and deletion,
taken from Bowyer et al. [2015], enables the system to transition from the origi-
nal DNA state (state 1) to the three genetically-differentiated DNA states (state
2, state 3, state 4). Expression and degradation of integrase A and B are denoted
by γbas,ind and δ respectively. Intermediate DNA:protein complexes with red and
green DNA strands are associated with state 2 and state 4 respectively. Up to four
integrase monomers are able to bind to free DNA, depicted by dashed outlines in the
legend. Single and double grey arrows depict irreversible and reversible reactions
respectively. Figure adapted from [Hsiao et al., 2016].
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for both monomeric and dimeric integrase binding to DNA attachment sites. This
process is widely supported in the experimental literature on DNA recombination
[Fogg et al., 2014; Ghosh et al., 2005, 2008; Khaleel et al., 2011]. Thus, four dis-
tinct intermediate DNA:protein complexes can potentially be formed in facilitating
recombination via this combination of monomeric and dimeric integrase binding.
These complexes are depicted by the smaller DNA strands in Fig. 4.3, with up to
four integrase monomers bound. We also include the formation of a dysfunctional
dimer by both integrases, which is subject to the same degradation as its functional
counterpart; this was shown to significantly improve the fit of model simulations to
experimental data in our previous study [Bowyer et al., 2015, 2016]. Deletion gives
rise to two distinct genetic products, the remaining linear sequence of the target
DNA and the excised circular DNA loop, and hence we account for two disparate Sb
states, Sbl (linear) and Sbc (circular). We refer to the DNA states S0, Sa, Sbl and Sab
as state 1, state 2, state 3 and state 4 respectively, noting that this system is void of
a fifth DNA state due to the ‘dead end’ state, state 3, which is unable to transition
to any subsequent state. We do not account for Sbc as a system state since it is
separate from the original DNA sequence that is intended to be manipulated.
Model validation against experimental data for an in vivo recombinase-based
system presents a number of factors that require careful consideration. Cellular
recombination in vivo is dependent on the expression and degradation of recombinase
proteins over time, thus contributing two additional parameters (γ, δ) to the model.
In the absence of induction, in vivo system exhibit background expression of SSRs,
commonly resulting in basal system output. Thus we include model parameters
describing both basal (γbas) and induced (γind) expression of the two integrases,
allowing for non-zero model output when simulating experiments void of integrase
induction.
4.3 Constructing a mechanistic model of the temporal
logic gate
Our mechanistic model is constructed through the application of mass action kinetics
to the following biochemical equations arising from the reaction network in Fig. 4.3:
IA
δ−−−−⇀↽ −
γbas,ind
∅, (4.1)
IA + IA
k1−−⇀↽−
k−1
I2A, (4.2)
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I2A
δ−→ ∅, (4.3)
IA + IA
kintX−−−→ I2AX , (4.4)
I2AX
δ−→ ∅, (4.5)
IB
δ−−−−⇀↽ −
γbas,ind
∅, (4.6)
IB + IB
k1−−⇀↽−
k−1
I2B, (4.7)
I2B
δ−→ ∅, (4.8)
IB + IB
kintX−−−→ I2BX , (4.9)
I2BX
δ−→ ∅, (4.10)
S0 + I2A
k4−−⇀↽−
k−4
S0I2A, (4.11)
S0I2A + I2A
k5−−⇀↽−
k−5
S0I4A, (4.12)
S0 + IA
k13−−−⇀↽ −
k−13
S0IA, (4.13)
S0IA + IA
k14−−−⇀↽ −
k−14
S0I2A, (4.14)
S0I2A + IA
k15−−−⇀↽ −
k−15
S0I3A, (4.15)
S0I3A + IA
k16−−−⇀↽ −
k−16
S0I4A, (4.16)
S0I4A
kRA−−→ SaI4A, (4.17)
Sa + I2A
k4−−⇀↽−
k−4
SaI2A, (4.18)
SaI2A + I2A
k5−−⇀↽−
k−5
SaI4A, (4.19)
Sa + IA
k13−−−⇀↽ −
k−13
SaIA, (4.20)
SaIA + IA
k14−−−⇀↽ −
k−14
SaI2A, (4.21)
SaI2A + IA
k15−−−⇀↽ −
k−15
SaI3A, (4.22)
SaI3A + IA
k16−−−⇀↽ −
k−16
SaI4A, (4.23)
S0 + I2B
k20−−−⇀↽ −
k−20
S0I2B, (4.24)
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S0I2B + I2B
k21−−−⇀↽ −
k−21
S0I4B, (4.25)
S0 + IB
k22−−−⇀↽ −
k−22
S0IB, (4.26)
S0IB + IB
k23−−−⇀↽ −
k−23
S0I2B, (4.27)
S0I2B + IB
k24−−−⇀↽ −
k−24
S0I3B, (4.28)
S0I3B + IB
k25−−−⇀↽ −
k−25
S0I4B, (4.29)
S0I4B
kRB−−→ SblI2B + SbcI2B, (4.30)
Sbl + I2B
k20−−−⇀↽ −
k−20
SblI2B, (4.31)
Sbl + IB
k22−−−⇀↽ −
k−22
SblIB, (4.32)
SblIB + IB
k23−−−⇀↽ −
k−23
SblI2B, (4.33)
Sbc + I2B
k20−−−⇀↽ −
k−20
SbcI2B, (4.34)
Sbc + IB
k22−−−⇀↽ −
k−22
SbcIB, (4.35)
SbcIB + IB
k23−−−⇀↽ −
k−23
SbcI2B, (4.36)
Sa + I2B
k20−−−⇀↽ −
k−20
SaI2B, (4.37)
SaI2B + I2B
k21−−−⇀↽ −
k−21
SaI4B, (4.38)
Sa + IB
k22−−−⇀↽ −
k−22
SaIB, (4.39)
SaIB + IB
k23−−−⇀↽ −
k−23
SaI2B, (4.40)
SaI2B + IB
k24−−−⇀↽ −
k−24
SaI3B, (4.41)
SaI3B + IB
k25−−−⇀↽ −
k−25
SaI4B, (4.42)
SaI4B
kRB−−→ SabI4B, (4.43)
Sab + I2B
k20−−−⇀↽ −
k−20
SabI2B, (4.44)
SabI2B + I2B
k21−−−⇀↽ −
k−21
SabI4B, (4.45)
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Sab + IB
k22−−−⇀↽ −
k−22
SabIB, (4.46)
SabIB + IB
k23−−−⇀↽ −
k−23
SabI2B, (4.47)
SabI2B + IB
k24−−−⇀↽ −
k−24
SabI3B, (4.48)
SabI3B + IB
k25−−−⇀↽ −
k−25
SabI4B, (4.49)
where reaction rates are denoted by the corresponding numbered k, which are re-
tained from [Bowyer et al., 2015, 2016] where necessary; S denotes DNA with sub-
scripts corresponding to the four distinct states (0, a, bl, ab); I denotes integrase
with subscripts corresponding to the number of monomers (1, 2, 3, 4), TP901-1 or
Bxb1 (A or B) and/or dysfunctionality (X). This produces the following system of
35 ODEs that are solved numerically to provide a deterministic model output:
d[IA]
dt
=γbas,ind − δ[IA] + 2k−1[I2A]− 2k1[IA]2 − kintX[IA]2+
k−13[S0IA]− k13[S0][IA] + k−13[SaIA]− k13[Sa][IA]+
k−14[S0I2A]− k14[S0IA][IA] + k−14[SaI2A]− k14[SaIA][IA]+
k−15[S0I3A]− k15[S0I2A][IA] + k−15[SaI3A]− k15[SaI2A][IA]+
k−16[S0I4A]− k16[S0I3A][IA] + k−16[SaI4A]− k16[SaI3A][IA], (4.50)
d[I2A]
dt
=k1[IA]
2 − k−1[I2A]− δ[I2A]+
k−4[S0I2A]− k4[S0][I2A] + k−4[SaI2A]− k4[Sa][I2A]+
k−5[S0I4A]− k5[S0I2A][I2A] + k−5[SaI4A]− k5[SaI2A][I2A], (4.51)
d[S0]
dt
=k−4[S0I2A]− k4[S0][I2A] + k−13[S0IA]− k13[S0][IA]+
k−20[S0I2B ]− k20[S0][I2B ] + k−22[S0IB ]− k22[S0][IB ], (4.52)
d[S0I2A]
dt
=k4[S0][I2A]− k−4[S0I2A] + k−5[S0I4A]− k5[S0I2A][I2A]+
k14[S0IA][IA]− k−14[S0I2A] + k−15[S0I3A]− k15[S0I2A][IA], (4.53)
d[S0I4A]
dt
=k5[S0I2A][I2A]− k−5[S0I4A] + k16[S0I3A][IA]− k−16[S0I4A]− kRA[S0I4A], (4.54)
d[Sa]
dt
=k−4[SaI2A]− k4[Sa][I2A] + k−13[SaIA]− k13[Sa][IA]+
k−20[SaI2B ]− k20[Sa][I2B ] + k−22[SaIB ]− k22[Sa][IB ], (4.55)
d[SaI2A]
dt
=k4[Sa][I2A]− k−4[SaI2A] + k−5[SaI4A]− k5[SaI2A][I2A]+
k14[SaIA][IA]− k−14[SaI2A] + k−15[SaI3A]− k15[SaI2A][IA], (4.56)
d[SaI4A]
dt
=k5[SaI2A][I2A]− k−5[SaI4A] + k16[SaI3A][IA]− k−16[SaI4A] + kRA[S0I4A], (4.57)
d[I2AX ]
dt
=kintX[IA]
2 − δ[I2AX ], (4.58)
d[S0IA]
dt
=k13[S0][IA]− k−13[S0IA]− k14[S0IA][IA] + k−14[S0I2A], (4.59)
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d[S0I3A]
dt
=k15[S0I2A][IA]− k−15[S0I3A]− k16[S0I3A][IA] + k−16[S0I4A], (4.60)
d[SaIA]
dt
=k13[Sa][IA]− k−13[SaIA]− k14[SaIA][IA] + k−14[SaI2A], (4.61)
d[SaI3A]
dt
=k15[SaI2A][IA]− k−15[SaI3A]− k16[SaI3A][IA] + k−16[SaI4A], (4.62)
d[IB ]
dt
=γbas,ind − δ[IB ] + 2k−1[I2B ]− 2k1[IB ]2 − kintX[IB ]2+
k−22[S0IB ]− k22[S0][IB ] + k−22[SaIB ]− k22[Sa][IB ]+
k−23[S0I2B ]− k23[S0IB ][IB ] + k−23[SaI2B ]− k23[SaIB ][IB ]+
k−24[S0I3B ]− k24[S0I2B ][IB ] + k−24[SaI3B ]− k24[SaI2B ][IB ]+
k−25[S0I4B ]− k25[S0I3B ][IB ] + k−25[SaI4B ]− k25[SaI3B ][IB ]+
k−22[SbIB ]− k22[Sb][IB ] + k−22[SabIB ]− k22[Sab][IB ]+
k−23[SbI2B ]− k23[SbIB ][IB ] + k−23[SabI2B ]− k23[SabIB ][IB ]+
k−24[SbI3B ]− k24[SbI2B ][IB ] + k−24[SabI3B ]− k24[SabI2B ][IB ]+
k−25[SbI4B ]− k25[SbI3B ][IB ] + k−25[SabI4B ]− k25[SabI3B ][IB ], (4.63)
d[I2B ]
dt
=k19[IB ]
2 − k−19[I2B ]− δ[I2B ]+
k−20[S0I2B ]− k20[S0][I2B ] + k−20[SaI2B ]− k20[Sa][I2B ]+
k−21[S0I4B ]− k21[S0I2B ][I2B ] + k−21[SaI4B ]− k21[SaI2B ][I2B ]+
k−20[SbI2B ]− k20[Sb][I2B ] + k−20[SabI2B ]− k20[Sab][I2B ]+
k−21[SbI4B ]− k21[SbI2B ][I2B ] + k−21[SabI4B ]− k21[SabI2B ][I2B ], (4.64)
d[S0I2B ]
dt
=k20[S0][I2B ]− k−20[S0I2B ] + k−21[S0I4B ]− k21[S0I2B ][I2B ]+
k23[S0IB ][IB ]− k−23[S0I2B ] + k−24[S0I3B ]− k24[S0I2B ][IB ], (4.65)
d[S0I4B ]
dt
=k21[S0I2B ][I2B ]− k−21[S0I4B ] + k25[S0I3B ][IB ]− k−25[S0I4B ]− kRB [S0I4B ], (4.66)
d[Sb]
dt
=k−20[SbI2B ]− k20[Sb][I2B ] + k−22[SbIB ]− k22[Sb][IB ], (4.67)
d[SbI2B ]
dt
=k20[Sb][I2B ]− k−20[SbI2B ] + k−21[SbI4B ]− k21[SbI2B ][I2B ]+
k23[SbIB ][IB ]− k−23[SbI2B ] + k−24[SbI3B ]− k24[SbI2B ][IB ], (4.68)
d[SbI4B ]
dt
=k21[SbI2B ][I2B ]− k−21[SbI4B ] + k25[SbI3B ][IB ]− k−25[SbI4B ] + kRB [S0I4B ], (4.69)
d[I2BX ]
dt
=kintX[IB ]
2 − δ[I2BX ], (4.70)
d[S0IB ]
dt
=k22[S0][IB ]− k−22[S0IB ]− k23[S0IB ][IB ] + k−23[S0I2B ], (4.71)
d[S0I3B ]
dt
=k24[S0I2B ][IB ]− k−24[S0I3B ]− k25[S0I3B ][IB ] + k−25[S0I4B ], (4.72)
d[SbIB ]
dt
=k22[Sb][IB ]− k−22[SbIB ]− k23[SbIB ][IB ] + k−23[SbI2B ], (4.73)
d[SbI3B ]
dt
=k24[SbI2B ][IB ]− k−24[SbI3B ]− k25[SbI3B ][IB ] + k−25[SbI4B ], (4.74)
d[SaI2B ]
dt
=k20[Sa][I2B ]− k−20[SaI2B ] + k−21[SaI4B ]− k21[SaI2B ][I2B ]+
k23[SaIB ][IB ]− k−23[SaI2B ] + k−24[SaI3B ]− k24[SaI2B ][IB ], (4.75)
d[SaI4B ]
dt
=k21[SaI2B ][I2B ]− k−21[SaI4B ] + k25[SaI3B ][IB ]− k−25[SaI4B ]− kRB [SaI4B ], (4.76)
d[Sab]
dt
=k−20[SabI2B ]− k20[Sab][I2B ] + k−22[SabIB ]− k22[Sab][IB ], (4.77)
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d[SabI2B ]
dt
=k20[Sab][I2B ]− k−20[SabI2B ] + k−21[SabI4B ]− k21[SabI2B ][I2B ]+
k23[SabIB ][IB ]− k−23[SabI2B ] + k−24[SabI3B ]− k24[SabI2B ][IB ], (4.78)
d[SabI4B ]
dt
=k21[SabI2B ][I2B ]− k−21[SabI4B ] + k25[SabI3B ][IB ]− k−25[SabI4B ] + kRB [SaI4B ], (4.79)
d[SaIB ]
dt
=k22[Sa][IB ]− k−22[SaIB ]− k23[SaIB ][IB ] + k−23[SaI2B ], (4.80)
d[SaI3B ]
dt
=k24[SaI2B ][IB ]− k−24[SaI3B ]− k25[SaI3B ][IB ] + k−25[SaI4B ], (4.81)
d[SabIB ]
dt
=k22[Sab][IB ]− k−22[SabIB ]− k23[SabIB ][IB ] + k−23[SabI2B ], (4.82)
d[SabI3B ]
dt
=k24[SabI2B ][IB ]− k−24[SabI3B ]− k25[SabI3B ][IB ] + k−25[SabI4B ]. (4.83)
The formation of intermediate DNA:protein complexes, due to monomeric and
dimeric integrase binding, in our mechanistic model gives rise to multiple state
variables associated with the two DNA states of interest, state 2 (Sa) and state 4
(Sab). Summing all the ODEs describing the dynamics of state variables associated
with the same DNA state of interest provides the total register of the system in those
states (SaT and SabT). Hence, model outputs are determined through the numerical
solutions to the following ODEs:
dSaT
dt
= kRAS0I4A − kRBSaI4B, (4.84)
dSabT
dt
= kRBSaI4B, (4.85)
where kRA and kRB are the parameters describing inversion and/or deletion medi-
ated by integrase A and B respectively, S0I4A represents four integrase A monomers
bound to DNA in state 1 and SaI4B represents four integrase B monomers bound
to DNA in state 2. The model also consists of 32 parameters that are optimised
through comparisons of the solutions to (4.84) and (4.85) with our experimental
data.
4.4 Model validation via global optimisation
Induction of integrase B prior to integrase A causes transition to the unwanted
deleted DNA state, state 3, and therefore we optimise our model against experi-
mental data regarding induction of integrase A prior to integrase B only (See Ex-
perimental methods for our experimental procedure). Our data was generated as
part of the research presented in [Hsiao et al., 2016], but was not presented in that
publication. It is comprised of both RFP and GFP levels (state 2 and state 4 respec-
tively) under eight distinct experimental conditions. Firstly, fluorescence is recorded
for no induction of either integrase and, secondly, fluorescence is recorded for induc-
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tion of integrase A only. A further six experimental procedures record fluorescence
for induction of integrase B at increasing time intervals, δT, such that δT = 0, . . . , 5
hours following induction of integrase A. We assume that RFP and GFP provide
a direct readout of the DNA state of the system that equates to the concentration
levels required to parameterise our model. Since the observed fluorescence has no
physical dimension, the raw data for state 2 and state 4 are converted to percent-
ages of the maximum fluorescence expression level recorded across all experiments
to enable mathematical comparisons. This establishes the percentage fluorescence
output data required to infer the parameters in our model.
Given that we are using a deterministic model to simulate recombination ef-
ficiencies within a single cell, we overcome uncertainty regarding physical quantities
of DNA by allocating an initial DNA concentration (state 1) of 1, hence all model
outputs are bounded within a solution space of [0, 1]. Once a numerical output has
been computed, it is divided by the maximum numerical output across all simula-
tions and multiplied by 100 in order to establish the same percentage of maximum
expression captured by our converted data. Hence, model outputs are subject to the
same conversion applied to the experimental data, establishing percentage changes
in observed fluorescence output for varying time intervals between the induction of
integrases A and B.
We employ a parallelised GA function in MATLAB on a high-performance
computing cluster to perform global optimisation of the mechanistic model against
our large experimental dataset. This enables us to run the GA with a large popu-
lation size and over a larger number of generations within manageable time frames,
and hence increases the likelihood of identifying the global optimum solution. We
select a parameter space of [10−6, 103] for all model parameters subject to inference.
This is sufficiently large in light of the lack of documented reactions rate constants
available in the literature, whilst minimising the potential for excessively stiff model
simulations that may cause the GA to fail. We run the GA over 1000 generations
to maximise the likelihood of convergence and hence identification of the global
optimum solution within the parameter space. The error function is comprised of
six components, each corresponding to the six datasets that we optimise the model
against. Since each dataset captures percentage concentrations of varying mag-
nitudes, an error function that computes mean absolute error consequently takes
individual contributions of varying magnitudes which may skew the optimisation
across all six datasets. Our error function instead computes normalised absolute
error with respect to the range of each dataset:
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E =
1
rNI2
21∑
i=1
|xNI2i − dNI2i |+
1
rNI4
21∑
i=1
|xNi4i − dNI4i |+ . . .
1
rA2
21∑
i=1
|xA2i − dA2i|+
1
rA4
21∑
i=1
|xA4i − dA4i|+ . . .
1
rAB2
21∑
i=1
|xAB2i − dAB2i |+
1
rAB4
21∑
i=1
|xAB4i − dAB4i |, (4.86)
where E is the error and xi, di are the model outputs and data values at each of
the twenty-one corresponding time points, ti, respectively. The superscripts NI, A
and AB denote simulations and data corresponding to No inducer, induction of A
only and induction of A and B simultaneously respectively. The subscripts 2 and
4 denote simulations and data corresponding to the DNA states of interest, state
2 (Sa) and state 4 (Sab) respectively. The range of data values, r, is calculated for
each dataset such that r = d21−d1, and is used to normalise each component of the
error function.
The optimised mechanistic model is able to capture the observed system
dynamics for both state 2 (Fig. 4.4A) and state 4 (Fig. 4.4B). The model is
initially simulated with the parameter describing basal expression of integrases A
and B (γbas) simultaneously in order to generate non-zero no-inducer model outputs.
Following basal simulations, the model is simulated with the parameter describing
induced expression of integrases A and B (γind), but for integrase A only. Finally,
the model is simulated with this induced expression parameter for integrases A and
B simultaneously. The expression of fluorescent protein is greatest in state 2 for
the induction of integrase A only. This is expected since the system is able to
transition from state 1 to state 2 without integrase B induction causing significant
competing transition to state 3. The system is able to maintain the transition to
this state over time since further transitioning to state 4 is also minimal in the
absence of integrase B induction; transitioning to state 3 and state 4 is only possible
in this case due to basal expression of integrase B. The optimised model simulation
corresponding to this case presents the greatest error observed across all six datasets,
specifically with respect to the initial evolution of the response. The sigmoidal
expression profile captured by this dataset is very difficult to emulate given our
description of protein expression via constant parameters, and may instead require
time-dependent protein expression to improve this fit. In contrast, the simultaneous
induction of both integrases results in decreased fluorescence output in state 2.
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Figure 4.4: Data fitting and model prediction results. A) Optimised responses of
our mechanistic model against three state 2 time course datasets. B) Optimised
responses of our mechanistic model against three state 4 time course datasets. C)
Model predictions of the transitioning to state 4 in response to different induction
separation intervals (A only, A and B fits included from B). Circles depict exper-
imental data; solid lines depict optimal model outputs (A only and δT= 0) and
model predictions (δT = 1, . . . , 5). Data generated as part of the research presented
in [Hsiao et al., 2016].
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There is a small increase initially due to the state 2:state 3 split however, state 2
cannot be maintained since integrase B induction is able to transition this transient
state to state 4. Fluorescence is relatively low in state 4 for the induction of integrase
A only. This is expected since transition from state 1 to state 4, in the absence of
integrase B induction, is only possible due to the basal expression of integrase B.
Fluorescence increases for the simultaneous induction of both integrases, but it does
not reach a similarly high level to that of state 2 for the induction of integrase A only.
This is due to the fact that the transition to state 3 and state 4 occurs simultaneously
and hence neither state can be maintained at maximal levels. Increased fluorescence
in state 4 is thus dependent on the delay between the induction of the two integrases.
The optimal parameter set identified by the GA implies that integrase A
operates on a slower time scale to that of integrase B. Although the parameters
describing integrase A-mediated DNA binding interactions (k±4,...,±16) and those
describing integrase B-mediated DNA binding interactions (k±20,...,±25) all take op-
timal values in the interval [10−2, 101], the parameter describing the rate of recombi-
nation mediated by integrase B, kRB, is ∼77% greater than that of integrase A, kRA
(Table 4.5). These are the two key parameters in generating the numerical solutions
Parameter Value (M−1s−1) Parameter Value (s−1) Parameter Value (Ms−1)
k1 0.1178 k−1 0.2507 γbas 0.0311
k4 0.6046 k−4 0.9999 γind 0.0988
k5 1.1962 k−5 1.2614 − −
k13 1.5835 k−13 0.6076 − −
k14 0.2511 k−14 0.0201 − −
k15 0.1693 k−15 1.0903 − −
k16 0.2192 k−16 0.9371 − −
kintX 1.4968 kRA 0.4239 − −
k20 0.7169 k−20 0.2434 − −
k21 0.1541 k−21 0.8693 − −
k22 2.6537 k−22 0.3342 − −
k23 0.9586 k−23 0.5976 − −
k24 0.3745 k−24 1.0478 − −
k25 1.0276 k−25 4.1887 − −
− − kRB 0.7535 − −
− − δ 0.6401 − −
Table 4.5: The optimal model parameter values inferred by the genetic algorithm
through global optimisation. Model parameters are dimensional, taking SI units
arising from standard mass action kinetics.
to (4.84) and (4.85) that comprise our model simulations and hence it appears that
the rate of inversion/deletion mediated by integrase B is greater than that of inte-
grase A in producing the dynamical behaviour captured by our experimental data.
This implies that the action of integrase B is naturally faster than that of integrase
A and may therefore be more useful as a component in the design of synthetic bi-
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ological circuitry. Note that we have assumed the parameters describing protein
binding interactions (k±1, kintX) are identical for each of the two integrases, just
as the protein expression and degradation parameters. This minimises the overall
number of model parameters, increasing the transferability of the model, and facil-
itates the inference of functional distinctions between the two integrase inputs as
described above. Further examination of potential protein binding distinctions is
possible for future studies at the cost of increasing the number of model parameters.
The optimal parameter set is used to generate all plots in Fig. 4.4, as well as all
subsequent plots.
After training our model using the datasets in Fig. 4.4A and 4.4B, we used
our optimised mechanistic model to predict a set of experimental data that was
excluded from the training set. Optimised model predictions align with experimental
data for increasing integrase induction delays (δT = 1, . . . , 5) (Fig. 4.4C). As the
delay between the induction of integrase A and B increases, the time afforded to the
maintenance of state 2 also increases. There is therefore a greater concentration of
state 2 than state 1 when integrase B is eventually induced and hence transition to
state 4 is increased by virtue of integrase B-mediated inversion. Consequently, the
transition to state 3 is decreased due to the decrease in concentration of state 1.
Additionally, we validated our model by predicting endpoint GFP concen-
trations relating to both A then B temporal response data and an entirely separate
dataset regarding B then A temporal responses. The endpoint response of the sys-
tem as a function of the integrase induction separation interval δT is shown in Fig.
4.5. Optimal endpoint percentage model outputs as a function of δT align closely
with that of the experimental data, providing further evidence of the model’s predic-
tive capability. Fig. 4.5 also supports the notion that the efficiency of recombination
induction via integrase B must be superior to that of integrase A since identical ef-
ficiencies would be expected to result in a 50:50 split for δT= 0. This inequality
in integrase-mediated inversion was previously observed in [Hsiao et al., 2016], but
no mechanistic comparisons had been performed at that time. Consequently, it re-
mains to experimentally examine functional differences between distinct integrases
as these properties may allow for specific logic operations dependent on the pair
of integrases selected, the arrangement of the associated attachment sites and the
specific roles each integrase input is assigned in the circuit.
4.4.1 Experimental methods
The experimental system for the temporal logic gate with Bxb1 and TP901-1 inte-
grases was implemented in DH5a-Z1 E. coli. The Bxb1 and TP901-1 integrases are
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 Figure 4.5: Endpoint GFP concentration results. A then B GFP percentage con-
centration endpoint predictions from Fig. 4.4C plotted as a function of δT (δT
= 0, . . . , 5; light blue plot line). Equivalent predictions of B then A temporal re-
sponses are depicted by the dark blue plot line. Model simulations generated using
our optimal parameter set. Data generated as part of the research presented in
[Hsiao et al., 2016].
on a high copy plasmid (available from the Addgene plasmid repository, ID 82351).
The temporal logic gate with integrase binding targets was chromosomally inte-
grated into the Phi80 site of the E. coli genome using CRIM integration [Haldimann
and Wanner, 2001]. A plasmid version of the same logic gate is also available from
Addgene (ID 82352).
M9CA media was prepared with 1× M9 salts (Teknova, M1906) augmented
with 100 mM NH4CL, 2 mM MGSO4, 0.01% casamino acids, 0.15 µg/ml biotin, and
1.5 µM thiamine. 0.2% glycerol was used as the sole carbon source and the entire
solution was sterile-filtered (0.2 µm). During the experiment, all media contained the
antibiotics chloramphenicol (Sigma-Aldrich, Inc (C0378); 50 µg/ml) and kanamycin
(Sigma-Aldrich, Inc (K1876); 30 µg/ml). L-arabinose, the inducer for TP901-1, was
used at a concentration of 0.01% by volume, and anhydrous tetracycline (aTc), the
inducer for Bxb1, was used a concentration of 200 ng/ml (450 nM). All experiments
were performed with the aid of timed liquid handling by a Hamilton STARlet Liquid
Handling Robot (Hamilton Company).
At the beginning of the experiment, the cells were diluted to OD 0.06-0.1
into a 96-well matriplate (Brooks Automation, Inc., MGB096-1-2-LG-L) with 500µl
total volume in M9CA. Cultures were incubated at 37C in a BioTek Synergy H1F
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plate reader with linear shaking (1096 cycles per minute) (BioTek Instruments,
Inc.), and inducers were added at various δT time points by the Hamilton robot.
OD and fluorescence measurements (superfolder-GFP ex488/em520, mKate2-RFP
ex580/em610) were taken every 10 min. Each experimental condition was performed
on the plate in triplicate.
4.5 Reversing the roles of integrase inputs
By allowing integrase B to occupy the role of integrase A and vice versa, we are
able to investigate the effect of input reversal on the output of the temporal logic
gate in silico using our optimised mechanistic model. This involves swapping the
optimal parameter values corresponding to reactions mediated by integrase A with
the equivalent optimal parameter values corresponding to reactions mediated by
integrase B. That is, our previous ‘A then B’ inputs are reversed in order to examine
‘B then A’ simulations. We simulate the same dynamical responses captured by our
experimental data (Fig. 4.6).
The effect of reversing integrase inputs on state 2, for the induction of inte-
grase B only, results in an increased response time that results in faster transitioning
to maximal RFP concentration (Fig. 4.6A). Induction of both integrases (δT= 0)
results in a dynamical response that exhibits a significant increase in transient RFP
concentration compared to the original inputs. The expected sequestration of RFP
concentration can be observed, however it is unable to reach 0 on the same timescale
as the original input data. These simulations demonstrate the increased speed of
the reactions mediated by integrase B since this transient state is expressed to a
greater level before sequestration via the slower action of integrase A. Input reversal
also has a significant impact on the expression of state 4 (Fig. 4.6B). Although the
induction of integrase B only causes increased transition to state 2, the relatively
slower action of integrase A results in negligible GFP concentration. However, si-
multaneous induction of both integrases (δT= 0) causes a significant increase in
concentration on the same timescale as the original inputs, thus demonstrating that
the action of the slowest integrase in the input pair is rate limiting in the overall
dynamical response of the temporal logic gate. This increase in concentration is
likely due to the increased concentration of state 2 caused by integrase B which can
be transitioned to state 4 via integrase A.
Induction separation intervals provide further evidence of the increased con-
centration achieved by reversing the integrase inputs (Fig. 4.6C). Here, the endpoint
responses as a function of δT confirm that the expected 50% endpoint concentration
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Figure 4.6: Model simulations of reversed integrase inputs. A) Optimised model
simulations of state 2 RFP concentration using reversed integrase inputs (No in-
ducer, B only, B and A (δT = 0)). B) Optimised model simulations of state 4 GFP
concentration using reversed integrase inputs (No inducer, B only, B and A (δT
= 0)). C) B then A GFP percentage concentration endpoint simulations plotted as
a function of δT (δT= 0, . . . , 5; light blue plot line). Equivalent predictions of A
then B temporal responses are shown by the dark blue plot line.
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for δT= 0 is shifted significantly towards the concentration of state 4 and the expres-
sion of GFP (∼80%). This highlights the potential benefit of employing the more
efficient integrase in the original role of integrase A, given the decreased transition-
ing to the unwanted state 3 that this provides. The endpoint concentrations plotted
in Fig. 4.6C are taken from outputs simulated over an increased timescale in order
to obtain steady-state levels that are not reached on the original timescale. As such,
the increased efficiency of the circuit to transition to state 4 requires more time,
and hence it is likely that a suitable trade-off between response time and efficiency
will be required for optimal performance. The speeds at which the system is able to
transition to each distinct DNA state for both input assignments are summarised
in Fig. 4.7.
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Figure 4.7: State transition speeds associated with input assignment. A) The orig-
inal circuit exhibits a faster transition to state 4 following slower accumulation of
state 2. B) The reversed circuit exhibits a slower transition to state 4 following
faster accumulation of state 2.
4.6 Conclusions
We have developed the first mechanistic mathematical model of a synthetic two-
input temporal logic gate using previously validated models of in vitro DNA recom-
bination reactions. Our model was validated against a series of time course datasets,
demonstrating quantitative replication of in vivo datasets relating to the induction
of none, one, or both integrases, and accurate prediction of the response of the logic
gate to inputs separated by five different induction separation intervals. Further
error reduction relating to the rise time of fluorescence output may be possible by
accounting for increased detail regarding the nature of integrase expression, however
115
the current model provides sufficient replication of the corresponding steady state
outputs which has greater importance as feature of a reliable design tool. Both our
modelling investigation and our experimental data provide evidence of functional
distinctions between the two integrase inputs, suggesting that integrase B, Bxb1,
operates more efficiently than integrase A, TP901-1 (∼1.8-fold faster). Experimen-
tal data for other distinct serine integrases would allow us to develop a lookup table
of logic functions dependent on the choice and assignment of inputs. The effect
of reversing the roles of the two integrases was subsequently shown to elicit a more
rapid response time as well as significantly greater GFP expression in state 4. Mech-
anistic models therefore have the potential to reveal functional nuances that might
exist between other characterised integrases and hence inform further experimental
verification. These results could therefore also have important implications in the
design of higher-order logic circuitry when considering the ideal pairs of integrase
inputs to select in order to realise the desired system output. Future work will ex-
tend our modelling investigations to higher-order logic circuits, namely 2-4 decoders
in mammalian cells for potential therapeutic applications.
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Chapter 5
DNA Recombination
Experiments
5.1 Establishing ideal bacterial growth conditions
In order to develop our biological understanding of recombinase-based genetic switches,
we performed experiments designed to facilitate the collection of primary data on the
efficiency of bacterial DNA recombination in vivo. We implemented an integrase-
excisionase-mediated genetic switch in the bacteria Streptomyces coelicolor by in-
tegrating an operon consisting of five lux genes, luxCDABE, into the S. coelicolor
M145 genome in order to enable the cells to exhibit luminescence. The luxA and
luxB genes produce luciferase enzymes that catalyse bioluminescence reactions, and
the three remaining genes produce the enzymes that provide the substrate of these
reactions. The production of the RDF gp3 in conjunction with the natural produc-
tion of pSAM2 integrase should be sufficient to cause excision of the luxCDABE
gene from the bacterial genome and should therefore ‘turn off’ luminescence. In
theory, the efficiency of the pSAM2-gp3-mediated excision of the luxCDABE operon
can be quantified by analysing the luminescence output of the bacteria.
The luxCDABE operon is carried on the L3 vector (Figure 5.1A). All S.
coelicolor M145 strains cultured in our experiments had the L3 vector integrated
into their genome. Integration of the L3 vector also resulted in resistance to the
antibiotic apramycin which allowed isolation of clones with the insert of interest.
In addition, these strains also had either the pCC4 vector (Figure 5.1B) or pRDF1
vector (Figure 5.1C) integrated into their genome. The pCC4 vector is ‘empty’
in the sense that it does not contain the gene gp3 necessary for the production of
gp3 excisionase, but it does provide resistance to the antibiotics aparamycin and
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Figure 5.1: Schematics of the vectors used in our DNA recombination experiments.
A) The L3 vector containing the luxCDABE operon and the apramycin resistance
gene. B) The pCC4 vector containing apramycin and hygromycin resistance genes
and the pSAM2 integrase gene. C) The pRDF1 vector containing ampicillin and
hygromycin resistance genes, the pSAM2 integrase gene and the RDF gene, gp3.
hygromycin and also naturally produces pSAM2 integrase (Table 5.1A). We refer
to S. coelicolor M145 strains containing the L3 and pCC4 vectors as L3+pCC4 and
these strains therefore provided an excionase-less control (Table 5.1B). The pRDF1
vector is identical to pCC4 with the exception that it does contain the gp3 gene
and provides resistance to ampicillin instead of apramycin. We refer to S. coelicolor
118
A
Vector Genes of interest Resistance
L3 luxCDABE Apr
pCC4 - Apr and Hyg
pRDF1 gp3 Amp and Hyg
B
Strain Genes of interest Resistance
L3+pCC4 luxCDABE Apr and Hyg
L3+pRDF1 luxCDABE and gp3 Apr, Amp and Hyg
Table 5.1: A) Summary of the vectors used in our DNA recombination experiments.
B) The nomenclature relating to S. coelicolor M145 strains containing these vectors.
Apr, Hyg and Amp denote the antibiotics apramycin, hygromycin and ampicillin
respectively.
M145 strains containing the L3 and pRDF1 vectors as L3+pRDF1.
The integration of the luxCDABE operon into the S. coelicolor M145 genome
is the ‘on’ switch in this system. To carry out DNA transfer (integration), E.
coli ET12567 cells containing the luxCDABE operon within the plasmid L3 vector
are grown to an optimal growth phase in liquid culture, then centrifuged and re-
suspended to remove any antibiotics used in the culture. S. coelicolor cells are heat
shocked for 10 minutes to make them more likely to accept the new DNA. Both
the ET12567 cells and S. coelicolor are plated out on soya flour mannitol (SFM)
plates and left to grow overnight (see Methods for SFM protocol). It is during
this time that the transfer of genetic material should occur. This is known as
intergenic conjugation (see Methods for full protocol). The following day the plates
are overlaid with nalidixic acid, which should kill all E. coli, and apramycin which
should kill any S. coelicolor which do not contain the desired genetic insert, thus
selecting for the luxCDABE operon. This process was also carried out for each of
the pCC4 and pRDF1 vectors, with hygromycin used to select for the desired strains
rather than apramycin. This does restrict our ability to test the efficiency of the
integration reaction since only the S. coelicolor strains with the desired integrated
genes are preserved. However, since the integration reaction is mediated purely
by integrase, integration is thought to be highly efficient in the absence of RDF,
a notion that is supported by our mathematical modelling investigation. We are
therefore interested in how efficiently the RDF is able to excise luxCDABE out of
the S. coelicolor genome in conjunction with pSAM2 integrase, turning the switch
‘off’ again and thus rendering the bacteria incapable of producing luminescence.
119
Before examining the efficiency of the excision reaction, we performed a num-
ber of experiments designed to elucidate the ideal growth conditions for S. coelicolor
that permit optimal luminescence production in the integrated cells. These prelimi-
nary trials were carried out using L3+pCC4 (containing no gp3) that is, we wanted
to optimise the protocol without RDF activity presenting additional variables. We
initially plated out L3+pCC4 strains onto 10 SFM plates, directly from glycerol
stocks. Our SFM plates were produced by adding 25 mL of SFM to a standard
Petri dish using a sterile pipette. The bacteria were diluted according to a serial di-
lution that gave rise to a countable number of colonies; highly concentrated bacterial
solutions grow very prolifically on SFM plates, forming ‘lawns’ of cells that make it
impossible to distinguish individual colonies. Each specific dilution is spread onto
its own SFM plate to permit the measurement of luminescence for each individual
colony. Serial dilution involves pipetting an appropriate volume of stock solution
(100%) into a volume of sterile water sufficient to produce a concentration of 10%
solution. For example, 20 µL of solution into 180 µL of sterile water gives 20 µL of
solution in a total 200 µL of mixture and is therefore 10% diluted. By pipetting 20
µL of the 10% dilution into another 180 µL of sterile water, the dilution is increased
further by a factor of 10 giving a 1% diluted mixture. Repeating this process pro-
duces a series of diluted solutions each of which is one tenth of the concentration
of the preceding solution and is an effective method of establishing the appropriate
concentrations that give rise to countable numbers of bacterial colonies. To measure
luminescence, we utilised a charge coupled device (CCD) camera which counts the
photons emitted via bioluminescence, and Image32 computer software which pro-
duces images of the analysed plate that depict the luminescence of colonies in their
exact locations on the plate.
All colonies grown on the 10 initial plates were expected to exhibit lumi-
nescence however, only 77 out of 94 colonies (∼82%) were seen to do so (Table
5.2). It is possible that this low percentage was caused by the freezing of glyc-
erol stocks and therefore, in an attempt to improve this result, we carried out a
repeat experiment in conjunction with a trial of an alternative method. We picked
three single colonies that had already been seen to exhibit luminescence on an SFM
plate and serially diluted these in order to achieve a countable number of colonies.
Picking colonies that had already exhibited luminescence was thought to increase
the likelihood of maintaining luminescence. The resulting dilution was spread on 3
SFM plates. The repeat produced a result consistent with the unexpected result of
the first trial, with 84 of 99 colonies (∼85%) exhibiting luminescence (Table 5.3A).
The alternative method, whereby luminescent colonies were picked from a ‘starter
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Plate Total Luminescent
number colonies colonies
1 12 12
2 12 11
3 16 11
4 11 5
5 10 8
6 9 8
7 6 5
8 8 7
9 7 7
10 3 3
Total 94 77
Table 5.2: Luminescence in L3+pCC4, grown from glycerol stocks.
A B
Plate Total Luminescent Plate Total Luminescent
number colonies colonies number colonies colonies
1 22 20 1 26 26
2 17 14 2 15 14
3 13 11 3 8 8
4 23 17 Total 49 48
5 24 22
Total 99 84
Table 5.3: A) Luminescence in L3+pCC4, grown from glycerol stocks (repeat). B)
Luminescence in L3+pCC4, grown from a dilution of luminescent colonies (starter
plate).
plate’, did however produce the result we expected with only one colony identified as
not exhibiting luminescence (∼100%) (Table 5.3B). This indicated that the freezing
process for glycerol stocks may have a detrimental effect on luminescence.
A repeat experiment using this starter plate method was carried out to vali-
date the result. In this case, six single colonies that had exhibited luminescence were
picked and spread onto six SFM plates at the appropriate dilution to produce single
colonies. These colonies gave rise only to luminescent colonies and hence this growth
method is most efficient in preserving the expression of the luxCDABE operon in
S. coelicolor (Table 5.4). It appears that plating S. coelicolor strains directly from
glycerol stocks is conducive to unpredictable results, most likely due to the freezing
of the cells for storage purposes.
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Plate Total Luminescent
number colonies colonies
1 14 14
2 10 10
3 2 2
4 24 24
5 6 6
6 10 10
Total 66 66
Table 5.4: Luminescence in L3+pCC4, grown from a starter plate (repeat).
We performed an additional experiment to examine the luminescence of lawns
of L3+pCC4. One luminescent colony and four non-luminescent colonies were picked
and spread onto standard Petri dishes of 25 mL SFM. The lawn grown from the
luminescent bacteria gave at least a 50-fold increase in the light reading compared to
that produced by the four lawns of previously non-luminescent bacteria (Table 5.5).
These four lawns were not expected to exhibit luminescence however, even allowing
Plate Colony of Light
number origin reading
1 Luminescent 3109779
2 Not luminescent 955
3 Not luminescent 58485
4 Not luminescent 17688
5 Not luminescent 609
Table 5.5: Light readings taken from five lawns of L3+pCC4 using a CCD camera
and Image32 software.
for background noise, plates 3 and 4 in particular appear to exhibit unexpectedly
high light readings. It appears that these cells did, in fact, retain the lux genes
which makes it unclear why they did not exhibit luminescence initially. It might
be that these particular bacteria require a period of time to adopt regular cellular
functionality that has skewed our preliminary results.
Having established that L3+pCC4 cultures originating from luminescent
colonies provide the most suitable test cultures, we were able to run trials relat-
ing to the activity of gp3 excisionase in this genetic switch system.
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5.2 Recording excision time courses
In order to investigate the efficiency of the excision reaction, RDF must be produced
within the system. We therefore performed a series of experiments implementing
L3+pRDF1 strains that possess both the luxCDABE operon and gp3 gene in order to
record time course excision efficiency. We aimed to record luminescence at four time
points (0, 24, 48 and 72 hours) to establish the time course evolution of excision
efficiency. These time points were chosen based on optimisation trials run by an
experimental collaborator working with similar strains [Styles, 2016]. We decided
to grow our L3+pRDF1 strains in liquid media 2xYT to facilitate the plating of
bacterial solutions at the intended time points (see Methods for 2xYT protocol).
Growing bacterial cultures in liquid media causes colonies to develop in clumps to
an extent that some are too large to be effectively taken up by a pipette. As a
result, we grew the cultures with glass beads mixed in with the solution to prevent
aggregation, the accumulation of large clumps. A total of twenty beads were added
to each flask and all flasks were incubated at 30 ◦C in a shaking incubator at 200
rpm. We spread our liquid samples onto solid SFM plates at the aforementioned
time points, however the light readings were taken 72 hours after each sample was
plated to allow enough time for colonies to develop. We required 72 hours to achieve
sufficient growth for measurable luminescence levels due to the doubling time of S.
coelicolor [Chen and Qin, 2011]. Therefore, the time points at which we recorded
the luminescence of the L3+pRDF1 colonies were in fact 0(+72), 24(+72), 48(+72)
and 72(+72) hours.
The first time point was recorded immediately after the appropriate cultures
were inoculated in order to get a 0 hour time point reading. L3+pRDF1 strains
were plated on 25 mL SFM plates; one non-selective set without antibiotics and one
selective set with 12.5 µg/mL hygromycin and 12.5 µg/mL apramycin. The selective
plates select for gp3 and luxCDABE respectively, thus the only colonies that should
grow successfully on this medium are those which have retained all integrated genes,
including the resistance markers. Any cells which have had their luxCDABE operon
excised are expected to have also lost the associated apramycin resistance and should
therefore not grow on these plates. Hence, we expected the RDF gp3 to take effect on
both selective and non-selective SFM plates but we expected fewer colonies, that are
all luminescent, to grow on the selective plates (Fig. 5.2). This process was carried
out for three different dilutions (Table 5.6) to increase the chance of producing
countable numbers of colonies. All experiments were also performed using L3+pCC4
strains as an experimental control. That is, bioluminescence was expected in all the
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 L3+pCC4 L3+pRDF1 
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SFM+Hyg+Apr 
Luminescent 
colonies 
(fewer) 
Luminescent 
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Non-luminescent 
colonies 
(mixed) 
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Control strain Excisive strain 
Non-selective plate: 
SFM 
Selective plate: 
SFM+Hyg+Apr 
Non-selective plate: 
SFM 
Plating 
Incubation 
Figure 5.2: Experimental design. The control strain L3+pCC4 and the excisive
strain L3+pRDF1 were used to record excision efficiency. L3+pCC4 strains on non-
selective media are expected to produce many luminescent colonies since there is no
gp3 to excise the luxCDABE operon. L3+pCC4 strains on selective media are also
expected to produce luminescent colonies, but in lower numbers due to antibiotic
selection which kills colonies of strains that do not have the full compliment of resis-
tance markers. L3+pRDF1 strains on non-selective media are expected to produce
non-luminescent colonies since the presence of gp3 is sufficient to mediate excision
of the luxCDABE operon in conjunction with pSAM2 integrase; the efficiency of
this reaction is determined by the number of non-luminescent colonies. L3+pRDF1
strains on selective media are expected to produce low numbers of luminescent
colonies since excision of the luxCDABE operon removes apramycin resistance and
hence only strains that retain the operon are preserved; a fully efficient excision re-
action would result in no growth. Hyg and Apr denote hygromycin and apramycin
respectively.
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0 hours L3+pRDF1
(+72 hours) SFM SFM+Hyg+Apr
Dilution Col Lum Col Lum
100 Lawn Even Lawn Even
10−1 TMTC Even 42 Even
10−2 23 19 6 6
L3+pCC4
SFM SFM+Hyg+Apr
Dilution Col Lum Col Lum
100 Lawn Even Lawn Even
10−1 TMTC Even TMTC Even
10−2 TMTC Even TMTC Even
Table 5.6: Excision efficiency at 0 hours. The selective media is denoted by
SFM+Hyg+Apr where Hyg and Apr denote 12.5 µg/mL of hygromycin and
apramycin respectively. The abbreviations Col and Lum denote the total number
of colonies and the number of those colonies that exhibited luminescence respec-
tively. Even denotes even luminescence observed across the plate. TMTC is an
abbreviation of too many to count.
control experiments since these strains were void of any integrated gp3 gene and were
therefore incapable of pSAM2-gp3-mediated excision. As expected, the L3+pCC4
strains grew very efficiently on the selective media at the chosen dilutions and all
of these colonies, or lawns of colonies, exhibited luminescence. The L3+pRDF1
strains grew in smaller numbers at this 0 hour time point and all of these colonies
also exhibited luminescence with the exception of four on the 10−2 non-selective
SFM plate. This suggests that the gp3, in conjunction with pSAM2, had excised
the luxCDABE gene from these strains and was therefore functioning as expected,
with an efficiency of ∼17%.
After the 0 hour collection, subsequent measurements were recorded every
24 hours, with some adaptations. We decided to increase the number of dilutions
to be plated in light of the growth recorded at 0 hours and also added different
amounts of hygromycin and apramycin to some of the dilutions in order to optimise
the selection of the desired strains. Since the L3+pCC4 strains were seen to grow
more efficiently than the L3+pRDF1 strains, we diluted these solutions further to
produce countable numbers of colonies for both strains. Bacterial growth occurred
on half of the plates used for the 24 hour time point (Table 5.7), with the vast
majority of colonies exhibiting luminescence. Again, all L3+pCC4 colonies were
luminescent, as expected. The two L3+pRDF1 colonies on selective media that
125
24 hours L3+pRDF1
(+72 hours) SFM SFM+Hyg+Apr
Dilution Col Lum Col Lum
10−3 Hyg+2Apr 23 19 8 7
10−3 12Hyg+
1
2Apr 8 7 4 3
10−4 12Hyg+
1
2Apr - - - -
10−5 12Hyg+
1
2Apr - - - -
10−5 No antibiotic 6 6 1 1
10−6 No antibiotic - - - -
10−7 No antibiotic 3 3 - -
L3+pCC4
SFM SFM+Hyg+Apr
Dilution Col Lum Col Lum
10−8 Hyg+2Apr 18 18 2 2
10−7 12Hyg+
1
2Apr 6 6 4 4
10−8 12Hyg+
1
2Apr - - 1 1
10−9 12Hyg+
1
2Apr 6 6 28 28
10−7 No antibiotic - - - -
10−8 No antibiotic - - - -
10−9 No antibiotic - - - -
Table 5.7: Excision efficiency at 24 hours. The selective media is denoted
by SFM+Hyg+Apr where Hyg and Apr denote 12.5 µg/mL of hygromycin and
apramycin respectively. The 12.5 µg/mL concentration is doubled or halved to 25
µg/mL or 6.25 µg/mL respectively as denoted in the table. The abbreviations Col
and Lum denote the total number of colonies and the number of those colonies
that exhibited luminescence respectively. Dashes denote plates on which no growth
occurred and therefore could not give a light reading.
did not exhibit luminescence indicate that the luxCDABE genes were not being
expressed properly since all bacteria void of this gene should have been killed. The
five non-luminescent L3+pRDF1 colonies that grew on non-selective media with
antibiotic added to their dilution was an unexpected result given that the equivalent
colonies were all luminescent in collections from the 0 hour time point. Although
there were fewer colonies on the selective plates which suggests that the gp3 was
active, the nine colonies on non-selective SFM plates with no antibiotic in their
dilution were all luminescent which contradicts our observations at the 0 hour time
point and thus suggests that the gp3 was, in fact, not having an effect.
The number of dilutions used was increased further for the 48 hour time
point. Bacterial growth occurred on 12 of the 36 plates (Table 5.8) and, again, the
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48 hours L3+pRDF1
(+72 hours) SFM SFM+Hyg+Apr
Dilution Col Lum Col Lum
10−4 Hyg+2Apr - - - -
10−3 12Hyg+
1
2Apr 4 3 2 2
10−4 12Hyg+
1
2Apr 2 2 - -
10−5 12Hyg+
1
2Apr - - - -
10−6 12Hyg+
1
2Apr - - - -
10−5 No antibiotic 2 2 - -
10−6 No antibiotic - - - -
10−7 No antibiotic - - - -
10−8 No antibiotic - - - -
L3+pCC4
SFM SFM+Hyg+Apr
Dilution Col Lum Col Lum
10−9 Hyg+2Apr - - - -
10−7 12Hyg+
1
2Apr 1 1 - -
10−8 12Hyg+
1
2Apr - - 1 1
10−9 12Hyg+
1
2Apr - - - -
10−10 12Hyg+
1
2Apr - - - -
10−7 No antibiotic - - 2 2
10−8 No antibiotic 2 2 5 5
10−9 No antibiotic 7 7 5 5
10−10 No antibiotic 29 28 - -
Table 5.8: Excision efficiency at 48 hours. The selective media is denoted
by SFM+Hyg+Apr where Hyg and Apr denote 12.5 µg/mL of hygromycin and
apramycin respectively. The 12.5 µg/mL concentration is doubled or halved to 25
µg/mL or 6.25 µg/mL respectively as denoted in the table. The abbreviations Col
and Lum denote the total number of colonies and the number of those colonies
that exhibited luminescence respectively. Dashes denote plates on which no growth
occurred and therefore could not give a light reading.
vast majority of colonies that grew exhibited luminescence. This was expected for
all L3+pCC4 colonies, the L3+pRDF1 colonies grown on selective media and the
L3+pRDF1 colonies grown on non-selective media with added antibiotic, but not
for the L3+pRDF1 colonies grown on non-selective media without added antibi-
otic. Again, there is no indication that the gp3 was having an effect since the two
colonies that grew on non-selective SFM plates without added antibiotic were both
luminescent.
Bacterial growth occurred on just 3 of the 36 plates at the 72 hour time point
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(Table 5.9), with all colonies exhibiting luminescence. All six L3+pCC4 colonies
72 hours L3+pRDF1
(+72 hours) SFM SFM+Hyg+Apr
Dilution Col Lum Col Lum
10−4 Hyg+2Apr - - - -
10−3 12Hyg+
1
2Apr 2 2 - -
10−4 12Hyg+
1
2Apr 4 4 - -
10−5 12Hyg+
1
2Apr - - - -
10−6 12Hyg+
1
2Apr - - - -
10−5 No antibiotic - - - -
10−6 No antibiotic - - - -
10−7 No antibiotic 1 1 - -
10−8 No antibiotic - - - -
L3+pCC4
SFM SFM+Hyg+Apr
Dilution Col Lum Col Lum
10−9 Hyg+2Apr - - - -
10−7 12Hyg+
1
2Apr - - - -
10−8 12Hyg+
1
2Apr - - - -
10−9 12Hyg+
1
2Apr - - - -
10−10 12Hyg+
1
2Apr - - - -
10−7 No antibiotic - - - -
10−8 No antibiotic - - - -
10−9 No antibiotic - - - -
10−10 No antibiotic - - - -
Table 5.9: Excision efficiency at 72 hours. The selective media is denoted
by SFM+Hyg+Apr where Hyg and Apr denote 12.5 µg/mL of hygromycin and
apramycin respectively. The 12.5 µg/mL concentration is doubled or halved to 25
µg/mL or 6.25 µg/mL respectively as denoted in the table. The abbreviations Col
and Lum denote the total number of colonies and the number of those colonies
that exhibited luminescence respectively. Dashes denote plates on which no growth
occurred and therefore could not give a light reading.
that grew at this time point on non-selective SFM plates with added antibiotic were
luminescent as expected. However, the single colony that grew on non-selective
SFM plates without added antibiotic was also luminescent and hence the effect of
gp3 was unclear over the 72 hours of growth. An explanation for this could be that
the gp3 was working efficiently, but that the integrase in the system was causing
the luxCDABE genes to be integrated back into the S. coelicolor genome and thus
re-establishing luminescence output.
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5.3 Conclusions
We have carried out a series of practical experiments in order to collect primary
data relating to the efficiency of DNA recombination in vivo using S. coelicolor bac-
teria. We initially determined that the most suitable method for growing bacterial
cultures was through picking colonies from a starter plate that were seen to exhibit
luminescence rather than diluting and plating directly from the glycerol stocks. We
were then able to grow L3+pRDF1 cultures, containing the appropriate luxCDABE
operon and gp3 gene, in order to examine the efficiency of the RDF in the excision
of the luxCDABE operon.
Growth was generally unsuccessful, with the majority of plates showing no
growth. Analysis of the well developed colonies was inconclusive. The colonies we
expected to show the effect of gp3-pSAM2-mediated excision were those L3+pRDF1
strains grown on selective and non-selective SFM plates. Of these, the non-selective
plates represented the best medium for recording excision efficiency. A total of
thirty-five such colonies grew across the four time points however, all of these colonies
exhibited luminescence with the exception of four colonies at the 0 hour time point.
We would have expected the number of non-luminescent colonies to increase over
time as the gp3 would be able to excise more luxCDABE genes in conjunction with
the natural production of pSAM2 integrase. In contrast, the control experiments
and the L3+pRDF1 colonies grown on selective media largely produced the expected
result of 100% luminescent colonies. The mechanistic model we have developed
(described in Chapter 3) predicted that the excision reaction would be susceptible
to low efficiency based on the duality of its mediation and thus aligns with our
experimental data that suggest the gp3 was functional, but that the integrase in
the system was causing natural re-integration of the luxCDABE operon and thus
re-establishing luminescence output. The period of time during which excision has
occurred, but the gene has not yet been re-integrated appears to be small and not
conducive to experimental measurement. Hence, we have tangible evidence that the
standard genetic switch may struggle to provide the hold states required to regulate
gene expression to the desired degree.
As more time elapsed, less growth was observed with only 3 plates out of 36
exhibiting growth at 72 hours. Since the SFM plates presented a finite quantity of
nutrients and moisture to the developing S. coelicolor colonies, which would have
diminished over time, the bacteria may have died naturally before reaching our
final time point. Another factor to consider is that the integration of new genes
into the bacterial genome is likely to place additional burdens on cell resources
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which could have a number of impacts including depleted antibiotic resistance and
general functional failures that contribute to premature cell death. We decreased
the concentrations of antibiotic used to select for the appropriate S. coelicolor strains
in the hope that these stresses placed on the cells would be reduced, however the
overall lack of growth we observed makes it unclear what effect this had.
We can conclude that further experimentation is required to record data
worthy of elucidating the excision efficiency that we are interested in. The exper-
imentation carried out involved ∼300 man-hours staggered over the course of 12
months. This is a substantial time frame considering that the results obtained were
inconclusive and warrant further work and, hence, we have demonstrated the techni-
cal difficulty in achieving sound experimental results as well as the time-consuming
nature of the necessary procedures. As the complexity of synthetic circuitry in-
creases, the relevant experimental procedures will undoubtedly require even greater
technical knowledge and time frames to achieve successful implementation. The
development of sophisticated mechanistic models that are capable of quantitative
dynamical predictions will therefore be invaluable in realising the practical applica-
tion of these novel systems.
5.4 Methods
5.4.1 Intergenic conjugation protocol
The transfer of vectors into S. coelicolor M145 was carried out using the protocol
specified in Kieser et al. [2000]. Single colonies of ET12567 cells with pUZ8002
containing the relevant vector were picked and grown overnight at 37 ◦C shaking
in lysogeny broth (LB) with the appropriate antibiotics. The next morning 200
µL of this starter culture was used to inoculate 10 mL fresh media (with the same
antibiotics) and this was grown at 37 ◦C shaking until the OD600 was between 0.4
and 0.6 (∼4 hours). This was then centrifuged for 10 minutes at 2000 rpm to pellet
the cells. The pellet was then re-suspended in 10 mL LB and centrifuged again
before the washing step was repeated to remove any remaining antibiotics. The cell
pellet was then re-suspended in the residual LB to give a total volume of 1 mL.
A volume of 10 µL Streptomyces spore stock was added to 500 µL 2xYT
media and the cells heat-shocked at 50 ◦C for 10 minutes before being mixed with
500 µL of the prepared ET12567 cells. This mixture was then serially diluted and
the two strains were grown overnight together on SFM media on four different plates
containing dilutions of between 10−1 and 10−4. The next morning the plates were
overlaid with nalidixic acid to kill the E. coli and apramycin or hygromycin to select
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for Streptomyces colonies contain the luciferase constructs or pCC4 vectors. This
was then left to grow for 3 to 4 days, when single colonies could be collected and
used to inoculate fresh plates.
5.4.2 Media stock solutions
SFM 2xYT
8 g bacto-agar 16 g tryptone
8 g soya flour 10 g yeast extract
8 g mannitol 5 g NaCl
Make up to 400 mL with tap water Make up to 1 L with distilled water,
and mix together before autoclaving adjust the pH to 7.0 and mix together
before autoclaving
Autoclaving was carried out at 121◦C for 20 minutes, with media then stored at room
temperature. Once antibiotics were added the media would be used immediately or
stored in the fridge until required [Styles, 2016].
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Chapter 6
Mechanistic Modelling of the
Regulatory System Controlling
Methylenomycin Production in
Streptomyces coelicolor
6.1 Scientific background
6.1.1 A brief history of antibiotics
The first known antibiotic was famously discovered by mistake by Alexander Fleming
in 1928. After returning from holiday, Fleming noticed that mould had formed on his
discarded Petri dishes containing cultures of the bacteria Staphylococcus (Figure 6.1).
He could see that there were areas around the mould where the bacteria had been
killed and, after further experimentation, he identified the active agent penicillin.
It was 1942 when penicillin was eventually cultivated sufficiently to treat bacterial
infections, a milestone that has revolutionised medicine as we know it through the
development of a variety of antibiotics enabling wide-ranging treatment of numer-
ous bacterial infections including pneumonia, tuberculosis and bacterial meningitis.
That said, an overwhelming eradication of many of the most pathogenic infections
that might have been predicted has not been realised due to the phenomenon of
bacterial resistance. Resistance to antibiotics was observed by Fleming even before
penicillin production reached a commercial scale, and has subsequently threatened
to nullify the therapeutic effects of any currently known antibiotics [Brown, 2005].
In the early 1950s, erythromycin was introduced as an alternative to penicillin
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 Figure 6.1: Photograph showing the antibacterial effect of a penicillium colony on
staphylococcal colonies, taken from Fleming [1980].
at Boston City Hospital in an attempt to combat Staphylococcus aureus infections.
Unfortunately, in less than a year, approximately 70% of S. aureus infections were
demonstrating resistance to erythromycin and the antibiotic was completely with-
drawn as a result [Finland, 1979]. A number of factors are thought to contribute
to the cause of such significant biological adaptation; “there is perhaps no better
example of the Darwinian notions of selection and survival” [Davies and Davies,
2010]. Human activities have contributed significantly to the prevalence of bacterial
resistance. Underuse of antibiotics allows target bacteria that survive an insuffi-
cient dose to proliferate in the absence of individuals with the greater susceptibility
to the antibiotic, creating a population with decreased susceptibility. Furthermore,
overuse and misuse of antibiotics in situations where they are not required can cause
otherwise harmless bacteria that encounter the antibiotics to develop resistance and
become pathogenic.
The mechanisms that facilitate the development of bacterial resistance in-
clude the aforementioned natural selection that enables bacteria with certain genetic
predispositions to evolve into populations possessing highly effective resistance to
antibiotics. Bacteria are also capable of transferring genetic information between
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individuals, which enables resistance genes to spread throughout populations. This
is referred to as horizontal gene transfer (HGT) and is considered the primary cause
of bacterial resistance. Resistance can also be caused by random mutations in the
bacterial DNA, in the event of which the bacteria would, again, possess an evolu-
tionary advantage that could easily proliferate quickly throughout populations be it
through selective pressures or intercellular transmission.
As a result of approximately 75 years of antibiotic misuse, so called ‘super-
bugs’ have emerged, some that are multidrug resistant (MDR), some that are ex-
tremely drug resistant (XDR), that is, resistant to at least four foremost associated
treatments, and others that appear to be resistant to all available antimicrobial
treatments, or totally drug resistant (TDR). The use of the antibiotics strepto-
mycin and isoniazid initially demonstrated considerable success in the treatment of
Mycobacterium tuberculosis infections however the rapid development of resistance,
thought to arise exclusively by virtue of spontaneous mutation [Davies and Davies,
2010], has led to the emergence of XDR strains of this bacteria which infect approx-
imately one-third of the entire world population, in both developed and developing
nations. Arguably the most publicised example of a superbug is methicillin-resistant
S. aureus (MRSA) which, despite lacking the historical notoriety of M. tuberculo-
sis, has become the primary cause of bacterial infection in hospital environments.
Again, the initial treatment of S. aureus infections using penicillin and the subse-
quent shift towards the newly derived methicillin was thought to inhibit the action
of this and other similar bacteria. However, within 3 years mutant strains appeared
demonstrating resistance to several recommended antibiotics and hence, today, the
MRSA acronym is used to describe multidrug-resistant S. aureus.
It is clear that the magnitude of the implications related to antibiotic resis-
tance cannot be overestimated, with many experts predicting a return to the days
before Fleming’s revolutionary discovery if a new global approach is not adopted ur-
gently. Systems biology approaches have improved understanding of the mechanisms
associated with the action of antibiotics on target bacteria and the propagation of
resistance in these microbes [Yeh et al., 2009]. One particular mathematical mod-
elling investigation yields direct predictions regarding the impact of drug synergy on
the emergence of resistance [Michel et al., 2008]. The model is capable of predicting
the effects of different multidrug combinations on the development of bacterial resis-
tance, with results suggesting that synergistic multidrug combinations are conducive
to the development of resistance, whereas antagonistic multidrug combinations are
actually conducive to the inhibition of resistance. Synergistic multidrug combina-
tions are typically favoured by clinicians due to the increased efficacy that arises
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from a broader spectrum of activity however, it appears that greater consideration
of the trade-off between efficacy and resistance limitation is required.
The study of soil-dwelling bacteria is integral to combating antibiotic resis-
tance. These microorganisms are not only responsible for antibiotic production, but
are also targeted by antibiotics produced by other bacterial populations. Synthetic
biology approaches place the native systems known to mediate antibiotic production
at the forefront of new research efforts in order to elucidate fundamental mechanistic
properties. Specialised gene clusters have been identified in model bacterial strains
that are known to regulate the production of useful antibiotics [Zou et al., 2017],
however there remains uncertainty regarding their structural composition and the
roles and actions of the associated regulatory elements. Examination of regulatory
gene clusters will identify highly functional motifs, the characterisation of which
through computational analyses will inform the assembly of novel synthetic antibi-
otic production circuits. Hence, mathematical modelling approaches will be key
to the systems-level elucidation of antibiotic action that can assist in delivering
measures devised to prevent resistance, as well as facilitating the discovery of new
antibiotics.
6.1.2 Streptomyces
Streptomyces refers to the genus of streptomycetes that represent the largest fam-
ily of the actinomycetes (actinobacteria) phylum [Fla¨rdh and Buttner, 2009]. These
Gram-positive bacteria naturally inhabit soil, producing the natural product geosmin
that is known to give the soil its typically earthy smell [Gerber and Lechevalier,
1965]. Despite being bacteria, Streptomyces exhibit behaviour that resembles fungi,
facilitating the decomposition of dead organisms and vegetation that contributes
to the nitrogen cycle. They bridge the gap between bacteria and fungi further by
virtue of their complex life cycle. Streptomyces begin life as a spore that germinates
in the presence of the appropriate nutrients. This causes the formation of vegetative
hyphae that extend into the immediate environment in becoming fungi-like mycelia.
Non-branching sporogenic aerial hyphae are formed in the event of nutrient deple-
tion [Fla¨rdh and Buttner, 2009]. The life cycle is restarted as these aerial hyphae
partition to form largely dormant unigenomic spores. During this spore formation
stage, a wide range of secondary metabolites and natural products are synthesised
[Jakimowicz and van Wezel, 2012]. Streptomycetes produce ∼70% of all commercial
antibiotics currently available, thus demonstrating their immense importance in the
discovery of new natural products [Watve et al., 2001].
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6.1.3 The methylenomycin regulatory gene cluster
The bacterium Streptomyces coelicolor A3(2) has emerged as the model organism
for studying streptomycetes, initially thanks to the production of coloured metabo-
lites that facilitated genetic studies, and more recently thanks to the sequencing
of its entire genome [Bentley et al., 2002]. These bacteria have a 8, 667, 507 base
pair single linear chromosome containing protein coding genes of which over 12%
are thought to be regulatory [Bentley et al., 2002]. These predicted transcriptional
regulators are thought to mediate antibiotic synthesis through the production of
microbial hormones, as well as influence structural and metabolic cellular responses
[Willey and Gaskell, 2011]. The linear SCP1 plasmid (∼356 kb) and the circular
SCP2 plasmid (∼31 kb) are both present within the S. coelicolor genome and have
also both been sequenced [Bentley et al., 2004]. This genome sequencing has re-
vealed many cryptic and ‘silent’ gene clusters: sets of genes predicted to produce
a natural product, but whose product has not been observed. Silent gene clusters
have been awakened through genetic manipulation of regulatory elements [Sidda
et al., 2014; Laureti et al., 2011]. Thus, characterisation of the regulatory system
that mediates the production of specialised metabolites is key to discovering new
natural products. Developing improved understanding of the regulatory architec-
tures that underlie natural product biosynthesis can also accelerate the design of
novel regulatory systems in synthetic biology.
The antibiotic methylenomycin A is a natural product of S. coelicolor A3(2)
and is of particular interest since all of the 21 biosynthetic, regulatory and resis-
tance genes, located in a cluster on the SCP1 plasmid [Bentley et al., 2002], have
been studied in detail [Corre and Challis, 2005], and a series of knockout mutant
strains has been generated [O’Rourke et al., 2009]. The regulation of methyleno-
mycin biosynthesis is mediated by the transcriptional repressor MmfR, a TetR-
family homodimeric protein consisting of an N-terminal DNA-binding domain and
a C-terminal ligand-binding domain (Fig. 6.2A) [Ramos et al., 2005; Corre, 2013].
In the initial growth phase of S. coelicolor, the MmfR N-terminal domain is thought
to be bound to the DNA at the methylenomycin auto-regulatory response element
(MARE) causing the transcriptional repression of downstream genes. MmfR holds
the system in this repressed state until the advent of the small signalling molecules,
methylenomycin furans (MMFs) [Corre et al., 2008]. MMFs bind specifically to the
C-terminal domain of the MmfR, forming an MmfR:MMF complex that results in
a conformational change in the MmfR. Consequently, MmfR is released from the
MARE, negating the repression and triggering gene transcription. The biosynthesis
of MMFs is controlled by the MmfLHP enzymes which are, themselves, repressed by
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Figure 6.2: A) Schematic diagram of the MmfR binding mechanism. Binding of
MmfR to DNA at the MARE represses gene transcription and therefore negates
system output. In the presence of MMF ligand, an MmfR:MMF complex is formed
which releases MmfR from the MARE and triggers gene transcription. B) Schematic
diagram of the methylenomycin gene cluster whereby fpm and apm represent the
DNA binding motifs recognised by MmfR and MmyR proteins. The fpm controls the
expression of mmfR, mmyR and mmfLHP genes while apm regulates the expression
of the mmy biosynthetic genes.
MmfR, thus forming a feedback control loop that governs the dynamical properties
of the system. A second repressor, MmyR, is homologous to MmfR yet its role in
methylenomycin regulation is currently less understood. There is, however, clear ev-
idence that the impact of MmyR is particularly significant, since S. coelicolor strains
with the mmyR gene knocked out have been found to over-produce methylenomycin
[Chater and Bruton, 1985].
Homologous architectures to that of the methylenomycin regulatory system
have been identified across a plethora of microorganisms [Liu et al., 2013], regulating
different classes of natural products and thus indicating the utility of this specific
type of regulatory architecture [Corre et al., 2008]. Responding to environmental
changes is of paramount importance to these bacteria. The soil they live in presents
a harsh environment with considerable competition for resources and it is therefore
vital that they possess sophisticated, tightly regulated mechanisms to turn on the
expression of specific genes when required. Hence, obtaining a detailed mechanistic
understanding of the regulatory system controlling the biosynthetic pathway to this
antibiotic has the potential to elucidate a host of other, less tractable, biosynthetic
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gene clusters and help standardise one of the most important regulatory networks
for the development of new antibiotics.
6.2 Formulation of candidate model architectures
The various binding interactions and protein expression summarised in Fig. 6.2
inform the formulation of our candidate model architectures. MmfR is thought to
bind to three distinct intergenic regions on the gene cluster [O’Rourke et al., 2009].
However, we combine the region associated with MmyR biosynthesis together with
the region associated with both MmfR and MMF biosynthesis to form a single DNA
module responsible for the biosynthesis of all three molecules (the furan producing
module, fpm). That is, we use the term fpm to refer to five distinct genes that provide
control over three distinct molecular products: MmyR, MmfR and MMF. The genes
mmfL, mmfH and mmfP are coregulated in an operon and are directly responsible for
the production (assembly) of MMF molecules; the mmfR and mmyR genes control
MmfR and MmyR production respectively [Corre et al., 2008; O’Rourke et al., 2009]
(Fig. 6.2B). The third distinct intergenic region is represented by our second DNA
module which we consider responsible for methylenomycin (MMY) biosynthesis only
(the antibiotic producing module, apm). Therefore, our model architectures all
consist of two fundamental DNA modules that can both be bound by MmfR, and
that have production of their respective proteins repressed as a consequence. Due
to its effect on the gene cluster and its homology to MmfR, we assume that MmyR
also binds both modules in a similar manner.
Our base architecture accounts for reversible MmfR and MmyR binding to
both the fpm and apm to form four complexes: fpm:MmfR, fpm:MmyR, apm:MmfR
and apm:MmyR. MMF binds MmfR reversibly at these complexes in order to
trigger gene expression; MMF binding MmfR in solution is also accounted for
since we have been able to co-crystallise MmfR:MMF complexes and solve the 3D-
structure through experimentation void of target DNA modules (data not shown).
MmfR:MMF complexes that dissociate from the MAREs return free MmfR and
MMF back into the system irreversibly. MmyR, MmfR and MMF production is
controlled by the fpm. We account for an initial repressed system state by imposing
non-zero initial concentrations upon the fpm:MmfR and apm:MmfR complexes; all
remaining model variables have initial concentrations equal to 0. MmfR, MmyR,
MMF and MMY all undergo degradation at constant rates (Fig. 6.3).
This model architecture represents the extent of our current mechanistic un-
derstanding, however there are certain details that require further investigation. For
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Figure 6.3: Schematic diagram of the reaction network comprising the base (BNN)
model architecture. Reversible and irreversible reactions are depicted by double and
single arrows respectively; reaction rate constants are denoted by the corresponding
numbered k. The empty set depicts protein degradation, with rate constants denoted
by the corresponding numbered γ. Solid arrows depict reactions that are common
to all 48 model architectures, whereas dashed arrows depict those that are subject
to adaptation. Cellular entities with non-zero initial concentrations are underlined.
example, although we believe that the MMF releases MmfR from the fpm:MmfR
and apm:MmfR complexes and also binds free MmfR in solution, it would be in-
sightful to examine the dynamical influence of each binding mechanism in isolation.
Similarly, although we believe there is no interaction between the MMF and MmyR
within the system (data not shown), the binding interactions of MMY are not as
well documented. It may therefore be possible that MMY is able to inhibit the ac-
tion of both MmfR and MmyR either through dissociation from their respective fpm
and apm complexes or binding in solution. Consequently, the aim of our modelling
investigation is to examine the effect of three key mechanistic properties on model
performance:
1. MMF-MmfR interactions occur at existing DNA:MmfR complexes (C), in so-
lution (S) or via both mechanisms (B).
2. MMY-MmfR interactions occur at existing DNA:MmfR complexes (C), in so-
lution (S), via both mechanisms (B) or do not occur at all (N).
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3. MMY-MmyR interactions occur at existing DNA:MmyR complexes (C), in
solution (S), via both mechanisms (B) or do not occur at all (N).
This set of possible molecular interactions results in 48 distinct candidate model ar-
chitectures for the methylenomycin regulatory system. Each candidate architecture
is given a three letter name corresponding to the interactions accounted for with
respect to each of the three properties listed above. The order of the letters in each
name corresponds strictly to the numerical order of these properties. For example,
our base architecture (described above) is given the name BNN since it accounts for
both mechanisms (B) regarding property 1, for no interactions at all (N) regarding
property 2 and for no interactions at all (N) regarding property 3.
Each of the 48 candidate architectures presents a distinct reaction network
and set of biochemical equations that can be used to derive a dynamical mathemat-
ical model. We apply mass action kinetics to the biochemical equations compris-
ing each reaction network to derive a corresponding system of ordinary differential
equations (ODEs). Each ODE describes the rate of change in concentration cor-
responding to each model variable (cellular entity). The solution to each system
of ODEs is determined numerically due to the non-linearity of the equations and
provides a deterministic output that can be used to simulate and predict in vivo
system dynamics in silico. For example, the BNN model architecture is comprised
of the following biochemical equations:
fpm + MmyR
k1−−⇀↽−
k−1
fpm:MmyR, (6.1)
fpm + MmfR
k2−−⇀↽−
k−2
fpm:MmfR, (6.2)
fpm
k7−→ MmyR + fpm, (6.3)
fpm
k8−→ MmfR + fpm, (6.4)
fpm
k9−→ MMF + fpm, (6.5)
fpm:MmfR + MMF
k3−−⇀↽−
k−3
fpm:MmfR:MMF, (6.6)
fpm:MmfR:MMF
k11−−→ fpm + MmfR:MMF, (6.7)
apm + MmyR
k4−−⇀↽−
k−4
apm:MmyR, (6.8)
apm + MmfR
k5−−⇀↽−
k−5
apm:MmfR, (6.9)
apm
k10−−→ MMY + apm, (6.10)
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apm:MmfR + MMF
k6−−⇀↽−
k−6
apm:MmfR:MMF, (6.11)
apm:MmfR:MMF
k12−−→ apm + MmfR:MMF, (6.12)
MmfR:MMF
k13−−→ MmfR + MMF, (6.13)
MmfR + MMF
k14−−−⇀↽ −
k−14
MmfR:MMF, (6.14)
MmyR
γ1−→ ∅, (6.15)
MmfR
γ2−→ ∅, (6.16)
MMF
γ3−→ ∅, (6.17)
MMY
γ4−→ ∅, (6.18)
from which we derive the following system of model ODEs:
d[MmyR]
dt
=k7[fpm]− k1[MmyR][fpm] + k−1[fpm:MmyR]− k4[MmyR][apm] + . . .
k−4[apm:MmyR]− γ1[MmyR], (6.19)
d[MmfR]
dt
=k8[fpm]− k2[MmfR][fpm] + k−2[fpm:MmfR]− k5[MmfR][apm] + . . .
k−5[apm:MmfR] + k11[fpm:MmfR:MMF] + k12[apm:MmfR:MMF] + . . .
k13[MmfR:MMF]− k14[MmfR][MMF] + k−14[MmfR:MMF]− γ2[MmfR], (6.20)
d[fpm]
dt
=k11[fpm:MmfR:MMF]− k1[MmyR][fpm] + k−1[fpm:MmyR] + . . .
k−2[fpm:MmfR]− k2[MmfR][fpm], (6.21)
d[apm]
dt
=k12[apm:MmfR:MMF]− k4[MmyR][apm] + k−4[apm:MmyR] + . . .
k−5[apm:MmfR]− k5[MmfR][apm], (6.22)
d[fpm:MmyR]
dt
=k1[MmyR][fpm]− k−1[fpm:MmyR], (6.23)
d[apm:MmyR]
dt
=k4[MmyR][apm]− k−4[apm:MmyR], (6.24)
d[fpm:MmfR]
dt
=k2[MmfR][fpm]− k−2[fpm:MmfR]− k3[fpm:MmfR][MMF] + . . .
k−3[fpm:MmfR:MMF], (6.25)
d[apm:MmfR]
dt
=k5[MmfR][apm]− k−5[apm:MmfR]− k6[apm:MmfR][MMF] + . . .
k−6[apm:MmfR:MMF], (6.26)
d[fpm:MmfR:MMF]
dt
=k3[fpm:MmfR][MMF]− k−3[fpm:MmfR:MMF]− k11[fpm:MmfR:MMF], (6.27)
d[apm:MmfR:MMF]
dt
=k6[apm:MmfR][MMF]− k−6[apm:MmfR:MMF]− k12[apm:MmfR:MMF], (6.28)
d[MMF]
dt
=k9[fpm]− k3[fpm:MmfR][MMF] + k−3[fpm:MmfR:MMF] + . . .
k−6[apm:MmfR:MMF]− k6[apm:MmfR][MMF] + k11[fpm:MmfR:MMF] + . . .
k12[apm:MmfR:MMF] + k13[MmfR:MMF]− k14[MmfR][MMF] + . . .
k−14[MmfR:MMF]− γ3[MMF], (6.29)
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d[MMY]
dt
=k10[apm]− γ4[MMY], (6.30)
d[MmfR:MMF]
dt
=k11[fpm:MmfR:MMF] + k12[apm:MmfR:MMF]− k13[MmfR:MMF] + . . .
k14[MmfR][MMF]− k−14[MmfR:MMF], (6.31)
where square brackets denote concentration and the reaction rate constants trans-
late to model parameters, denoted by each numbered k. Reactions associated with
reversible DNA:protein binding (k1, k−1, k2, k−2, k4, k−4, k5 and k−5), the produc-
tion of MmyR, MmfR, MMF and MMY (k7, k8, k9 and k10) and each individual
protein degradation reaction (γ1,2,3,4) are common to all of our candidate model
architectures. Other reactions that are associated with the release of MmfR from
existing DNA:MmfR complexes or the sequestration of MmfR and MmyR via bind-
ing in solution are not common to all models and are thus subject to investigation
through our computational simulations.
Model simulations are provided by the numerical solutions to the relevant
model ODEs, which are calculated using the ODE solver ode45 in MATLAB. We
are interested in examining the dynamics of methylenomycin production in each of
the 48 candidate models and therefore analyse the simulations of MMY provided by
numerical solutions to the corresponding ODE (6.30).
6.3 Available experimental data
Methylenomycin production by S. coelicolor has been shown to adopt a typical dy-
namical profile [Hobbs et al., 1992; Hayes et al., 1997]. Once expression is initiated,
usually by environmental conditions that are thought to establish MMF produc-
tion, it increases relatively quickly towards a global maximum level. Expression
then decreases from this maximum, reaching a relatively low level at steady-state.
This profile aligns with the premise that the system is initially held in a repressed
state until MmfR is released by MMF to trigger methylenomycin expression, which
then increases quickly until free MmfR and MmyR cause secondary repression and
eventual equilibrium of the feedback loop.
We consider the binding affinity of MmfR to the fpm and apm to be strong,
based on experimental data regarding binding interactions between a similar protein,
SAV2270, and its associated DNA motifs (our unpublished data). We characterised
the binding of this protein to Streptavidin Immobilized oligonucleotides using a Bio-
core T200 SPR instrument. Our data reveal that the association and dissociation
rates of this protein:DNA binding are on the order of 105 M−1s−1 and 10−2 s−1
respectively. As a result, we fix the model parameters relating to MmfR associ-
142
ation and dissociation from both the fpm and apm at 105 and 10−2 respectively
(k2 = k5 = 10
5; k−2 = k−5 = 10−2). The dimensionality of our experimental mea-
surements agree with the corresponding parameters in our dimensional model and
we are therefore able to apply these values directly. We assume that MmyR binding
interactions are identical to that of MmfR and hence the same values are fixed for
the parameters describing MmyR association and dissociation from the fpm and
apm (k1 = k4 = 10
5; k−1 = k−4 = 10−2).
Mutant strains of S. coelicolor that account for specific gene knockouts re-
veal qualitatively different methylenomycin production dynamics (Table 6.1). The
S. coelicolor strain Methylenomycin production
Wildtype +
∆mmyR +++
∆mmfLHP -
∆mmfLHP+∆mmyR+∆mmfR +++
∆mmfLHP+exogenous MMF +
Table 6.1: The effects of knocking out certain genes and combinations of genes
observed experimentally, adapted from O’Rourke et al. [2009]. The wildtype strain is
allocated a single ‘+’ to denote typical methylenomycin expression. Over-expression
and the cessation of expression are denoted by ‘+++’ and ‘-’ respectively.
mutant strain accounting for mmyR deletion, ∆mmyR, has been shown to exhibit
increased methylenomycin expression compared to the wildtype; in the absence of
MmyR, the overall capacity of the system to repress methylenomycin production is
reduced and therefore the production of the antibiotic is increased. The ∆mmfLHP
strain exhibits a complete cessation of methylenomycin expression; in the absence
of the mmfLHP genes, the system is locked in the apm:MmfR complex since the ex-
pression of MmfR, MmyR and particularly MMF is prevented and thus the bound
MmfR cannot be released. The ∆mmfLHP+∆mmyR+∆mmfR strain exhibits in-
creased methylenomycin production compared to the wildtype; in the absence of
MmfR and MmyR, both initially and as a result of any subsequent production by
the fpm, the apm is able to produce methylenomycin in an unrestricted manner. The
∆mmfLHP strain with exogenous MMF exhibits relatively similar methylenomycin
expression to that of the wildtype; in the absence of endogenous MMFs, exogenous
MMF permits the release of MmfR and, in turn, methylenomycin expression. Ex-
perimentation with the ∆mmfR strain has thus far yielded inconclusive results and,
as such, presents the opportunity for mathematical modelling simulations to inform
future experimental studies.
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6.4 Model selection via approximate Bayesian compu-
tation
In order to assess the potential of the 48 candidate architectures to reproduce the
known characteristics of the system, we perform model selection based on approxi-
mate Bayesian computation using the ABC-SysBio software package. The procedure
determines the model, from a set of candidate models, that is most likely to have
produced the associated experimental data. Extensive quantitative data regarding
methylenomycin expression is lacking in the literature, however a time course ex-
pression profile is reported in Hobbs et al. [1992]. We therefore provide ABC-SysBio
with a dataset designed to replicate this profile (Fig. 6.4), with two important excep-
 
Figure 6.4: Experimental data representing current biological knowledge of typical
methylenomycin expression in S. coelicolor . Real experimental data points taken
from Hobbs et al. [1992]. Synthetic data points are added uniformly between real
data points to increase the rigour of model selection and parameter inference.
tions. Firstly, we specifically account for the dynamical series of data points in the
40 hour interval between hours 54 and 94 of the time course. This is because the 54
hour experimental time point is when methylenomycin expression commences and
translates to the 0 hour time point in our simulations. The time points that precede
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54 hours record the repression of methylenomycin production prior to the environ-
mental trigger and are hence excluded when fitting a model that accounts purely
for the dynamical response of the system. Secondly, we incorporate additional uni-
formly distributed ‘synthetic’ data points, increasing the size of the dataset from 5
points to 41, in order to provide a more rigorous data fitting task to the ABC-SysBio
algorithm.
ABC-SysBio also requires a prior probability distribution on each model pa-
rameter subject to inference in order to establish the parameter space within which
to locate acceptable parameter sets. The prior distributions chosen for all param-
eters associated with each of the 48 candidate models are uniform distributions on
the interval [10−4, 104], that is, all candidate models are given an equal parameter
space in attempting to identify parameter values capable of replicating our experi-
mental dataset. We also impose prior distributions on the initial conditions of the
necessary state variables due to the lack of experimental data regarding the physical
quantity of DNA in the system: the prior distributions are uniform distributions on
the interval [0, 1] and are assigned only to the MmfR:fpm and MmfR:apm complexes,
all other initial conditions are set equal to 0. ABC-SysBio convergence is dependent
on the sequential satisfaction of a predefined series of decreasing error thresholds by
a predefined number of solutions. Here, the number of solutions required to satisfy
each error threshold is 500 [Woods and Barnes, 2016] in order to reduce the time
frame required for convergence; the number of models subject to selection coupled
with the inability to parallelise the process presents a particularly time consuming
computational workload. The user-defined error function designed to measure the
accuracy of simulations takes the mean absolute value of the difference between
model outputs and data values:
E =
1
41
41∑
i=1
|xi − di|, (6.32)
where E is the error and xi, di are the model outputs and data values at each of
the 41 corresponding time points, ti, respectively.
The results of our model selection are shown in Fig. 6.5. The final probability
distributions reveal that the model most likely to have produced the experimental
data is BNN, the model formulated based on our current knowledge (Fig. 6.5A).
The BNN model achieved a 0.916 probability of producing our data which is vastly
superior to the remaining models, 36 of which were statistically eliminated through
the selection process. This suggests that the most plausible network of molecular in-
teractions underlying this system should account for MMF-MmfR interactions both
145
 A 
B 
Figure 6.5: ABC-SysBio model selection results. A) Histograms showing the prob-
abilities of producing the full dataset for the 48 candidate models. B) Histograms
showing the probabilities of producing the real experimental dataset for the 48 can-
didate models. The numbers above each histogram denote the population number,
the error threshold  (square brackets) and the acceptance rate (parentheses) respec-
tively. The number of accepted solutions required to satisfy each error threshold is
500.
at existing DNA:MmfR complexes and in solution, no MMY-MmfR interactions at
all and no MMY-MmyR interactions at all, as depicted in Fig. 6.3.
In order to verify that the addition of synthetic data points does not restrict
the emergence of other viable candidate models, we repeated the model selection
procedure using only the 5 real experimental data points taken from Hobbs et al.
[1992]. Mean absolute error generally increases with decreasing numbers of data
points which subsequently increases the difficulty for each population of solutions
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to meet the same error thresholds. Hence, the acceptance rate decreases and the
process becomes more time consuming; this run took longer than the original run
and met 7 thresholds compared to the previous 11 (Fig. 6.5B). The probability
distribution across all models clearly identified the most likely models as early as
P2, which converged further at P4 and P6 to suggest that BNN was a likely model
architecture, in agreement with our initial result. However, P3, P5 and P7 identified
a different distribution which suggested that models SCS and SNS were also likely
candidates. Given that ABC-SysBio appeared to present two alternating probability
distributions, it is probable that additional local minima were identified in this case.
To further investigate the set of plausible models identified using this Bayesian infer-
ence framework, we next employed global optimisation methods as well as analysis
of mutant versions of the candidate models, as described in the following sections.
6.5 Parameter inference via global optimisation
ABC-SysBio performs parameter inference by producing probability distributions
on the numerical values that comprise accepted parameter sets during the model
selection process. For example, the distributions on the initial conditions imposed
on the fpm:MmfR and apm:MmfR complexes reveal that statistically these values
can be approximated to be 0.6 and 0.5 respectively (Fig. 6.6). These distributions
 
Figure 6.6: ABC-SysBio parameter inference results. Histograms show the proba-
bility distributions on the two parameters describing the initial concentration of the
fpm:MmfR and apm:MmfR complexes.
are insightful, but cannot provide complete clarity over the numerical values inferred
in all cases. Other parameter inference methods, such as global optimisation, place
greater focus on the identification of specific numerical parameter sets capable of
minimising the user-defined error function. We therefore employ the genetic algo-
rithm (GA), a well established global optimisation method, to assess the data fitting
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qualities of our BNN model.
In this case, the error function minimised by the GA is the same absolute
mean error function used for ABC-SysBio model selection (6.32). We also allo-
cate the same parameter space to the GA by imposing lower and upper bounds
on the inferred parameters of 10−4 and 104 respectively. Again, the initial condi-
tions imposed on the model variables are 0 with the exception of those regarding
the fpm:MmfR and apm:MmfR complexes which we approximate to be 0.55 in light
of our ABC-SysBio probability distributions and given that we require both initial
concentrations to be equal. The results of our global optimisation are shown in Fig.
6.7. The BNN model is capable of accurately matching the experimental time course
 
Figure 6.7: Genetic algorithm global optimisation results. The BNN model is able to
fit the experimental data using the optimal parameter set identified by the GA. The
absolute mean error provided by this optimal solution is 6.12×10−6. The optimal
fits provided by the SCS and SNS models are similar and are not as accurate as the
BNN model. The absolute mean error provided by both of these optimal solutions
is 2.39×10−5.
data when optimised within the same parameter space used for model selection. The
optimal parameter set identified by the GA is listed in Table 6.2 and provides an
absolute mean error of 6.12 × 10−6. The four parameter values describing protein
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Reaction Value (M−1s−1) Reaction Value (s−1)
k3 3.6119 k−3 0.1092
k6 0.9079 k−6 5.7766
k14 0.0065 k−14 0.2208
− − k7 2.6978
− − k8 0.8902
− − k9 5.8903
− − k10 0.1101
− − k11 0.6296
− − k12 0.5307
− − k13 0.0880
− − γ1 0.9470
− − γ2 2.7057
− − γ3 0.2248
− − γ4 0.1646
Table 6.2: Optimal parameter values for our BNN model. This optimal parameter
set is dimensional, with parameters in the first and second reaction columns taking
the units M−1s−1 and s−1 respectively based on standard mass action kinetics.
degradation (γ1,2,3,4) vary by one order of magnitude at most; the remaining pa-
rameter values all describe protein:protein association and dissociation and vary by
three orders of magnitude at most. Hence, we conclude that the numerical ranges
of these optimal parameter values are reasonable within this biological context.
To investigate further, we also optimised the parameters of the SCS and SNS
models against the experimental data using the GA, in an identical manner to that
previously carried out for the BNN model. This revealed that neither model was
able to achieve the same quality of fit to the data as the BNN (minimum error of
2.39× 10−5 for both SCS and SNS compared to 6.12× 10−6 for BNN). In addition,
neither the SCS or SNS models were able to even qualitatively replicate the non-
monotonicity in the response that is clearly exhibited in the experimental data.
6.6 Monte Carlo simulations of methylenomycin pro-
duction in mutant strains
We perform additional model validation by testing the BNN model against our qual-
itative data regarding methylenomycin production in mutant S. coelicolor strains.
We employ Monte Carlo simulations to examine methylenomycin production under
four distinct conditions corresponding to the mutant strains described in Table 6.1.
By examining the dynamical response to specific gene knockouts against the wild-
type strain, represented by the optimal BNN model output in Fig. 6.7, we are able
to investigate the qualitative effect of adapting our BNN model to emulate these
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mutant strains.
When simulating MMY production in the different mutant strains, we ac-
count for ∆mmyR by simply setting the parameter describing MmyR production
from the fpm, k7, to 0. However, ∆mmfR strains are incapable of producing MmfR
and therefore cannot be simulated in the initial repressed state comprised of the
fpm:MmfR and apm:MmfR complexes. Hence, the parameter describing MmyR
production from the fpm, k8, is set to 0 and the allocation of initial concentrations
is adapted to exclude the fpm:MmfR and apm:MmfR complexes. The ∆mmfLHP
strain is simulated by setting the initial concentration of the fpm and its associated
complexes to 0, since the entire DNA module has been knocked out. The addi-
tion of exogenous MMF involves allocating this variable an initial concentration of
0.55 to align with the initial concentrations allocated to the relevant variables, that
is, no new model parameters are introduced to describe production of exogenous
MMF. Mutant strains comprising combinations of gene knockouts are simulated by
combining the appropriate adaptations.
Specifically, in order to simulate the ∆mmyR strain we set k7 = 0. To
simulate the ∆mmfLHP strain the initial concentration of 0.55 is imposed on the
apm:MmfR complex only, all other initial concentrations are set equal to 0. To
simulate the ∆mmfLHP+∆mmyR+∆mmfR strain we set k7 = k8 = 0 and all initial
concentration are set equal to 0 with the exception of the apm which is set equal to
0.55. To simulate the ∆mmfLHP+exogenous MMF strain initial concentrations of
the apm and MMF are set equal to 0.55, and all other initial concentrations are set
equal to 0.
Monte Carlo simulations assign random values in the interval [10−4, 104] to
all model parameters, excluding those that retain their fixed values assigned for pre-
vious model selection and parameter inference purposes, as we continue to examine
dimensional dynamic responses. We run a total of 104 Monte Carlo simulations to
allow for substantial sampling of the parameter space within a feasible time frame.
Each simulation outputs MMY production for each of the four mutant strains and
calculates the ratio of the mean value to that of the optimal wildtype simulation.
We utilise these ratios to investigate the ability of our model to satisfy the following
four criteria, which capture the experimentally observed responses of the mutant
strains:
1. ∆mmyRwildtype > 1.1,
2. ∆mmfLHPwildtype < 0.9,
3. ∆mmfLHP+∆mmyR+∆mmfRwildtype > 1.1,
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4. 0.9 < ∆mmfLHP+MMFwildtype < 1.1,
where over-production translates to an increase in mean MMY production of >10%,
cessation translates to a decrease in MMY production of >10% and comparable
production translates to a maximum increase or decrease in MMY production of
less than 10%. The results of our Monte Carlo simulations are shown in Fig 6.8.
Parameter sets were identified that are capable of satisfying each of the four criteria,
 
A 
B C 
Figure 6.8: Monte Carlo simulation results. A) The BNN model is able to simulate
the qualitative data regarding four mutant S. coelicolor strains when adapted to
replicate the corresponding gene knockouts. B) The SCS model is unable to simulate
qualitative data regarding the ∆mmfLHP and ∆mmfLHP+MMF knockout strains.
C) The SNS model is unable to simulate qualitative data regarding the ∆mmfLHP
and ∆mmfLHP+MMF knockout strains.
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within the same dimensional solution space as the optimised wildtype model (Fig.
6.8A). Given the uncertainty regarding the effect of gene knockouts on the reaction
kinetics and MMY production of the system, this qualitative agreement offers further
validation of the replication and prediction capabilities of the BNN model.
The SCS and SNS models are also able to simulate the responses observed
experimentally for the ∆mmyR and the ∆mmfLHP+∆mmyR+∆mmfR knockout
strains, but not for the ∆mmfLHP and ∆mmfLHP+exogenous MMF knockouts
(Fig. 6.8B and 6.8C). This is likely due to the most significant mechanistic property
separating them from BNN, i.e. the interaction of MMY with one or both of MmyR
and MmfR. This interaction results in decreased repression of the apm since the
MMY is negating the action of either or both regulators and hence the apm is less
restricted in producing MMY, which causes an over-production of the antibiotic
for the ∆mmfLHP and ∆mmfLHP+exogenous MMF knockouts that has not been
observed experimentally (Fig. 6.8B and 6.8C). We therefore conclude that the
BNN model remains the most likely candidate model to explain all the available
experimental data for this system.
6.7 Experimental design for future studies
We are able to inform the design of future experimental studies in light of our re-
sults. For example, we are interested in quantifying the response of the ∆mmyR
and ∆mmfLHP + ∆mmyR+ ∆mmfR strains in order to verify our model predic-
tion that the five gene mutant elicits a more rapid and far greater over-production
of MMY. This has implications both in terms of improving product yields for in-
dustrially relevant natural products, and also regarding the potential adverse effects
this might cause in the cells such as toxicity. The result of these experiments would
subsequently reveal whether the ∆mmfLHP + ∆mmyR + ∆mmfR is the most
effective knockout for improving antibiotic production in novel synthetic regulatory
systems.
In the event that directly quantifying MMY production is inconclusive, we
would be interested in replacing the gene controlled by the apm with a reporter
gene coding for fluorescence or luminescence such as GFP or lux genes respectively.
This output may enable us to measure the response of the different mutant strains
with greater clarity since experiments of this nature are already well characterised,
particularly in the related bacterium S. venezuelae.
Finally, we are also interested in examining the ∆mmfLHP+MMF mutant
in order to establish the quantity of exogenous MMF and the specific time point
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of induction that provides optimal MMY production. Our model predicts a narrow
production window for this strain which may suggest that direct MMY quantification
is not straightforward and that, again, experimental designs incorporating reporter
genes would provide improved results.
6.8 Conclusions
We have developed a plausible model architecture for the regulatory system con-
trolling methylenomycin production in Streptomyces coelicolor. This architecture
was found to be the most likely to reproduce the dynamical responses described
by experimental time series data, when tested against 47 other candidate architec-
tures of the same system. Global optimisation of the model parameters produced
close agreement with the experimental data. Appropriate adjustments to the pro-
posed model architecture allow it to replicate observed changes in the dynamics of
methylenomycin production in a number of mutant S. coelicolor strains.
The mechanistic details captured in the proposed regulatory architecture
provide useful insights for the design of future experiments to further investigate
the operation of this system, and demonstrate the potential of mathematical models
to elucidate the design principles of complex biological control systems. We expect
that the emergence of further quantitative experimental data for this system will
inform further model development and validation, and allow for the generation of
optimised models that are capable of accurately predicting the dynamical responses
of one of the most prevalent and important gene regulatory networks in nature.
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Chapter 7
Conclusions and Future Work
7.1 Conclusions and discussion
The research presented in this thesis provides clear evidence of the importance of
mathematical modelling approaches in synthetic biology. We have demonstrated
that mechanistic models developed to reflect detailed biological observations can
simulate and predict the dynamical responses of parts and devices, thus facilitating
the engineering of novel biological systems.
Chapter 2 introduced the field of synthetic biology and outlined some of the
techniques required to construct mechanistic mathematical models of biological sys-
tems. Mechanistic models are typically more complicated to derive and analyse in
comparison with black box models, however this is often a small sacrifice to make
for quantitative simulations and predictions. Construction of mathematical models
is typically achieved through the application of mass action kinetics to systems of
biochemical equations. The resulting system of ODEs can be solved explicitly using
calculus although this is seldom applicable in practice due to the considerable dimen-
sionality and non-linearity that often arises. Model ODEs are therefore commonly
solved numerically in silico to provide approximate simulations of system dynamics.
Model reduction is able to decrease dimensionality and non-linearity whilst preserv-
ing dynamical responses, however this is mainly beneficial in cases where rigorous
mathematical analyses are prioritised. The dynamical response of biological sys-
tems is governed by the rates of the associated molecular interactions. Uncertainty
regarding reaction rates is commonplace in synthetic biology, which often translates
to large sets of unknown model parameter values. Two methods of parameter infer-
ence were demonstrated with respect to the same basic model, the first being the
global optimisation technique known as the genetic algorithm and the second being
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a Bayesian inference technique, ABC-SMC. Both methods were able to locate an op-
timal model parameter set in relation to a synthetic dataset. We demonstrated how
a non-dimensional re-scaling of a mathematical model is another effective method
of producing reliable simulations in light of parameter uncertainties.
Chapter 3 introduced DNA recombination and the significance of cellular
memory in engineering novel synthetic systems. DNA recombination provides an
ideal platform for cellular data storage and has formed the basis of the development
of a rewritable RAD module, capable of efficient data storage within a chromo-
some. We have developed the first mechanistic model of DNA recombination, and
validated it, through global optimisation, against a new set of in vitro data on re-
combination efficiencies across a range of different concentrations of integrase and
gp3. We investigated in vivo recombination dynamics by exploiting non-dimensional
model simulations. Our model revealed the importance of fully accounting for all
mechanistic features of DNA recombination in order to accurately predict the effect
of different switching strategies on RAD module performance, and highlighted the
over-arching efficacy of models as design tools for building future synthetic circuitry.
The results of this modelling investigation confirm that DNA inversion events
mediated solely by integrase proteins are highly efficient compared to dual-mediated
inversion events that occur in the presence of integrase and gp3. Difficulties arise
due to the residual concentration of integrase following an excision reaction which
causes re-integration, rather than preserving the desired HOLD state. Our model
also reveals two alternative strategies for overcoming such issues i.e. staggered
cessation of integrase and gp3 induction, and constant integrase induction with
switching efficiency as a function of gp3 induction. The latter strategy provides a
step-like digital response, however neither of these solutions has practical viability
since they both depend on extended induction of integrase or gp3, and the module
is designed to hold state efficiently in the absence of induction. It is likely that new
circuit designs will exploit inversion and deletion reactions mediated by integrase
only until sufficient understanding of dual-mediated reactions is established.
The notion of a digital response may be misleading with regards to biological
systems. It is unlikely that a step-like response can be induced biologically given
that the time frames required for engineered cells to respond is relatively large, on
the order of hours or even days. That said, our results serve as a promising proof
of concept that suggests that the, more likely analogue, responses that arise from
engineered genetic switches will be sufficient to elicit the same switching efficiency
as their electronic counterparts on the required timescales.
Having demonstrated the efficacy of our mechanistic model against a sim-
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plified alternative, it is clear that accounting for increased mechanistic detail is
conducive to achieving reliable quantitative model outputs. That said, this simpli-
fied model is capable of providing qualitative simulations that are sufficient to direct
experimental studies and its reduced dimensionality gives it the added advantage of
presenting simplified mathematical analysis. Hence, although our modelling inves-
tigation does not prioritise rigorous mathematical analyses, model refinement is an
important process that demands consideration in synthetic biology research.
Chapter 4 introduced Boolean logic functions and biological systems that ex-
hibit analogous functionality. Recombinase-based circuitry that accounts for more
than one protein input has been shown to enable the construction of circuits ca-
pable of temporal logic operations in vivo. Associated mathematical models had,
to date, only captured the qualitative dynamical features of such systems and are
thus of limited utility as tools to aid in the design of such circuitry. Our model of
the RAD module was adapted in order to develop a detailed mechanistic model of
a two-input temporal logic gate circuit based on unidirectional DNA recombination
mediated by two distinct bacteriophage integrases, with the ability to detect and
encode sequences of input events. We validated the model against in vivo experi-
mental data through global optimisation and thus revealed quantitative replication
and prediction of key dynamical features of the logic gate. Our model also predicts
the effect of reversing integrase inputs on the output of the logic gate.
The results of this modelling investigation confirm that our model is capable
of quantitative simulations of the temporal logic gate system, and therefore verify
that the assembly of appropriate mechanisms comprising our validated model of the
RAD module is an effective method for generating mechanistic models of higher-
order circuitry. The preconception of the two integrase inputs, Bxb1 and TP901-1,
was that their functional properties are very similar and could be assumed to be
the same for modelling purposes. However, our model reveals that, in order for
the logic gate circuit to produce the experimental data used to validate our model,
there must be a notable difference in the rate of recombination mediated by the
two integrases. Specifically, global optimisation identified the rate of recombination
via Bxb1 to be ∼1.8-fold greater than that of TP901-1. This has implications for
the design of synthetic logic circuits since there is no guarantee that the expected
functionality will be realised regardless of the specific roles assigned to each integrase
input. Our model simulations confirmed that the reversal of integrase inputs has a
significant impact on dynamical response, with both the steady state concentrations
of fluorescent protein and the response time shown to increase as a result. Future
modelling studies could potentially aim to characterise similar functional distinctions
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between other integrases in order to provide synthetic biologists with the maximum
amount of information regarding selection of integrase inputs for the functionality
required. As the number of new, orthogonal integrases increases, a lookup table of
responses might be useful to ensure that circuits function as expected.
Fitting our mechanistic model to the experimental data was successful in
general, however datasets that captured a sigmoidal dynamical response presented
the most difficulty with regard to matching model simulations. This highlights a
limitation with the assumption that integrase expression can be represented math-
ematically by a constant parameter. Such constant parameters arise as a result
of model derivation via mass action kinetics and are therefore valid mathematical
terms, but this also restricts simulations to a particular form. The concentration
of state variables will generally increase significantly within a short time frame due
to constant inputs, making it difficult to replicate a more gradual, delayed increase
without tuning specific parameter values. Hence, our model delivers greatest error
for simulations of sigmoidal responses which suggests that greater consideration of
the input expression parameters may be required to make improvements to these
outputs. For example, time-dependent input expression parameters could be used to
model additional dynamical intricacies, however the selected functions themselves,
and any new associated parameters, would require conceptual validation with re-
gards to biological systems. In all, we concluded that the error delivered by our
model was minimised sufficiently to inform the design of recombinase-based logic
circuitry without added complexities.
The notion of Boolean logic gate circuits may be misleading with respect
to biological systems. Electronic logic circuits provide precise binary outputs de-
pendent on precise binary inputs, and we do not claim that the biological logic
circuits investigated in this thesis are capable of such performance. However, our
results prove that recombinase-based logic circuits are capable of qualitative logic
operations whereby induced inputs elicit transitioning to the associated outputs of
the system in a similar manner to electronic circuits. Hence, logic gate is the term
adopted throughout the literature to describe biologically equivalent circuits and is
used throughout our research as a result.
Chapter 5 detailed the experimental project carried out to record in vivo
DNA recombination efficiency. The integration reaction was not analysed due to
its relative simplicity, however the efficiency of the excision reaction was quantified
by recording the luminescence of the bacteria over time. Trial experiments were
performed that identified the most suitable method of selecting bacteria that will
grow efficiently and express their integrated genes in a predictable manner. Gen-
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erally, however, bacterial growth was unpredictable and the resulting experimental
data collated during the project were inconclusive. We concluded that validated
mathematical models are invaluable tools in identifying and predicting dynamical
behaviour, particularly in instances where the limitations of experimentation pro-
hibit the collection of credible primary data.
A greatly important factor to consider with respect to experimental data and
associated model simulations is the manner in which the data are processed prior
to fitting. There is currently no standard practice for data processing given the
considerable variety of experimental procedures that can be used to record biological
system responses and mathematical modelling approaches that can be applied. In
most cases, data must be normalised in order to fit a given model due to the fact that
data collection is often performed using equipment that measures relative changes
in outputs that are non-dimensional, and models derived on the basis of mass action
kinetics retain dimensionality. Data collected in vitro, such as the data presented
in Chapter 3, is potentially the most straightforward to process since the relevant
biological quantities can be synthesised and used to normalise the resultant data.
By contrast, data collected in vivo, such as the data presented in Chapter 4, can
be more difficult to normalise since precise quantities of the reactants are often
unobtainable. As synthetic biology research advances, there is likely to be increasing
demand for standardised data processing techniques to broaden the acceptance of
modelling investigations across the community. The development of procedures for
the measurement of biological quantities in vivo will also be highly beneficial for
establishing accurate conditions with which to initiate mathematical models.
Chapter 6 highlighted the historical significance of the discovery of antibi-
otics, and introduced the bacterium Streptomyces coelicolor as the model organism
used to study the natural biosynthesis of the antibiotic methylenomycin A. Three
candidate model architectures of the regulatory system controlling methylenomycin
production were identified as the most plausible via an ABC-SMC model selection
approach. The resultant mathematical models were optimised against an experi-
mental time series dataset using the GA, revealing the strongest model architecture
that can simulate the dynamical response of the system with minimal error. Monte
Carlo simulations revealed distinct parameter sets capable of qualitatively replicat-
ing methylenomycin production in mutant S. coelicolor strains, based on a set of
gene knockouts.
The results of this modelling investigation confirm that our current knowl-
edge of the methylenomycin regulatory network is sufficient to inform the construc-
tion of a corresponding valid mathematical model. By identifying the most plausible
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model architecture out of a set of 48 candidates, not only have we established a po-
tential tool for the design of synthetic regulatory networks, but we have also revealed
the likelihood of the existence of several structural mechanisms regarding the molec-
ular interactions of certain regulatory elements. Further experimental studies will
provide the opportunity for model development and verification of the plausible
mechanistic properties that were statistically eliminated through model selection.
The model was partially parameterised due to our kinetic data regarding the asso-
ciation and dissociation rates of the MmfR regulator to/from the MARE sequences.
Performing specific experimental studies that run in tandem with modelling investi-
gations by prioritising the measurement of kinetic data for model parameterisation
was remarkably beneficial to our research efforts, and is likely to develop as a key
goal for the field of synthetic biology.
In all, there can be no doubt that mathematical modelling approaches are
deserving of a fundamental role in synthetic biology. Although we cannot claim
that mathematical models are able to deliver perfect quantitative simulations of
biological systems, the research presented in this thesis is evidence of the efficacy
of models regarding the analysis of existing systems to assist the design of novel
synthetic circuits. Synthetic biology remains a biology discipline at heart and, as
such, modelling approaches are yet to receive the full attention and acceptance of
the community as whole. Although there are currently multidisciplinary programs
in place designed to produce new researchers with the full range of necessary skills,
it may take several years before engineering and mathematical principles become
totally integrated with experimental biology. In the meantime, it is likely that open-
minded and proactive collaborations between biology and engineering labs will be
essential in bridging existing interdisciplinary gaps, as well as realising a number
of the primary goals of the field. Such collaborative efforts have contributed to the
majority of the results presented in this thesis and will continue to strengthen the
quality of the research carried out in subsequent studies.
7.2 Future work
The mechanistic nature of the models presented in this thesis has been shown to
provide increased efficiency in comparison with simplistic models of the same sys-
tems. That said, the resultant complexity and dimensionality of our models has
restricted our ability to provide full mathematical analyses. The application of
model reduction was considered for our modelling investigations, particularly with
respect to our model of the methylenomycin A producing gene cluster due to its
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relatively small number of ODEs and parameters. However, reducing the model
by two ODEs did not provide a sufficient reduction in mathematical investment
to facilitate model analysis (not shown). We plan to undertake further work in
identifying additional model reduction techniques to enable extensive mathematical
analysis of our mechanistic models. A recent study by Hancock et al. [2015] presents
a model reduction methodology that can be applied to gene regulation systems with
scalability, and provides rigorous mathematical conditions on the relevant kinetic
parameters. Reduction of a detailed gene regulation model preserves mechanistic
output for just two dependent variables, the total concentration of mRNA and the
total concentration of protein. When applied to the repressilator and toggle switch,
the reduced models replicate the expected quantitative dynamical responses. This
approach is developed in conjunction with transcriptional models of gene regula-
tion, thus presenting very different dynamical mechanisms compared to our DNA
recombination models. The proposed methodology is still applicable however, and
may enable us, in future studies, to derive the mathematical criteria required of the
desired functionality that we have identified.
Since the publication of the research presented in Chapter 3, a new model
of DNA recombination reactions has been published [Pokhilko et al., 2016]. The
model shares many similarities with our mechanistic model, being a deterministic
ODE model constructed in light of structural analyses of serine integrases [Ruther-
ford et al., 2013; van Duyne and Rutherford, 2013] that were included in our own
literature mining. However, some significant differences are also reported. The new
model is smaller dimensionally since less detail regarding DNA:protein binding is
accounted for, for example the binding of monomeric protein is ignored. That said,
greater detail regarding changes to the structural composition of the synaptic com-
plexes as recombination occurs is modelled and therefore presents additional insight
that could improve the output of our mechanistic model. The new model accounts
for the formation of integrase:RDF tetramers in solution that are able to bind to
free DNA however, we decided to exclude this mechanism from our model in light of
literature mining and the depreciation in performance exhibited by models account-
ing for the mechanism. The new model also assumes that all system interactions
are reversible, whereas we model the widely supported view that the recombination
reactions themselves are unidirectional. We carried out an investigation into the
reversibility of the excision reaction and observed a depreciation in model perfor-
mance (see Chapter 3). The new model does not acknowledge the same formation
of dysfunctional integrase dimers included in our mechanistic model. We are inter-
ested in examining the effect of these alternative mechanistic features on our model
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outputs in order to improve the predictive capabilities of our design tools.
We also want to extend the investigation of temporal logic gate circuitry in
Chapter 4 to infer the functional variations between distinct serine integrases. Our
current results suggest that the two integrases used in implementing the temporal
logic gate in vivo are not functionally identical since simultaneous induction of the
integrases did not produce the expected 50% concentration of the final system state.
Furthermore, we demonstrated that the reversal of integrase inputs caused consider-
able variation in the output of the logic gate (see Chapter 4). This suggests that our
optimal parameter sets may infer new information regarding the rate of binding in-
teractions for the two integrases, and also raises questions relating to output-specific
induction schedules regarding a whole range of orthogonal integrases. That is, we
would investigate whether our model could infer similar information for any pair of
known integrases which might then enable us to establish a lookup table of dynami-
cal outputs based on both the choice of the pair of integrase inputs, their associated
induction schedule and their roles within the system.
Having validated mechanistic models of the recombinase-based genetic switch
and temporal logic gate systems, the natural progression of this work is to consider
the functional scope of more sophisticated logic gates and higher-level computing
devices such as adders, subtracters and decoders. These devices implement multi-
ple switches and logic gates and therefore present ideal platforms for extending our
modelling investigations. We now plan to carry out an extensive modelling inves-
tigation regarding rewritable biocomputers in mammalian cells, together with our
experimental collaborators at the Wong lab, Boston University. We will develop a
2-4 decoder, a foundational circuit topology that can form the basis of many other
circuits. A 2-4 decoder takes two specific inputs and returns one of four distinct
outputs. We have demonstrated how this can be achieved by the temporal logic gate
(see Chapter 4) however, it can also be realised through standard logic functions
with increased numbers of attachment site pairs. Our experimental collaborators
have proposed two architectures for the decoder circuit design, one based on tyrosine
recombination and one based on serine recombination. Both employ three pairs of
specific attachment sites however, they employ just two distinct SSR inputs; one
recombinase specific to two of the three pairs of sites and one recombinase specific
to the remaining pair of sites. The tyrosine decoder is purely excision-based and
is referred to as a Boolean Logic and Arithmetic through DNA Excision (BLADE)
platform [Weinberg et al., 2017]. The serine decoder is purely inversion-based and
exploits the recombinase binding interactions that have formed the focus of the re-
search presented in Chapters 3 and 4. Constructing two models of the same system
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that are distinguished by their recombinase mediation mechanisms will allow us to
examine the comparative advantages and disadvantages concerning the choice of
these systems to suit various applications.
The practical implementation of the biological decoder will require a detailed
experimental analysis of serine integrase activity and specificity. Specifically, we will
characterise Bxb1, φC31, TP901-1 and TG1 integrase systems in mammalian cell
lines. We also plan to define the relationship between integrase expression level and
specificity and toxicity as well as determine potential off-target sites that can cause
harmful side effects. The design and characterisation of such inducible rewritable
memory switches for the production of biopharmaceuticals will also require an ex-
ploration of the relationship between kinetic parameters and dose response profiles
through integrated experimentation and mathematical modelling. To this end, we
will characterise the performance of a range of memory switches, for example the T
cell-stimulating factor interleukin-12 (IL-12) in CHO cells.
Since we already have validated serine integrase models that can potentially
be extended or adapted to account for a wide variety of higher-level circuitry, the
construction of a model of the serine decoder should be straightforward. However,
we have yet to examine the mechanistic properties of tyrosine recombinase-based
systems due to their comparatively limited functionality described in the literature.
Future work will involve characterisation of genetic switches and logic gates that
are mediated by tyrosine recombinases that we can then extend to tyrosine decoder
models in the same manner that we have outlined for our mechanistic serine recom-
binase models.
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